
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15251FFA8AEF6CA3051FFA000D639998.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="transneuro">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372260/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Translational Neurodegeneration">
<meta name="citation_title" content="Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease">
<meta name="citation_author" content="Michael Okafor">
<meta name="citation_author_institution" content="Laboratory of Biometals and Biological Chemistry, Institut de Chimie (UMR 7177), Université de Strasbourg-CNRS, 4 Rue Blaise Pascal, 67000 Strasbourg, France">
<meta name="citation_author_institution" content="Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, 67000 Strasbourg, France">
<meta name="citation_author" content="Peter Faller">
<meta name="citation_author_institution" content="Laboratory of Biometals and Biological Chemistry, Institut de Chimie (UMR 7177), Université de Strasbourg-CNRS, 4 Rue Blaise Pascal, 67000 Strasbourg, France">
<meta name="citation_author" content="Nicolas Vitale">
<meta name="citation_author_institution" content="Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, 67000 Strasbourg, France">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="14">
<meta name="citation_firstpage" content="42">
<meta name="citation_doi" content="10.1186/s40035-025-00504-6">
<meta name="citation_pmid" content="40847318">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372260/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372260/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372260/pdf/40035_2025_Article_504.pdf">
<meta name="description" content="Alzheimer&#x27;s disease (AD) is a complex neurodegenerative disorder characterized by progressive decline of cognitive functions, yet its underlying aetiology remains elusive. While amyloid-β (Aβ) and tau pathologies have been extensively studied, ...">
<meta name="og:title" content="Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Alzheimer&#x27;s disease (AD) is a complex neurodegenerative disorder characterized by progressive decline of cognitive functions, yet its underlying aetiology remains elusive. While amyloid-β (Aβ) and tau pathologies have been extensively studied, ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372260/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372260">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s40035-025-00504-6"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/40035_2025_Article_504.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372260%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372260/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372260/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372260/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-transneuro.png" alt="Translational Neurodegeneration logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Translational Neurodegeneration" title="Link to Translational Neurodegeneration" shape="default" href="https://translationalneurodegeneration.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Transl Neurodegener</button></div>. 2025 Aug 22;14:42. doi: <a href="https://doi.org/10.1186/s40035-025-00504-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s40035-025-00504-6</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Transl%20Neurodegener%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Transl%20Neurodegener%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Transl%20Neurodegener%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Transl%20Neurodegener%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Okafor%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Michael Okafor</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Michael Okafor</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biometals and Biological Chemistry, Institut de Chimie (UMR 7177), Université de Strasbourg-CNRS, 4 Rue Blaise Pascal, 67000 Strasbourg, France </div>
<div class="p">
<sup>2</sup>Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, 67000 Strasbourg, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Okafor%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Michael Okafor</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Faller%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Peter Faller</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Peter Faller</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biometals and Biological Chemistry, Institut de Chimie (UMR 7177), Université de Strasbourg-CNRS, 4 Rue Blaise Pascal, 67000 Strasbourg, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Faller%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Peter Faller</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vitale%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Nicolas Vitale</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Nicolas Vitale</span></h3>
<div class="p">
<sup>2</sup>Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, 67000 Strasbourg, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vitale%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nicolas Vitale</span></a>
</div>
</div>
<sup>2,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Laboratory of Biometals and Biological Chemistry, Institut de Chimie (UMR 7177), Université de Strasbourg-CNRS, 4 Rue Blaise Pascal, 67000 Strasbourg, France </div>
<div id="Aff2">
<sup>2</sup>Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, 67000 Strasbourg, France </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 4; Accepted 2025 Jul 29; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>. The Creative Commons Public Domain Dedication waiver (<a href="https://creativecommons.org/publicdomain/zero/1.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372260  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40847318/" class="usa-link">40847318</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by progressive decline of cognitive functions, yet its underlying aetiology remains elusive. While amyloid-β (Aβ) and tau pathologies have been extensively studied, emerging evidence suggests that metal and especially copper dyshomeostasis may also play a crucial role in the pathogenesis of AD. This review explores the intricate relationship between copper and AD, shedding light on the multifaceted mechanisms through which copper dysregulation contributes to neurodegeneration. We delve into the impact of copper ions on Aβ aggregation, tau phosphorylation, and oxidative stress, providing a comprehensive overview of the molecular pathways involved. Furthermore, we discuss the interplay between different brain cell types and the impact Cu dysregulation may have on them. The therapeutic implications of targeting copper dysregulation for AD treatment are also addressed, emphasizing the potential of copper-modulating agents in ameliorating cognitive decline. In summary, this review discusses copper dyshomeostasis as a central player in the intricate tapestry of AD pathology, offering new insights and avenues for therapeutic interventions.</p>
<section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Alzheimer's disease, Amyloid, Copper, Neurodegeneration, Oxidative stress</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par24">Alzheimer’s disease (AD) is the leading cause of dementia as well as the leading neurodegenerative disease at present. Although we have gained some insights into some of the underlying mechanisms of the disease through intense research effort, there is still no cure after over a hundred years of research. The first known description of AD was published by the German psychiatrist, Alois Alzheimer in 1907, with a more comprehensive description a few years later, independently by Solomon Carter Fuller and Alois Alzheimer [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>–<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. They commented on the presence of aggregates, inside and outside neurons, known today as neurofibrillary tangles (NFTs) and amyloid plaques, respectively [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. These represent the major hallmarks of AD. Amyloid plaques can vary in structure and composition, with the main two being diffuse and neuritic plaques composed primarily of Aβ. Diffuse plaques tend to be non-fibrillary, loose and can also be present in people without dementia [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Neuritic plaques on the other hand, have a dense core, constituted of Aβ surrounded by dystrophic neurites. In addition to the plaques in the brain, up to 90% of AD patients also have Aβ deposited in cortical blood vessels (cerebral amyloid angiopathy) [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>, <a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. This leads to degeneration of vascular smooth muscle and weakening of the blood-brain barrier (BBB), leading to microinfarctions and haemorrhages [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>].</p>
<p id="Par25">Despite the countless evidence of the accumulation of amyloid plaques in AD, tau load seems to show a better correlation with disease progression. Thus, the progression of AD was categorised into six Braak stages according to the spread of NFTs: stage I–II with NFTs in the entorhinal cortex and hippocampus, III–IV in the limbic lobe, amygdala and fusiform gyrus, V in the associated areas of the neo cortex, and VI in the primary sensory and motor areas [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. Physiologically, tau proteins are found at the axons of neurons where they stabilise microtubules to permit transport of cargoes. However, recent work shows that, unlike the established dogma, in adult human brain cortical neurons tau is abundant within the somatodendritic compartments compared to axons [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Tau possesses many sites for phosphorylation, and tau phosphorylation is increased in the CSF of AD patients [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. In AD, hyperphosphorylated tau is present as paired helical filaments (PHFs) and aggregates in neurons forming NFTs [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>].</p></section><section id="Sec2"><h2 class="pmc_sec_title">Amyloid precursor protein (APP), a major player?</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Different forms of AD</h3>
<p id="Par26">AD can be classified under two general families, familial (fAD) and sporadic (sAD). fAD, the familial form, also known as early-onset, is the hereditary form as it can be transferred from parents to offspring. fAD accounts for an estimated 1% of AD patients and presentation of symptoms usually occurs before the age of 65 [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. All forms are autosomal dominant with a high degree of penetrance. Mutations in genes involved in APP metabolism, such as <em>APP</em>, <em>PSEN1</em> (<em>PS1</em>) and <em>PSEN2</em> (<em>PS2</em>) have been shown to induce fAD.</p>
<p id="Par27">APP is a transmembrane protein with functions still not well defined, although it is thought to be a surface receptor and is involved in synaptic plasticity, neurite outgrowth as well as adhesion amongst others [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. Interestingly, <em>APP</em> does not seem to be a vital gene in neurodevelopment, as <em>APP</em> knockout mice do not display any physical and cognitive defects in comparison to wild-type mice [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. However, after 14 weeks of age there is abnormal reactive gliosis in the hippocampus and neocortex of these mice, accompanied by decreased locomotor activity [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. It would take the deletion of the APP family genes (<em>APP</em>, <em>APLP1</em>, <em>APLP2</em>) all together for lethality to occur. This hints at some kind of compensatory action between these genes for different functions [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>].</p>
<p id="Par28">In the secretory pathway, APP is naturally subject to two distinct metabolic processing pathways, namely the alpha and the beta pathways, with the former being the dominant and primary pathway under non-pathological conditions [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. In the beta pathway, APP is first cleaved by β-secretases (optimal activity in low pH [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]) mostly at the Asp1 residue or less frequently at Glu11, resulting in two distinct fragments (Fig. <a href="#Fig1" class="usa-link">1</a>), APPsβ and C89/C99. The latter is then cleaved in the intra-membrane region by γ-secretases to form the intracellular domain of the amyloid precursor protein (AICD) and the Aβ<sub>11-40/42</sub> or Aβ<sub>1-40/42</sub> peptide [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. BACE1, the major β-secretase in the beta pathway, is mainly found in the endosomes and the trans-Golgi network (TGN) where it preferentially generates the Aβ peptides. However, it has been shown that BACE1 can also cleave APP in the endoplasmic reticulum (ER) [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. On the other hand, the alpha pathway first involves α-secretases cleaving the intramembrane segment of Aβ to form APPsα (neurotrophic and neuroprotective properties) and C83, mainly at the plasma membrane or TGN [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. C83 is then cut by γ-secretases to form AICD and p3 fragments [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>].</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372260_40035_2025_504_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffba/12372260/6038b37cd3cd/40035_2025_504_Fig1_HTML.jpg" loading="lazy" id="MO1" height="441" width="769" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Representation of the alpha and beta metabolic pathways of APP. Dashed lines represent cleavage by secretases</p></figcaption></figure><p id="Par29">The Aβ<sub>40</sub>/Aβ<sub>42</sub> ratio from the beta pathway can be altered by mutations in genes involved in APP processing. Mutations outside the Aβ regions on APP lead to an increase in β-secretase activity, whereas mutations in the Aβ regions usually lead to local oligomer formation and changes in the interactions with proteins such as APOE and LRP1, and affect their clearance [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. It has also been shown that posttranslational modifications such as phosphorylation can change the proportions of Aβ secreted. Phosphorylation of APP at Ser655 permits retrograde transport of APP from endosomes to TGN and disfavours lysosome targeting [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. The phosphorylation at Ser655 can be carried out by GSK, protein kinase C (PKC), CaMKII (calcium–calmodulin (CaM)-dependent protein kinase II) or APP kinase 1 and dephosphorylation by PP1 and PP2 [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>–<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Conversely, phosphorylation at Thr668 occurs on immature APP in the ER and permits ER retention [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>].</p>
<p id="Par30">Nearly 90% of fAD are linked to mutations in <em>PS1</em> and <em>PS2</em>, leading to a defect in APP processing [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>, <a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. However, they are also involved in the cleavage of Notch-1, N- and E-cadherin, LRP, Syndecan, Delta, Jagged, CD44, ErbB4, and Nectin1a [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. PS1/PS2 are cleaved to form an N- and a C-terminal fragment and are the catalytic core of the γ-secretase complex along with Nicastrin, Aph-1 and Pen-2. Counterintuitively, the mutations in <em>PS</em>1/<em>PS</em>2 as seen in fAD lead to a decrease in the γ-secretase activity [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Sun et al. tested in vitro 138 mutations in the human <em>PS1</em> gene known to lead to AD and found that 90% of these mutations led to reduced production of Aβ<sub>40</sub> and Aβ<sub>42</sub> but with an overall increase in the Aβ<sub>42</sub>/Aβ<sub>40</sub> ratio [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>].</p>
<p id="Par31">In sAD, the greatest risk factor for the development of AD is age. The chance of developing AD doubles every 5 years after 65 and reaches up to 50% after 85 years of age [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. However, there is also an array of both environmental and genetic factors that lead to the development of AD. The environmental factors include socioeconomic status, smoking, diabetes, hypertension, high cholesterol levels, etc. [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Equally, there is an increasing number of gene polymorphs that are strongly associated with sAD, including <em>APOE</em>-ε4, <em>TREM2</em> and <em>PLD3</em> variants amongst others [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. The highest genetic risk factor in the development of AD is the <em>APOE</em>-ε4 variant [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. The human ApoE exists in 3 isoforms, ApoE2, ApoE3 and ApoE4, with ApoE3 being the most common [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. In mice, ApoE is expressed in glial cells under normal conditions, but during stress it is also produced by neurons [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. However, in humans, transcription of <em>APOE</em> has also been detected in neurons of the cortex and hippocampus [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. ApoE is involved in the uptake and distribution of lipids and has been shown to bind to Aβ and influence its removal from the brain [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. ApoE2 has the best lipid efflux activity in astrocytes and neurons, followed by ApoE3, then ApoE4 [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. Accordingly, impaired interaction of low-density lipoprotein receptor (LDLR) and lipidated ApoE2 prevents LDLR recycling defects observed with lipidated ApoE3/E4, and decreases the uptake of cholesteryl esters, lipids linked to neurodegeneration [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. In AD, <em>APOE</em>-ε4 carriers generally have more plaques and tangles than carriers of other isoforms, with &gt; 65% of AD patients having an <em>APOE</em>-ε4 allele [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. Presence of both alleles of <em>APOE</em>-ε4 increases the chances of AD to 91%, compared to 20% in patients with one copy of <em>APOE</em>-ε2 or <em>APOE</em>-ε3 [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>].</p>
<p id="Par32">Recently, a possible link between sAD and fAD was suggested. Hou et al. showed that ApoE has the capacity to interact with and inhibit γ-secretase activity through its C-terminal region, leading to a significant decrease of Aβ<sub>40</sub> and Aβ<sub>42</sub> production but not APPsβ (β-secretase activity) [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. The effectiveness of this inhibition inversely correlates with the risk nature of <em>APOE,</em> with ApoE2 having the most efficient inhibitory activity followed by ApoE3 and ApoE4, which has no inhibitory activity [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. Of note, <em>APOE</em>-ε2 is known to be protective against the development of AD [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>].</p>
<p id="Par33">Another important genetic risk factor is the presence of certain variants in <em>TREM2</em> gene. TREM2 is a transmembrane surface protein found on microglia that has also been shown to be important in the initial seeding phase of amyloid plaques. Previous studies have shown that TREM2 is a receptor for Aβ oligomers [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>, <a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]. Different variants of <em>TREM2</em>, p.R47H, R62H, H157Y, and D87N, are known to increase the risk of AD by 2–4 folds [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>–<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. Furthermore, the absence or loss of function of TREM2 causes a decrease in plaque phagocytosis [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>, <a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]. TREM2 acts to compact amyloid plaques, reducing the perimeter covered by the plaques and therefore likely lowering plaque-induced toxicity. Accordingly, in the absence of TREM2, amyloid plaques are more diffuse with a loose structure [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>, <a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. Interestingly <em>Trem2</em>-deficient mice display similar phenotypes compared to <em>Apoe</em>-deficient mice, bringing to light the APOE-TREM2 axis [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]. All the factors mentioned above provide support for the “amyloid hypothesis”.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Amyloid hypothesis</h3>
<p id="Par34">The amyloid hypothesis was coined by Hardy and Higgins, 1992, who proposed that AD is caused by the presence of amyloid plaques in the brain, leading to the emergence of NFTs, cell loss, vascular damage, and dementia [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]. This theory came into fruition thanks to the discovery by George Glenner and Caine Wong, where they identified Aβ as the central molecule of amyloid plaques found in AD and trisomy 21 (Down’s syndrome) [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>, <a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>].</p>
<p id="Par35">The backbone of the amyloid hypothesis lies on the observation that in AD, there is abnormal APP metabolism which results in increased Aβ peptide in the brain and the blood [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]. This alteration in APP metabolism could arise from any or a combination of the following: increased expression of APP, resulting in increased metabolites (both alpha and beta pathways); or an abnormal increase in the beta processing pathway, resulting in increased Aβ production; or simply from a defect in Aβ clearance. Previous studies have shown defects in the activity and levels of neprilysin and insulin degrading enzyme (IDE) in AD, proteases known to efficiently cleave Aβ [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>–<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. Miners et al. (2009) reported an increased activity of IDE and neprilysin in the brains of AD patients [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. This signifies that there is an upregulation in the clearance of Aβ in AD, but it might be inefficient due to the presence of Aβ in different conformations (aggregates for example). Another key factor is the clearance of Aβ by transporters from the brain. Export of Aβ from the brain is primarily attributed to low-density lipoprotein (LDL) receptor-related protein (LRP1) and has been argued to be defective in AD; however, this is still not clear [<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>]. Indeed, work suggesting that LRP1 can uptake Aβ directly or indirectly via ApoE or α2M binding [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>–<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>], remains highly controversial. Additional roles of LRP1 in APP metabolism have been established more firmly. For instance, LRP1 has been shown to compete with APP for cleavage by γ-secretase [<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>, <a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>]. LRP1 also interacts with neuronal APP via the C-terminal domain and mediates endocytosis of APP, thereby increasing the production of Aβ in neuronal cells [<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>–<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>]. Another argument in support of the amyloid hypothesis is the presence of <em>APP</em> on chromosome 21, which is thought to account for the higher incidence of AD in people with Down’s syndrome [<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>].</p>
<p id="Par36">However, an argument against the amyloid hypothesis in AD is the weak correlation between plaque accumulation and severity of disease progression. In fact, there is a higher correlation between the extent of tau pathology and AD, although the ratio between Aβ<sub>42</sub>/Aβ<sub>40</sub> is a useful CSF biomarker [<a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>–<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>]. In AD brain, there is an average of seven-fold more tau proteins compared to that in the normal brain and they are in an hyperphosphorylated state [<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>]. Tau phosphorylation is prominent at positions Ser202, Thr231, Ser235, etc. [<a href="#CR80" class="usa-link" aria-describedby="CR80">80</a>, <a href="#CR81" class="usa-link" aria-describedby="CR81">81</a>], attributed to glycogen synthase kinase 3β (GSK3β), cyclin-dependent kinase 5 (Cdk5), JNK and MARK (microtubule-associated regulatory kinase) amongst others [<a href="#CR82" class="usa-link" aria-describedby="CR82">82</a>–<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>]. These tau kinases are believed to be activated by Aβ, suggesting AD as a secondary tauopathy [<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>–<a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>].</p>
<p id="Par37">All these observations led to the revision of the amyloid hypothesis, stating that the soluble oligomeric forms are responsible for neurotoxicity in AD and that the plaques might be in fact, protective [<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>]. These Aβ oligomers can form pores in the plasma membrane, therefore breaking the ionic polarity of the cell, leading to cell death [<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>]. This goes in line with reports that in AD brains there are more soluble Aβ<sub>42</sub> monomers and oligomers than in healthy brain [<a href="#CR93" class="usa-link" aria-describedby="CR93">93</a>].</p>
<p id="Par38">Over the years, the amyloid hypothesis has become quite popular among researchers and thereafter for the pharmaceutical industry. Today, the amyloid hypothesis is the most studied among researchers and is the most frequently involved in clinical trials [<a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>]. Numerous clinical trials have been carried out based on the improvement of Aβ clearance or inhibition of Aβ production. However, most trials targeting either β- or γ-secretase have failed. Indeed, these therapies appeared quite toxic, highlighting the importance of these secretases in regulating other pathways (ex. Notch, LRP1, ApoER2, RAGE) [<a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>–<a href="#CR98" class="usa-link" aria-describedby="CR98">98</a>]. More recently, many clinical trials have been based on the use of monoclonal antibodies to clear the plaques from the brain. Some have failed, while others were able to clear Aβ plaques. However, unanticipatedly, clearing the plaques was not able to reverse the cognitive decline in these patients, nor did it improve the patients’ outcomes. An explanation is that once damages induced by Aβ plaques/oligomers have already occurred, they are irreversible. Therefore, treatment should be done before the appearance of more advanced AD phenotypes.</p>
<p id="Par39">This has led to clinical trials that enrol exclusively patients in the early stages of the disease. One of such more recent clinical trials was conducted on Aducanumab which was later fast-tracked approved by the FDA in June 2021 for use in AD patients. This drug did decrease AD biomarkers in patients; however, there was no amelioration of symptoms in the ENGAGE trial although there was a 22% decrease in cognition and function worsening in the EMERGE phase 3 trial [<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>]. However, the drug was later abandoned by Biogen [<a href="#CR100" class="usa-link" aria-describedby="CR100">100</a>, <a href="#CR101" class="usa-link" aria-describedby="CR101">101</a>]. In these and previous monoclonal antibody therapies, there have been reports of amyloid-related imaging abnormalities (ARIAs) in patients [<a href="#CR102" class="usa-link" aria-describedby="CR102">102</a>–<a href="#CR104" class="usa-link" aria-describedby="CR104">104</a>]. ARIAs are a set of observations noticed during magnetic resonance imaging scan of patients taking these monoclonal antibodies. They include oedema, effusion, microhaemorrhages and superficial siderosis [<a href="#CR104" class="usa-link" aria-describedby="CR104">104</a>, <a href="#CR105" class="usa-link" aria-describedby="CR105">105</a>]. ARIAs usually occur early in treatment, with a higher incidence in <em>APOE</em>-ε4 carriers.</p>
<p id="Par40">More recently, clinical trials using another monoclonal anti-Aβ drug, Lecanemab developed by Eisai and Biogen or Donanemab by Eli Lilly, showed decreases of cognitive and functional decline [<a href="#CR106" class="usa-link" aria-describedby="CR106">106</a>, <a href="#CR107" class="usa-link" aria-describedby="CR107">107</a>]. These clinical trials are the first of their kind that accomplished such definitive results and have given a new breath to the amyloid hypothesis. Lecanemab is believed to target Aβ oligomers (protofibrils), as compared to the Aβ plaques for other drugs, going in line with the revised amyloid hypothesis [<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>, <a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>, <a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]. Nevertheless, there have been some cases of ARIA in patients treated with Lecanemab, with oedema and effusion (ARIA-E) occurring in 9.9% and microhaemorrhages and superficial siderosis (ARIA-H) in 10.7% of patients, and Donanemab had even more incidences [<a href="#CR107" class="usa-link" aria-describedby="CR107">107</a>, <a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>]. It can be argued that these symptoms may result from progressive weakening of the brain blood vessels because of advanced cerebral amyloid angiopathy in these patients [<a href="#CR110" class="usa-link" aria-describedby="CR110">110</a>–<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>]. However, more work is clearly needed to improve safety of these approved drugs, especially at the light of recent death reports [<a href="#CR113" class="usa-link" aria-describedby="CR113">113</a>].</p>
<p id="Par41">Although these antibodies are very efficient in clearing amyloid load, linked to cognitive benefit in AD patients, their effects remain limited. This brings to light the pivotal role that other factors may play in the pathology of AD, possibly in concomitance with Aβ (Fig. <a href="#Fig2" class="usa-link">2</a>). One such factor may be the dyshomeostasis of metal ions in AD brains, which will be developed thereafter.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372260_40035_2025_504_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffba/12372260/6ed0481dece1/40035_2025_504_Fig2_HTML.jpg" loading="lazy" id="MO2" height="619" width="797" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Examples of different causative agents in AD brain. Created with BioRender.com</p></figcaption></figure></section></section><section id="Sec5"><h2 class="pmc_sec_title">Intersections between amyloid hypothesis and metal dyshomeostasis</h2>
<p id="Par42">About a third of all enzymes are metalloenzymes, which are enzymes that need metals for their activity. Most of the metalloenzymes contain d-block metals, known for their rich chemistry. The most common of these metals in the body are Zn that serves as a Lewis acid, and Fe and Cu that serve mostly as redox active cofactors for enzymes [<a href="#CR114" class="usa-link" aria-describedby="CR114">114</a>, <a href="#CR115" class="usa-link" aria-describedby="CR115">115</a>]. The metal dyshomeostasis theory states firstly that the natural localization of these transition metals in the brain is deregulated and secondly that pathological ligands such as Aβ can bind these metals, therefore catalysing and/or modulating their aggregation in the brain. In addition, Fe or Cu bound to Aβ is also able to catalyse the production of ROS (H<sub>2</sub>O<sub>2</sub>, O<sub>2</sub><sup>•−</sup> and HO<sup>•</sup>), which are toxic when present in excess [<a href="#CR116" class="usa-link" aria-describedby="CR116">116</a>, <a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>]. Overproduction of such ROS, known as oxidative stress, is seen from the early stages of AD, and leads to neuronal death.</p>
<p id="Par43">Data have shown significant levels of Zn, Fe and Cu in amyloid plaques in the amygdala of AD patients. For instance, there was a four-fold increase in Cu, and a two-fold increase in Zn and Fe with a concomitant intracellular decrease of these metals [<a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>, <a href="#CR119" class="usa-link" aria-describedby="CR119">119</a>]. Miller et al. also identified Cu and Zn in amyloid plaques, with a high correlation in hotspots in AD brain [<a href="#CR120" class="usa-link" aria-describedby="CR120">120</a>]. However, different studies reported variable findings regarding metal levels in the brains of AD patients. A meta-analysis by Schrag et al. analysing over 30 different published articles between 1990 and 2011 showed that for bulk metal concentrations in AD brains, only Cu levels were specifically decreased in neocortex (frontal, parietal, temporal and occipital lobes), whereas Fe levels were increased in the putamen [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>].</p>
<section id="Sec6"><h3 class="pmc_sec_title">Fe and Zn dysregulation in AD</h3>
<p id="Par44">Fe is required for essential cellular processes, such as myelination, DNA replication and generation of ATP in mitochondria, where it is a cofactor for complexes I, II, III and IV, and catalyses the transfer of electrons from NADH to O<sub>2</sub> and translocates protons across the inner mitochondrial membrane in eukaryotes.</p>
<p id="Par45">Among brain cells, Fe, transferrin (Fe-transporter) and ferritin (Fe-storage) are found predominantly in oligodendrocytes [<a href="#CR122" class="usa-link" aria-describedby="CR122">122</a>, <a href="#CR123" class="usa-link" aria-describedby="CR123">123</a>]. In AD, there is a switch of transferrin distribution from oligodendrocytes to microglia. Additionally, around plaques there is a diffuse extracellular localisation of transferrin [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>]. On the other hand, ferritin increase is associated more specifically with neuritic plaques and not with diffuse plaques or intracellular tangles [<a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>]. Interestingly, it has been shown that Fe can increase the alpha cleavage of APP and that this is regulated via an iron response element on APP [<a href="#CR126" class="usa-link" aria-describedby="CR126">126</a>, <a href="#CR127" class="usa-link" aria-describedby="CR127">127</a>]. Increase in Fe levels also leads to increased APP production [<a href="#CR128" class="usa-link" aria-describedby="CR128">128</a>]. Furthermore, APP is believed to provide complementary ferrireductase activity and might also be involved in Fe export by stabilising Ferroportin [<a href="#CR129" class="usa-link" aria-describedby="CR129">129</a>, <a href="#CR130" class="usa-link" aria-describedby="CR130">130</a>].</p>
<p id="Par46">Fe could be toxic in AD by both redox-mediated ROS production and ferroptosis [<a href="#CR131" class="usa-link" aria-describedby="CR131">131</a>]. Ayton et al. proposed the hypothesis that Fe acts upstream in AD to alter the processing of APP, or to accelerate the formation of plaques and NFTs [<a href="#CR132" class="usa-link" aria-describedby="CR132">132</a>]. However, only a moderate association between Fe levels in the inferior temporal lobe and the total brain NFT burden was detected.</p>
<p id="Par47">Zn is another essential biometal that is involved in several processes including DNA synthesis, neurotransmission, and immunity. There have been many studies trying to elucidate the role of Zn in AD. For instance, an increase in extracellular Zn levels in amyloid plaques in AD patients was reported, but this has not reached a consensus in the literature [<a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>, <a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>]. Nonetheless, Zn has been shown to promote the formation of amorphous, non-fibrillar Aβ aggregates [<a href="#CR133" class="usa-link" aria-describedby="CR133">133</a>–<a href="#CR135" class="usa-link" aria-describedby="CR135">135</a>]. Zn also contributes to tau pathology independently of the phosphorylation of tau, by direct binding on tau [<a href="#CR136" class="usa-link" aria-describedby="CR136">136</a>, <a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>]. Additionally, Zn transporters are found in amyloid plaques [<a href="#CR138" class="usa-link" aria-describedby="CR138">138</a>]. Studies have shown changes in the levels of different Zn transporters in AD [<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>, <a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>]. In transgenic mice expressing the human Swedish mutant APP, deletion of the gene encoding zinc transporter 3 (ZnT3) which is required for zinc transport into synaptic vesicles, leads to decreases of plaque loads and insoluble Aβ, accentuating a possible role of synaptic zinc in Aβ deposition [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>]. Conversely, there is no change in Zn levels in the CSF or the brains of AD patients, although meta-analysis data showed that serum Zn levels are significantly lower in AD patients than in healthy controls [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>, <a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>, <a href="#CR143" class="usa-link" aria-describedby="CR143">143</a>].</p></section><section id="Sec7"><h3 class="pmc_sec_title">Cu dysregulation in AD</h3>
<p id="Par48">Cu is an essential element for humans. It has been shown to have various important functions in the brain and is deregulated in several pathologies. Under physiological conditions, the level of Cu in the brain is primarily controlled by Cu transporters at the BBB. CTR1, present on the apical side of brain endothelial cells, imports Cu from the bloodstream. CTR1 heterozygote mice (CTR1<sup>+/-</sup>) have a 50% decrease in Cu content in the brain and spleen, with no changes in Cu levels in other organs, accentuating the importance of CTR1 in Cu transport into the brain [<a href="#CR144" class="usa-link" aria-describedby="CR144">144</a>]. On the other hand, ATP7A located on the basolateral membrane serves to import Cu into the brain parenchyma, whereas ATP7B, located on the apical membrane, serves to expel excess Cu from the brain (Fig. <a href="#Fig3" class="usa-link">3</a>). These three transporters are also present on cells of the choroid plexus of the blood-cerebrospinal fluid barrier (BCB) [<a href="#CR145" class="usa-link" aria-describedby="CR145">145</a>].</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372260_40035_2025_504_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffba/12372260/cd784a4d7c7d/40035_2025_504_Fig3_HTML.jpg" loading="lazy" id="MO3" height="511" width="783" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Localisation of the different Cu transporters involved in Cu importation from blood to brain. Cu is represented as a blue dot, whereas Cu carriers in the blood are green. Created with BioRender.com</p></figcaption></figure><p id="Par49">ATP7A and ATP7B are related both in structure and function with 60% homology [<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>]. Their N-terminus possess six conservative Cu-binding domains and eight transmembrane domains that form a pore for Cu passage [<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>]. Cu is delivered to ATP7A/B via Atox1 [<a href="#CR147" class="usa-link" aria-describedby="CR147">147</a>]. The binding of Cu on ATP7A/B regulates their localization in the cell, and is believed to be phosphorylation-dependent [<a href="#CR148" class="usa-link" aria-describedby="CR148">148</a>, <a href="#CR149" class="usa-link" aria-describedby="CR149">149</a>]. At low basal Cu levels, ATP7A/B are mainly found in the TGN, where they mainly serve to supply Cu to newly synthesized cuproenzymes, such as ceruloplasmin and dopamine β-hydroxylase [<a href="#CR150" class="usa-link" aria-describedby="CR150">150</a>]. ATP7B seems to be the major Cu exporter in neurons, as the level of ATP7A declines with time in the brain [<a href="#CR151" class="usa-link" aria-describedby="CR151">151</a>]. However, ATP7A has been shown to deliver Cu to extracellular superoxide dismutase 3 (SOD3) and to ceruloplasmin in macrophages during hypoxic conditions [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>, <a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>]. Similar to its localization in the BBB and BCB, ATP7A is located on the basolateral membrane of enterocytes in the intestine where it pumps Cu into vesicles and serves to secrete excess Cu into the blood [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>]. ATP7B is at the apical membrane where it can sequester Cu ions in vesicles of enterocytes and expels excess Cu into the lumen of the intestine for excretion [<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>, <a href="#CR155" class="usa-link" aria-describedby="CR155">155</a>]. In the liver, ATP7B is also important for the expulsion of excess hepatic Cu, where it translocates toward the canalicular area of hepatocytes into lysosomes, thereby pumping excess Cu into the lysosome for Cu expulsion into the bile [<a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>]. Therefore, changes in expression or function of these Cu transporters are found to have important pathophysiological repercussions.</p>
<p id="Par50">Apart from its general role in cells, such as a catalytic center in the cytochrome <em>c</em> oxidase of respiratory chain or in the antioxidant enzyme SOD1 or SOD3, Cu is also involved in more brain-specific processes such as the synthesis of neurotransmitters (dopamine and catecholamines), myelination of neurons and synaptic function [<a href="#CR150" class="usa-link" aria-describedby="CR150">150</a>, <a href="#CR157" class="usa-link" aria-describedby="CR157">157</a>, <a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>]. However, Cu is heterogeneously distributed between different brain regions with the total Cu content in human brain being approximately 5 µg/g wet brain. The brain regions containing the highest amount of Cu are the substantia nigra and locus coeruleus [<a href="#CR159" class="usa-link" aria-describedby="CR159">159</a>]. However, different cell types in these regions as well as other regions or different cellular compartments possess a heterogeneous distribution of Cu. For example, glial cells show higher Cu content than neurons. Equally, in neurons Cu is mainly located in the neck of the dendrite spines, where it seems to be necessary for the stability of the F-actin network [<a href="#CR160" class="usa-link" aria-describedby="CR160">160</a>–<a href="#CR163" class="usa-link" aria-describedby="CR163">163</a>]. Interestingly, unpublished data from our lab show that recombinant tau releases very slowly Cu(II), thus tau could act as a Cu sink in neurons. However, the binding of Cu(II) by tau might not be relevant intracellularly in physiological conditions, where most of Cu is believed to be in its reduced state. However, in lysosomes or in neuritic plaques, tau could easily act as a Cu sink. Nonetheless, it is possible that Cu could play a role in the stability of both actin and tau in the dendrites of neurons. These observations shine a light on the well-controlled levels and distribution of Cu in the brain.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Cu and Aβ as partners in crime</h3>
<p id="Par51">There are many studies elucidating the interaction between Cu and Aβ or APP in the context of AD. The most convincing link comes from the presence of two Cu-binding sites in the extracellular E2 domain of APP, that have been shown to relocalize APP and may permit increased APP metabolism [<a href="#CR164" class="usa-link" aria-describedby="CR164">164</a>, <a href="#CR165" class="usa-link" aria-describedby="CR165">165</a>]. Secondly, in APP knockout mice, there is a 40% increase in Cu levels, suggesting a possible impact of APP or its metabolites on Cu import/excretion [<a href="#CR166" class="usa-link" aria-describedby="CR166">166</a>]. Importantly, Cu binding to Aβ in vitro catalyses the production of ROS, more efficiently than Fe [<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>, <a href="#CR167" class="usa-link" aria-describedby="CR167">167</a>], which may promote neuronal death. Similarly, some in vitro data show that the binding of Cu(II) to Aβ might stabilize oligomers [<a href="#CR133" class="usa-link" aria-describedby="CR133">133</a>, <a href="#CR135" class="usa-link" aria-describedby="CR135">135</a>].</p>
<p id="Par52">Another important link between Cu and AD-linked APP metabolites is that there is a decrease in Cu levels in AD brain. Results from several groups and meta-analysis have, however, shown a general decrease in brain Cu levels in AD using various quantitative approaches [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>, <a href="#CR168" class="usa-link" aria-describedby="CR168">168</a>, <a href="#CR169" class="usa-link" aria-describedby="CR169">169</a>]. In the same line, recent studies have shown a decrease in Cu levels in the cytoplasm of brain cells, which is associated with a 25% increase of exchangeable Cu in the brain (probably extracellular) [<a href="#CR170" class="usa-link" aria-describedby="CR170">170</a>, <a href="#CR171" class="usa-link" aria-describedby="CR171">171</a>]. Along with the decrease of brain Cu levels, blood Cu and non-ceruloplasmin-bound Cu (exchangeable pool) levels appear increased [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>, <a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>, <a href="#CR172" class="usa-link" aria-describedby="CR172">172</a>, <a href="#CR173" class="usa-link" aria-describedby="CR173">173</a>]. Accordingly, there is a 3–4-fold increase in the risk of AD associated with the presence of excess Cu (exchangeable) in the blood [<a href="#CR173" class="usa-link" aria-describedby="CR173">173</a>]. A study on rabbits showed that trace amounts of Cu in the drinking water of cholesterol-fed rabbits leads to an increase in Aβ-positive neurons and plaques, as well as cognitive decline [<a href="#CR174" class="usa-link" aria-describedby="CR174">174</a>]. It has thus been proposed to group AD patients according to the levels of Cu in the exchangeable pool, with normal-Cu AD having exchangeable Cu ≤ 1.6 µmol/L and CuAD &gt; 1.6 µmol/L (normal range maximum is at 1.6 µmol/L) [<a href="#CR173" class="usa-link" aria-describedby="CR173">173</a>]. Importantly, although there is no apparent difference between the two groups in terms of disease progression and severity, CuAD patients performed worse on neuropsychological tests such as MMSE than normal-Cu AD [<a href="#CR173" class="usa-link" aria-describedby="CR173">173</a>]. Interestingly, variants of <em>ATP7B</em> have been linked to CuAD [<a href="#CR173" class="usa-link" aria-describedby="CR173">173</a>], with the ATP7B<sup>K832R</sup> (rs1061472) confirmed to have almost no Cu exporting activity [<a href="#CR175" class="usa-link" aria-describedby="CR175">175</a>, <a href="#CR176" class="usa-link" aria-describedby="CR176">176</a>]. This is similar to Wilson disease where there is a loss of function of ceruloplasmin and ATP7B. In <em>ATP7B</em> variants, there might be an increase in exchangeable Cu pool due to the lack of excess Cu export to the bile from the liver as seen in Wilson disease [<a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>, <a href="#CR177" class="usa-link" aria-describedby="CR177">177</a>–<a href="#CR179" class="usa-link" aria-describedby="CR179">179</a>]. Although there is no change in Cu CSF levels in AD, there is a lower percentage of holo-ceruloplasmin (active form) in the CSF but no change in ceruloplasmin level or activity, similarly to what is seen in patient with Down syndrome [<a href="#CR172" class="usa-link" aria-describedby="CR172">172</a>, <a href="#CR180" class="usa-link" aria-describedby="CR180">180</a>–<a href="#CR182" class="usa-link" aria-describedby="CR182">182</a>]. However, the lower percentage of holo-ceruloplasmin in the CSF is puzzling since this is not the case in the blood, although CSF ceruloplasmin is produced by the cells of the choroid plexus [<a href="#CR183" class="usa-link" aria-describedby="CR183">183</a>]. In conclusion, a shift from intracellular to extracellular brain pools of Cu might be an important aspect of the disease that has been overlooked so far.</p></section></section><section id="Sec9"><h2 class="pmc_sec_title">Cu and Aβ: in vitro chemical studies</h2>
<p id="Par53">As highlighted in this review, Cu seems to be implicated in the toxicity observed in AD. A significant part of this is believed to come from the accumulation of Cu in amyloid plaques and from the ability of Cu(I) and Cu(II) to interact with Aβ at relatively high affinities (Log K<sub>7.4</sub> ≈ 10<sup>9–10</sup>) and with similar or slightly higher affinity in the aggregated state [<a href="#CR184" class="usa-link" aria-describedby="CR184">184</a>–<a href="#CR188" class="usa-link" aria-describedby="CR188">188</a>]. Cu(I)-Aβ is bound mainly in a digonal coordination predominantly to His13 and His14, whereas Cu(II)-Aβ exists in a square planar geometry in an equilibrium between two components at pH 7.4 (Fig. <a href="#Fig4" class="usa-link">4</a>). Component I is coordinated by N-terminal amine, the carboxyl of the first amide bond, the imidazole of His6 and an imidazole of His13/14 [<a href="#CR189" class="usa-link" aria-describedby="CR189">189</a>]. Component II is coordinated by the N-terminal amine, the first amide, a carboxyl from the Ala2-Glu3 amide bond and an imidazole [<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>, <a href="#CR189" class="usa-link" aria-describedby="CR189">189</a>, <a href="#CR190" class="usa-link" aria-describedby="CR190">190</a>].</p>
<figure class="fig xbox font-sm" id="Fig4"><h3 class="obj_head">Fig. 4.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372260_40035_2025_504_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffba/12372260/081fbe39e639/40035_2025_504_Fig4_HTML.jpg" loading="lazy" id="MO4" height="552" width="783" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Coordination spheres of Aβ in the presence of Cu(II) (above) and Cu(I) (below). Cu(II) coordination mode consists of components I and II, while Cu(I) has a preference for the His13 and His14 linear geometry. </p>
<p>Adapted from Cheignon et al. 2017 [<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>]</p></figcaption></figure><p id="Par54">Under aerobic conditions and in the presence of reductants such as ascorbate (AscH<sup>−</sup>), or even dopamine [<a href="#CR191" class="usa-link" aria-describedby="CR191">191</a>], Aβ can cycle Cu between Cu(II) and Cu(I), thereby producing ROS (as in Fig. <a href="#Fig5" class="usa-link">5</a>). Amongst the transition metals available in the body, Cu generates ROS most effectively since both redox states bind Aβ. However, given that the two redox states prefer different coordination geometries for Aβ binding, it was postulated that the redox reaction occurs in a pre-organized state, where Aβ can bind both redox states to permit electron transfer during the reduction or oxidation of Cu on Aβ. This pre-organized state was termed the “in-between state” and is different from the main states shown in Fig. <a href="#Fig4" class="usa-link">4</a>. This “in-between” state is believed to represent 0.1% of the main states and has a fast exchange with the main states. Recently, a new approach including partial thermal relaxation was reported with the aim to trap such a state and characterize it by X-ray absorption spectroscopy [<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>, <a href="#CR192" class="usa-link" aria-describedby="CR192">192</a>]. Before that, approaches to characterizing this in-between state consisted of theoretical calculation or indirect methods.</p>
<figure class="fig xbox font-sm" id="Fig5"><h3 class="obj_head">Fig. 5.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372260_40035_2025_504_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffba/12372260/88731fc3255a/40035_2025_504_Fig5_HTML.jpg" loading="lazy" id="MO5" height="242" width="797" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Cycling of Cu(I)/Cu(II) by ascorbate (AscH<sup>−</sup>) to catalyse the production of ROS</p></figcaption></figure><p id="Par55">Based on the idea that the highest level of oxidation damage to Aβ is expected to be on the ligands coordinating Cu(I)/Cu(II) in the in-between state (involved in ROS production), the in-between state was predicted to coordinate Cu(I)/Cu(II) with the amine and carboxylate of Asp1, and with the imidazole of His13/14 [<a href="#CR193" class="usa-link" aria-describedby="CR193">193</a>, <a href="#CR194" class="usa-link" aria-describedby="CR194">194</a>]. Phe19/20 and Met35 are also highly oxidized during ROS production, but another amino acid that has been reported to be oxidized is Tyr10, which is responsible for the formation of the degradation-resistant tyrosine bridges in Aβ and thus favours the formation of oligomers [<a href="#CR195" class="usa-link" aria-describedby="CR195">195</a>]. Cu(II) binding to two Aβ peptides could also facilitate the formation of aggregates and/or β-sheet fibril [<a href="#CR188" class="usa-link" aria-describedby="CR188">188</a>]. Interestingly, Cu(II) has been shown to promote the formation of Aβ<sub>42</sub> protofibrils in both wild-type and fAD as well as the dissolution of mature fibres into protofibrils/oligomers, thus accentuating membrane toxicity [<a href="#CR196" class="usa-link" aria-describedby="CR196">196</a>, <a href="#CR197" class="usa-link" aria-describedby="CR197">197</a>]. It was suggested that substochiometric Cu(II) in mixture with Aβ provides the most oligomer formation [<a href="#CR198" class="usa-link" aria-describedby="CR198">198</a>]. However, the bridging role of Cu(II) between two Aβ molecules remain unclear as it was suggested to be an off-path in the aggregation process [<a href="#CR199" class="usa-link" aria-describedby="CR199">199</a>].</p>
<p id="Par56">Truncated or pyroglutamate form of Aβ such as Aβ<sub>4-40/42</sub>, Aβ<sub>11-40/42</sub>, pAβ<sub>3-40/42</sub> and pAβ<sub>11-40/42</sub> have also been found in vivo in plaques [<a href="#CR200" class="usa-link" aria-describedby="CR200">200</a>, <a href="#CR201" class="usa-link" aria-describedby="CR201">201</a>]. Aβ<sub>11-40/42</sub> accounts for around 20% of the plaque load in the brains of AD patients and accelerates the formation of fibrils by the full Aβ<sub>1-40/42</sub> in vitro [<a href="#CR201" class="usa-link" aria-describedby="CR201">201</a>, <a href="#CR202" class="usa-link" aria-describedby="CR202">202</a>]. These N-truncated species containing an ATCUN (amino-terminal Cu/Ni binding) domain (Aβ<sub>4-40/42</sub> and Aβ<sub>11-40/42</sub>) have an extremely rapid rate of Cu binding [<a href="#CR203" class="usa-link" aria-describedby="CR203">203</a>–<a href="#CR205" class="usa-link" aria-describedby="CR205">205</a>]. They also bind Cu(II) with a higher affinity than Aβ<sub>1-40/42</sub> (Log K<sub>7.4</sub> ≈ 10<sup>14</sup>) and a high Cu(II) specificity over other metal ions (including Cu(I)). This renders the Cu(II) bound to Aβ<sub>4-40/42</sub> and Aβ<sub>11-40/42</sub> quasi redox inert with very low ROS production [<a href="#CR204" class="usa-link" aria-describedby="CR204">204</a>]. Therefore, under normal conditions, Cu should not be present on full-length Aβ peptides, except in pathological states for example in amyloid plaques where Cu is highly concentrated [<a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>–<a href="#CR120" class="usa-link" aria-describedby="CR120">120</a>]. This is supported by the finding that only Aβ<sub>4-40/42</sub> and Aβ<sub>11-40/42</sub> are bound to Cu(II) in the CSF of healthy, MCI or AD patients [<a href="#CR206" class="usa-link" aria-describedby="CR206">206</a>]. More detailed literature on the chemical interaction between Cu and Aβ has been reviewed in [<a href="#CR187" class="usa-link" aria-describedby="CR187">187</a>, <a href="#CR188" class="usa-link" aria-describedby="CR188">188</a>, <a href="#CR207" class="usa-link" aria-describedby="CR207">207</a>, <a href="#CR208" class="usa-link" aria-describedby="CR208">208</a>].</p>
<p id="Par57">All these Aβ species might play complementary roles in the toxicity seen in AD. It is therefore important to rationalise their function and understand how they affect different cells in the brains of AD patients. Towards this aim, interactions of Cu ions with these forms have been studied [<a href="#CR207" class="usa-link" aria-describedby="CR207">207</a>].</p></section><section id="Sec10"><h2 class="pmc_sec_title">Link between the amyloid pathology and Cu dyshomeostasis in cells of the central nervous system (CNS)</h2>
<p id="Par58">The brain is comprised primarily of neurons (excitatory or inhibitory) as well as glial cells including astrocytes, microglia and oligodendrocytes. Their intricate proportion and localization are the basis for the spatial arrangement and function of the brain. Pelvig and colleagues report a glial population consisting of 76%–75% oligodendrocytes, 17%–20% astrocytes and 5%–7% microglia in the human cerebral cortex [<a href="#CR209" class="usa-link" aria-describedby="CR209">209</a>]. These characteristics are specific to each brain structure and are minutely monitored during neural development. Deregulations during development lead to an array of neurodevelopmental diseases.</p>
<p id="Par59">In AD pathology, there is a loss of normal brain functions that arise from the loss of neurons, as well as the “over-activation” of astrocytes and microglial cells. All these alterations reduce brain plasticity, a characteristic of neurodegenerative diseases [<a href="#CR210" class="usa-link" aria-describedby="CR210">210</a>–<a href="#CR214" class="usa-link" aria-describedby="CR214">214</a>]. Therefore, it is of importance to evaluate the role each cell type plays in the development and exacerbation of AD and if or how Aβ and Cu catalyse the progression of the disease.</p>
<section id="Sec11"><h3 class="pmc_sec_title">Neurons: a major victim of Aβ and Cu?</h3>
<p id="Par60">Although glial cells outnumber neurons in the human brain, neurons are regarded as the central cell population that encodes and perpetuates transmission of signals between different regions. Nonetheless, glia cells play a critical supporting role [<a href="#CR215" class="usa-link" aria-describedby="CR215">215</a>]. In AD, cortical regions are the first regions where amyloid deposits are detectable, before they appear in the hippocampus, where the CA1 is the first region affected [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. In these regions, neurons are the central cells affected and are regarded as the source of the pathology [<a href="#CR216" class="usa-link" aria-describedby="CR216">216</a>, <a href="#CR217" class="usa-link" aria-describedby="CR217">217</a>]. However, there is an initial massive neuronal loss in other regions such as the cholinergic innervation of Meynert’s cells to the cortex or cells in the locus coeruleus [<a href="#CR218" class="usa-link" aria-describedby="CR218">218</a>–<a href="#CR220" class="usa-link" aria-describedby="CR220">220</a>]. Some other regions are not as much affected by the pathology, with very little cell death detected, for instance in the cerebellum [<a href="#CR216" class="usa-link" aria-describedby="CR216">216</a>]. However, the structures affected can be paralleled with increased presence of neuritic plaques and tau pathology. Understanding the causes of this specific neuronal vulnerability undoubtedly represents one of the greatest challenges to better understand the development of AD.</p>
<p id="Par61">Another hallmark of AD is the presence of granulovacuolar degenerations seen in pyramidal neurons. However, these are also seen in healthy aged brains but at a much lesser extent. In AD, granulovacuolar degeneration seems to arise in the hippocampus and spreads to other structures of the temporal lobe [<a href="#CR221" class="usa-link" aria-describedby="CR221">221</a>]. It was shown that although granulovacuolar degeneration is associated with and proceeds cytosolic tau aggregates, they are independent of tau [<a href="#CR222" class="usa-link" aria-describedby="CR222">222</a>]. Of importance, granulovacuolar degeneration correlates with NFT and Aβ stages [<a href="#CR221" class="usa-link" aria-describedby="CR221">221</a>]. This could signify that these granulovacuoles are formed due to the presence of intracellular aggregates (tau, Aβ, or others), therefore inducing an autophagic response that is ultimately defective in AD.</p>
<p id="Par62">Among the d-block metals, only Cu has been shown to be significantly reduced in the brains of AD patients, with neocortical regions being the most affected [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>, <a href="#CR223" class="usa-link" aria-describedby="CR223">223</a>]. The interaction between Cu and Aβ, and how they aggravate AD phenotypes, are not clear and obvious. However, there seems to be a link of Cu decrease in neocortical regions with cell atrophy, as well as with neuritic plaques and tau pathology [<a href="#CR224" class="usa-link" aria-describedby="CR224">224</a>]. Despite the general decrease of Cu levels, there seems to be concomitantly an increase of labile Cu in AD brains [<a href="#CR170" class="usa-link" aria-describedby="CR170">170</a>, <a href="#CR171" class="usa-link" aria-describedby="CR171">171</a>]. This labile Cu could be partially bound to Aβ and cycle between its redox states, thereby producing ROS. Some ROS produced could attack cell membranes in proximity, leading to lipid and protein oxidation, whereas some ROS (ex: H<sub>2</sub>O<sub>2</sub>) could also cross the plasma membrane and attack intracellular structures.</p>
<p id="Par63">The decrease in intraneuronal Cu could also lead to dysfunction of Cu-dependent functions, such as defect in cytochrome <em>c</em> oxidase leading to mitochondria dysfunction as seen in AD [<a href="#CR225" class="usa-link" aria-describedby="CR225">225</a>]. Cu homeostasis also seems to be important for the normal functioning of V-ATPase or F-ATPase, with defect in these ATPases activity leading to reduced synaptic vesicles and lysosome acidification, potentially altering processes such as neurosecretion, autophagy or mitochondrial energy production [<a href="#CR226" class="usa-link" aria-describedby="CR226">226</a>, <a href="#CR227" class="usa-link" aria-describedby="CR227">227</a>]. It is also possible that the intraneuronal Cu deficiency leads to a decrease in catalytically active Cu/Zn-SOD, thereby hampering the ability of these neurons to deal with ROS produced from Aβ-Cu cycling.</p>
<p id="Par64">Long-term potentiation (LTP), important for learning and memory, is clearly impaired in AD [<a href="#CR228" class="usa-link" aria-describedby="CR228">228</a>]. Interestingly, Aβ oligomers have been shown to inhibit hippocampal LTP in animal models [<a href="#CR229" class="usa-link" aria-describedby="CR229">229</a>, <a href="#CR230" class="usa-link" aria-describedby="CR230">230</a>]. These oligomers can arise from Cu binding outside or inside of cells, in the presence of lower levels of Cu chaperones/binding-proteins or peptides (GSH, cysteine or metallothioneins). In vitro experiments have shown that metallothionein and GSH outcompete Aβ in Cu-binding [<a href="#CR231" class="usa-link" aria-describedby="CR231">231</a>, <a href="#CR232" class="usa-link" aria-describedby="CR232">232</a>]. Remarkably, it has been shown that there is a significant decrease in GSH levels and other antioxidants in the frontal cortex and hippocampus of AD patients [<a href="#CR233" class="usa-link" aria-describedby="CR233">233</a>]. These conditions might pave the road for Aβ to “stably” bind Cu intracellularly. This model is supported by the fact that Cu facilitates the formation of oligomers and that oligomers seem to be predominantly generated intracellularly [<a href="#CR234" class="usa-link" aria-describedby="CR234">234</a>]. </p>
<p id="Par65">In normal conditions, Aβ<sub>40</sub> is proposed to be formed mostly in the TGN, while Aβ<sub>42</sub> forms both in the ER and in the Golgi compartments [<a href="#CR235" class="usa-link" aria-describedby="CR235">235</a>, <a href="#CR236" class="usa-link" aria-describedby="CR236">236</a>]. Strikingly, in AD there is a decrease in the Aβ<sub>40</sub>/Aβ<sub>42</sub> ratio, due to an increased production of Aβ<sub>42</sub> [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. In line with this, accumulation of Aβ<sub>42</sub> inside human hippocampal and cortical neurons has been reported, although the exact location of this accumulation has not been elucidated [<a href="#CR237" class="usa-link" aria-describedby="CR237">237</a>]. Therefore, in the advent of an intracellular Cu dyshomeostasis in AD, it seems possible that the change in Aβ<sub>40</sub>/Aβ<sub>42</sub> ratio could be related to an increased Cu level in the Golgi apparatus or the ER. BACE1, found in the Golgi apparatus or ER, has been shown to bind Cu through the Cu chaperone for SOD, copper chaperone for superoxide dismutase (CCS) [<a href="#CR238" class="usa-link" aria-describedby="CR238">238</a>]. This might lead to increased BACE1 expression as seen in chronically Cu-fed 3 × Tg-AD mice [<a href="#CR239" class="usa-link" aria-describedby="CR239">239</a>]. There could also be higher Cu levels in these compartments, thereby leading to Cu-Aβ association and formation of stable oligomers in an oxidative environment. It was equally shown that overexpression of BACE1 causes a reduction in SOD1 activity due to the competition with CCS, which was reversed by overexpression of CCS [<a href="#CR238" class="usa-link" aria-describedby="CR238">238</a>]. This could in part hamper the cell ability to get rid of ROS, therefore favouring the development of the pathology. Interestingly, apart from the increased expression of APP and its metabolites induced by high Cu levels, there is also an induced phosphorylation of APP at Thr668 by GSK3β, leading to axonal transport of APP [<a href="#CR240" class="usa-link" aria-describedby="CR240">240</a>, <a href="#CR241" class="usa-link" aria-describedby="CR241">241</a>]. These vesicles seem to colocalise with ATP7A both in the presence and in the absence of Cu [<a href="#CR240" class="usa-link" aria-describedby="CR240">240</a>], implying that they are compartments loaded with Cu (probably parts of ER and Golgi apparatus).</p>
<p id="Par66">Wirths et al. proposed in 2004 that intracellular accumulation of Aβ is a leading cause of cell death in AD [<a href="#CR242" class="usa-link" aria-describedby="CR242">242</a>]. This might be due to the intracellular accumulation of Aβ facilitating the phosphorylation of tau, hence the disruption of mitochondrial function and cell toxicity [<a href="#CR243" class="usa-link" aria-describedby="CR243">243</a>]. This goes in line with the observation that neuropils threads (PHFs) and NFTs precede neuritic plaques [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. However, it has equally be shown that neurons attempt to re-enter cell cycle before manifestation of pathological hallmarks, tau and amyloid burden [<a href="#CR244" class="usa-link" aria-describedby="CR244">244</a>, <a href="#CR245" class="usa-link" aria-describedby="CR245">245</a>]. Altogether, this strongly suggests that intracellular Aβ oligomers are also toxic on their own.</p>
<p id="Par67">Nonetheless, after a certain threshold, neurons excrete the intracellularly accumulated Aβ, which can thus bind extracellular labile Cu. Regardless of their Cu-binding state, these oligomers have been shown to bind the cellular prion protein PrPc [<a href="#CR246" class="usa-link" aria-describedby="CR246">246</a>–<a href="#CR248" class="usa-link" aria-describedby="CR248">248</a>]. This binding alters the functions of PrPc, one of which is the Cu-dependent degradation of NMDA receptor (NMDAR) via <em>S</em>-nitrosylation [<a href="#CR249" class="usa-link" aria-describedby="CR249">249</a>]. Post-synaptic NMDAR activation leads to the ATP7A-dependent export of Cu into the synaptic cleft, which decreases NMDAR activity and protects cells from excitotoxicity [<a href="#CR250" class="usa-link" aria-describedby="CR250">250</a>]. Aβ oligomers can also directly provoke NMDAR-induced toxicity, by binding to NMDAR or binding to Cu. In the absence of Cu-induced NMDAR inhibition, there is an increase in intraneuronal calcium levels (excitotoxicity). These factors have been shown to lead to phosphorylation of tau through Fyn or Cdk5 (Fig. <a href="#Fig6" class="usa-link">6</a>) [<a href="#CR251" class="usa-link" aria-describedby="CR251">251</a>, <a href="#CR252" class="usa-link" aria-describedby="CR252">252</a>]. Equally, an increased level of intraneuronal calcium can lead to nitric oxide (<sup>•</sup>NO) production by nitric oxide synthase (NOS), resulting in peroxynitrite (ONOO<sup>−</sup>) in the presence of superoxide anion (O<sub>2</sub><sup>•−</sup>), that can attack lipids and proteins [<a href="#CR253" class="usa-link" aria-describedby="CR253">253</a>]. In AD, there is indeed an aberrant expression of iNOS, eNOS and nNOS [<a href="#CR254" class="usa-link" aria-describedby="CR254">254</a>]. This aberrant expression may be due to brain hypofusion (i.e., reduced amount of blood flow) [<a href="#CR255" class="usa-link" aria-describedby="CR255">255</a>]. The hypofusion seen in AD could arise from structural abnormalities of the cerebral vasculature, for example, vasoconstriction in most areas and aberrant vasodilation (diverting blood from where it is needed), thereby restricting nutrients in parts of the brain [<a href="#CR256" class="usa-link" aria-describedby="CR256">256</a>].</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372260_40035_2025_504_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffba/12372260/58b23a01192c/40035_2025_504_Fig6_HTML.jpg" loading="lazy" id="MO6" height="486" width="784" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Link between Cu dyshomeostasis and AD pathology in neurons and microglia. (1) Secreted Cu from neurons is sequestered by extracellular ligands (ex: Aβ), competing with PrPc-induced <em>S</em>-nitrosylation of NMDAR, thereby promoting calcium influx. (2) Imported calcium causes increased phosphorylation of tau and increased excitotoxicity. (3) The reduced intake of Cu into neurons, induced by sequestration of Cu by Aβ, leads to less available Cu for cupro-proteins (ex: SOD, COX4), therefore lessening defence against ROS and mitochondrial dysfunction. (4) Microglia can ingest Aβ with Cu, which increases cell Cu levels. (5) This increased microglial level of Cu promotes activation of microglia through IFN-γ, exacerbating DAM profile</p></figcaption></figure><p id="Par68">All the possibilities discussed above may lead to aberrant functioning of neuronal cells and could on their own lead to cell death or at least alter LTP as seen in AD. This would reduce connection between synapses that can also indirectly lead to neuronal death.</p></section><section id="Sec12"><h3 class="pmc_sec_title">Microglia: the main effector of neurotoxicity?</h3>
<p id="Par69">White blood (leukocytes) cells such as neutrophils, monocytes, eosinophils, basophils and lymphocytes, play a vital role in the defence of the body from non-self-antigens as well as taking care of cell debris or mutated cells [<a href="#CR257" class="usa-link" aria-describedby="CR257">257</a>]. Given that the brain is well protected from the circulatory system by the BBB, a semi-permeable membrane, colonization of the brain by peripheral white blood cells is limited under normal conditions. The brain possesses a small array of immune cells that are quite similar to monocytes (precursor of macrophages), with different localizations such as meninges, choroid plexus, and perivascular spaces, where they play a barrier function [<a href="#CR258" class="usa-link" aria-describedby="CR258">258</a>].</p>
<p id="Par70">The major type of brain immune cells are microglial cells, which account for 5%–7% of glial cells, and are found in the parenchyma of the brain where they serve as sentinels. They are derived from the yolk sac and invade the CNS prior to vasculogenesis [<a href="#CR259" class="usa-link" aria-describedby="CR259">259</a>]. During development they are involved in synaptogenesis and dendritic pruning of immature synapses as well as phagocytosis of cell debris [<a href="#CR260" class="usa-link" aria-describedby="CR260">260</a>, <a href="#CR261" class="usa-link" aria-describedby="CR261">261</a>]. Under normal conditions in the adult brain, these cells patrol the brain within a few hours with extremely motile processes and protrusions surveying normal brain function [<a href="#CR262" class="usa-link" aria-describedby="CR262">262</a>]. However, during microglial cell activation, the cells change phenotypes to a more pro-inflammatory signature, termed ‘M1’ as for macrophages. The M1 signature is activated by interferon γ, leading to expression of pro-inflammatory cytokines such as TNF‐α, interleukin (IL)‐1β, and IL‐12 (Fig. <a href="#Fig6" class="usa-link">6</a>) and production of <sup>•</sup>NO and ROS, as well as increased expression of lysosomal proteins involved in degradation [<a href="#CR263" class="usa-link" aria-describedby="CR263">263</a>]. In the advent of clearance of the pathogen, microglial cells switch to the M2 signature that involves the production of anti-inflammatory signals IL-4, IL-10, IL-13 and TGF‐β. This is followed up by an upregulation of tissue repair mechanisms such as synthesis of collagen, arginase‐1, Ym1/2 and polyamines [<a href="#CR264" class="usa-link" aria-describedby="CR264">264</a>, <a href="#CR265" class="usa-link" aria-describedby="CR265">265</a>]. However, more recently, there have been observations of different microglial signatures arising from different stimuli of microglial activation, questioning the existence of the M1/M2 activation signatures [<a href="#CR266" class="usa-link" aria-describedby="CR266">266</a>]. This has brought up the notion of a subset of microglia termed disease-associated microglia (DAM) as a general immunological signature for neurodegenerative diseases [<a href="#CR267" class="usa-link" aria-describedby="CR267">267</a>, <a href="#CR268" class="usa-link" aria-describedby="CR268">268</a>].</p>
<p id="Par71">In AD, the role of microglia is still under question. Some research proposed that their role is disease-stage dependent, being neuroprotective in early stages and neurotoxic in the later stages [<a href="#CR269" class="usa-link" aria-describedby="CR269">269</a>, <a href="#CR270" class="usa-link" aria-describedby="CR270">270</a>]. However, DAM microglia are found surrounding amyloid plaques in AD brains and TgCRND8 mice, and a higher level of ATP7A has been found in microglia but not in neurons or astrocytes [<a href="#CR271" class="usa-link" aria-describedby="CR271">271</a>]. In BV-2 cells, IFN-γ was shown to be responsible for this, leading to the relocalisation of ATP7A from the TGN to vesicular structures and to an increase in <em>CTR1</em> mRNA levels, leading to Cu accumulation [<a href="#CR271" class="usa-link" aria-describedby="CR271">271</a>]. IFN-γ activation is Cu-dependent in this case since Cu chelation reduces ATP7A relocalisation [<a href="#CR271" class="usa-link" aria-describedby="CR271">271</a>]. It has equally been shown that Aβ and IFN-γ together promote the activation of microglia, associated with the production of <sup>•</sup>NO and TNF-α [<a href="#CR272" class="usa-link" aria-describedby="CR272">272</a>]. This was confirmed in the plasma of AD patients, suggesting that IFN-γ precedes <sup>•</sup>NO and TNF-α production [<a href="#CR273" class="usa-link" aria-describedby="CR273">273</a>].</p>
<p id="Par72">Interestingly, subtoxic levels of Cu have also been shown to induce microglial activation and the release of <sup>•</sup>NO and TNF-α via an NF-κb-dependent pathway in murine microglial BV-2 cell line. However, N-acetyl-cysteine (ROS scavenger) was able to prevent this activation [<a href="#CR274" class="usa-link" aria-describedby="CR274">274</a>]. In AD, there is an increase of labile extracellular Cu in the brain and studies have shown that Cu chelation by tetrathiomolybdate decreases expression of IL-1α, IL-6, IL-8 and NF-κB [<a href="#CR275" class="usa-link" aria-describedby="CR275">275</a>, <a href="#CR276" class="usa-link" aria-describedby="CR276">276</a>]. The increase in labile Cu in AD brain might come from neurons that export Cu through ATP7A, possibly during the activation of NMDAR [<a href="#CR250" class="usa-link" aria-describedby="CR250">250</a>, <a href="#CR277" class="usa-link" aria-describedby="CR277">277</a>, <a href="#CR278" class="usa-link" aria-describedby="CR278">278</a>]. Bagheri et al. proposed that the low level of Cu seen in neurons in AD could be also due to excessive uptake by microglia during their activation [<a href="#CR278" class="usa-link" aria-describedby="CR278">278</a>]. Another idea could be that the lower levels of antioxidants in AD hamper the uptake of Cu from the bloodstream, explaining the generalized lower levels of Cu in the brain. This is supported by the fact that lower levels of GSH prevent Cu internalisation [<a href="#CR279" class="usa-link" aria-describedby="CR279">279</a>].</p>
<p id="Par73">TREM2, a transmembrane surface protein found on microglia, is also important in the initial seeding phase of amyloid plaques, with studies showing its ability to bind Aβ oligomers (possibly stabilised by Cu). The absence or loss of function of TREM2 causes a decrease in Aβ phagocytosis and degradation [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>, <a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>, <a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]. TREM2 may thus help compact amyloid plaques, thereby reducing their perimeter and toxicity [<a href="#CR280" class="usa-link" aria-describedby="CR280">280</a>]. Accordingly, in the absence of TREM2, plaques are more diffuse with a loose plaque structure, associated with the absence of increased IL-6 and MIP-1α levels [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>, <a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>, <a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>].</p>
<p id="Par74">Lastly, Cu activates microglial inflammasome, leading to secretion of pro-inflammatory factors (IL-1β, TNF-α) and apoptosis-associated speck (ASC), which are suspected to play an important role in the early stages of AD [<a href="#CR281" class="usa-link" aria-describedby="CR281">281</a>, <a href="#CR282" class="usa-link" aria-describedby="CR282">282</a>]. ASC favours seeding of Aβ, as ASC specks are found in the core of plaques and accelerate oligomer formation and possibly the spreading of amyloid pathology [<a href="#CR283" class="usa-link" aria-describedby="CR283">283</a>].</p></section><section id="Sec13"><h3 class="pmc_sec_title">Astrocytes: a secondary effector for neurotoxicity?</h3>
<p id="Par75">Astrocytes are star-shaped glial cells present in the brain and originate from neuroepithelium-derived radial glia, which are universal neural progenitor cells, by direct transformation or by the generation of intermediate progenitors [<a href="#CR284" class="usa-link" aria-describedby="CR284">284</a>–<a href="#CR286" class="usa-link" aria-describedby="CR286">286</a>]. Astrocytes are very important in the spatial temporal functioning of the brain as they control ionic homeostasis, synthesis and clearance of neurotransmitters, plasticity, formation and maturation of synapses as well as elimination of unnecessary synapses [<a href="#CR287" class="usa-link" aria-describedby="CR287">287</a>–<a href="#CR291" class="usa-link" aria-describedby="CR291">291</a>]. They form a network between themselves via gap junctions and in response to synaptic activity, they can release gliotransmitters which can act on neurons (synaptic plasticity) and vascular smooth muscle tone (blood flow) [<a href="#CR292" class="usa-link" aria-describedby="CR292">292</a>].</p>
<p id="Par76">Astrocytes exist in both grey and white matter, known as protoplasmic and fibrous astrocytes, respectively. The latter send out long processes that contact axons at the node de Ranvier and contact the blood vessels, hence forming the end feet [<a href="#CR293" class="usa-link" aria-describedby="CR293">293</a>]. On the other hand, protoplasmic astrocytes make contacts between pre- and post-synaptic neurons, forming the tripartite synapse, and also make contacts with brain capillaries. Unlike fibrous astrocytes, protoplasmic astrocytes arrange themselves in domains, with a certain degree of minimized overlap, giving rise to various morphological shapes of astrocytes [<a href="#CR294" class="usa-link" aria-describedby="CR294">294</a>]. It is of note that human astrocytes are quite different from rodent’s, therefore animal models will not encompass all the characteristics of human astrocytes in disease models. Some of these features include the facts that human protoplasmic astrocytes are 2.6 times larger in diameter and propagate calcium waves fourfold faster than those from mice [<a href="#CR295" class="usa-link" aria-describedby="CR295">295</a>]. Additionally, in primates, there are two additional types of astrocytes, interlaminar and varicose-projection astrocytes, in the cortex [<a href="#CR295" class="usa-link" aria-describedby="CR295">295</a>]. However, in both AD mouse models and human patients, there is an atrophy of astroglia (both of cell volume and of processes), accompanied by reactive astrocytes characterised by increased volume and an increase in glial fibrillary acidic protein (GFAP) expression [<a href="#CR296" class="usa-link" aria-describedby="CR296">296</a>, <a href="#CR297" class="usa-link" aria-describedby="CR297">297</a>].</p>
<p id="Par77">GFAP is a type III intermediate filament protein that is a known marker for astrocytes. The expression of GFAP has been shown to increase in pathological conditions including at the late stage of AD in transgenic mouse models as well as in AD postmortem tissues. However, GFAP also increases with age, and it has been shown to be sensitive to the presence of ROS in the company or absence of microglial cells [<a href="#CR298" class="usa-link" aria-describedby="CR298">298</a>]. This sheds light on the existence of ROS production in the parenchyma of healthy individuals. However, under pathological conditions, ROS production is far superior. Interestingly, in 3 × Tg-AD mice, a reduction of GFAP expression at initial stages of AD has been shown, followed by an increase at later stages. Nonetheless, astrocytes surrounding plaques are clearly hypertrophic (reactive) with an increase in surface and volume [<a href="#CR296" class="usa-link" aria-describedby="CR296">296</a>]. These reactive astrocytes seem to lose their function, such as in new synapse formation and synaptic pruning [<a href="#CR299" class="usa-link" aria-describedby="CR299">299</a>]. They can be activated by a combination of IL-1α, TNFα, and C1q but not IL-1β, released by microglial activation [<a href="#CR299" class="usa-link" aria-describedby="CR299">299</a>]. Intriguingly, IL-1α induces production of APP and α-secretase-mediated APP metabolism in human astrocytic cells [<a href="#CR300" class="usa-link" aria-describedby="CR300">300</a>]. This might be neuroprotective, since the α-secretase-mediated APP metabolism is believed to have a protective effect in AD.</p>
<p id="Par78">The role astrocytes play in AD appears complex and it is not clear if they play a principal or a secondary role (reacting to microglial activation). A factor nailing the importance of astrocytes in AD pathogenesis is that several AD risk factors are genes mostly expressed in astrocytic cells. These include <em>APOE</em> and Clusterin (<em>APOJ</em>), with the latter being important in the importation of lipids/Aβ in the brain [<a href="#CR301" class="usa-link" aria-describedby="CR301">301</a>]. LRP1 is another protein affected, which is highly expressed in glial cells and astrocytes, and helps in the clearance of Aβ [<a href="#CR302" class="usa-link" aria-describedby="CR302">302</a>, <a href="#CR303" class="usa-link" aria-describedby="CR303">303</a>]. Interestingly, in aging mice chronically dosed via their drinking water with Cu (2 µmol/L), Cu accumulated in the brain capillaries but not in the parenchyma and that this accumulation led to a decrease in LRP1, possibly through PrPc-induced <em>S</em>-nitrosylation [<a href="#CR304" class="usa-link" aria-describedby="CR304">304</a>]. Conversely, in APP<sup>sw/0</sup> mice, there was an increased Cu levels in both the parenchyma and capillaries which might be explained by a compromised BBB. Nonetheless, in these mice there was a lower LRP1 level, accompanied by higher Aβ load. This might be relevant in AD, where there is a higher level of non-ceruloplasmin Cu, which might affect the ability of astrocytes to export Aβ through LRP1. Additionally, Aβ oligomers can activate astrocytes in mice possibly through binding directly to C1q (released by microglia), leading to activation of NF-κB and release of C3 complement (increased in AD patients), which are toxic to both microglia and neurons [<a href="#CR299" class="usa-link" aria-describedby="CR299">299</a>, <a href="#CR305" class="usa-link" aria-describedby="CR305">305</a>, <a href="#CR306" class="usa-link" aria-describedby="CR306">306</a>].</p>
<p id="Par79">Some of the most important astrocytic functions for neurons are the uptake of glucose and release of lactate, the uptake of glutamate and release of glutamine and the uptake of GSH precursors and release of GSH, all of which are deregulated in AD [<a href="#CR307" class="usa-link" aria-describedby="CR307">307</a>]. In cultured astrocytes there is an increased release of GSH and an increased glucose consumption in the presence of Cu [<a href="#CR308" class="usa-link" aria-describedby="CR308">308</a>]. Additionally, Cu(II)Aβ, as well as Zn(II)Aβ, have been shown to decrease glutamate uptake and increase lactate release (in the absence of mitochondrial dysfunction) by astrocytes [<a href="#CR309" class="usa-link" aria-describedby="CR309">309</a>]. The increase of GSH secretion could be explained as a response to suppress ROS production, whereas the increase in glucose metabolism is more complex to understand. However, it has been shown that Cu stabilises HIF-1α through a CCS-dependent mechanism and leads to the expression of lactate dyshydrogenase for conversion of pyruvate to lactate under normoxic conditions, apart from VEGF upregulation for angiogenesis [<a href="#CR310" class="usa-link" aria-describedby="CR310">310</a>, <a href="#CR311" class="usa-link" aria-describedby="CR311">311</a>]. It can thus be argued that in AD, due to the reduced levels of GSH in regions affected [<a href="#CR233" class="usa-link" aria-describedby="CR233">233</a>], there is a lesser import of Cu in astrocytic cells from the blood as well as a lack of Cu-dependent stabilization of HIF-1α, therefore leading to decreased levels of lactate dehydrogenase, and thus reduced lactate production. Paradoxically, increased levels of ROS, which can be generated by Cu, should also increase activation of nuclear factor erythroid 2-related factor 2 (NRF2) that increases the expression of antioxidant genes including GSH [<a href="#CR312" class="usa-link" aria-describedby="CR312">312</a>].</p></section></section><section id="Sec14"><h2 class="pmc_sec_title">Therapeutic molecules and mechanisms of action</h2>
<section id="Sec15"><h3 class="pmc_sec_title">Clinical trials: metal dyshomeostasis regulators</h3>
<p id="Par80">In the healthy brain, there is a heterogeneous distribution of metal ions, which is tightly regulated in a localisation-dependent manner. Given the dyshomeostasis of metal ions in AD, clinical trials attempting to increase or decrease metal ion levels have been tested (Fig. <a href="#Fig7" class="usa-link">7</a>).</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372260_40035_2025_504_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffba/12372260/4607fc85417e/40035_2025_504_Fig7_HTML.jpg" loading="lazy" id="MO7" height="524" width="784" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Scheme illustrating the mechanism of action for a Cu dyshomeostasis regulator. In AD brain, there is an excess amount of exchangeable Cu pool which leads to the generation of ROS. Potentially, treatment with a Cu dyshomeostasis regulator relocalises this excess Cu back into cells in the brain</p></figcaption></figure><p id="Par81">Zinthionein is a formulation containing Zn and cysteine that demonstrated no significant benefit on any of the cognitive tests in an AD context [<a href="#CR313" class="usa-link" aria-describedby="CR313">313</a>]. Cu supplement was also tested in patients with mild AD; however, there was no benefit on AD evolution [<a href="#CR314" class="usa-link" aria-describedby="CR314">314</a>]. D-Penicillamine, a reducing agent and chelator used in Wilson disease to chelate excess Cu, was used in a pilot phase trial. The chelate did decrease ROS indicators in the blood but did not have a beneficial effect on cognitive decline in AD [<a href="#CR315" class="usa-link" aria-describedby="CR315">315</a>]. This is however not surprising since the chelate does not correct the neurological symptoms due to excess Cu in Wilson disease [<a href="#CR316" class="usa-link" aria-describedby="CR316">316</a>].</p>
<p id="Par82">A few clinical trials based on disrupting the interaction between protein and Fe, Cu or Zn have also been enacted. The first one showed that the Fe(III) chelator desferrioxamine slows AD progression in regard to cognitive decline. However, no follow up was carried out and there were some issues with the trial, including the authors initially aiming for aluminium and the control not being double-blinded [<a href="#CR317" class="usa-link" aria-describedby="CR317">317</a>]. Two additional clinical trials using clioquinol and PBT2 have been conducted with the aim of redistributing Cu/Zn in the brain [<a href="#CR318" class="usa-link" aria-describedby="CR318">318</a>–<a href="#CR320" class="usa-link" aria-describedby="CR320">320</a>]. Clioquinol is a Cu and Zn chelator that can cross the BBB. The trial was intended to slow the progression of amyloid plaques by removing Cu and Zn, thus reducing Aβ aggregation and their toxic effects. Although the clinical trial showed a decrease in plasma Aβ, the trial was stopped due to a toxic impurity associated with the compound [<a href="#CR319" class="usa-link" aria-describedby="CR319">319</a>]. The clioquinol derivative, PBT2, was later developed and was shown to reduce the level of Aβ in CSF but without significant improvement of cognitive parameters. It also had no effect on plasma biomarkers of AD or serum Zn and Cu concentrations [<a href="#CR318" class="usa-link" aria-describedby="CR318">318</a>, <a href="#CR320" class="usa-link" aria-describedby="CR320">320</a>]. Criticisms of these studies are that the molecules used have other functions apart from the chelation of Cu and Zn, and the lack of specificity for either metal ion as well as potential binding to Fe, which obviously make it difficult to distinguish the role of Cu, Zn or Fe in AD. It is also possible that these molecules induce an excess import of Cu into neurons, leading to cuproptosis as seen for the elesclomol derivatives [<a href="#CR321" class="usa-link" aria-describedby="CR321">321</a>].</p></section><section id="Sec16"><h3 class="pmc_sec_title">Proposed general mechanisms of action for Cu dyshomeostasis regulators in AD</h3>
<p id="Par83">Extensive studies have been carried out on the metal-protein attenuating properties of 8-hydroxyquinolines (e.g., clioquinol and PBT2) and Bis(thiosemicarbazonato) such as glyoxal-bis N4-methylthiosemicarbazonato (GTSM). These molecules proved to be capable of importing Cu into cells, leading to the decrease in extracellular Aβ in both cellular and animal models of AD [<a href="#CR241" class="usa-link" aria-describedby="CR241">241</a>, <a href="#CR322" class="usa-link" aria-describedby="CR322">322</a>]. However, of the listed compounds, only GTSM might be selective for Cu(II).</p>
<p id="Par84">The clinically tested clioquinol, as well as GTSM, in complex with Cu, can activate the PI3K/Akt pathway that leads to the phosphorylation of GSK3β at Ser9 [<a href="#CR241" class="usa-link" aria-describedby="CR241">241</a>, <a href="#CR323" class="usa-link" aria-describedby="CR323">323</a>]. GSK3β is constitutively active in cells and is abundant in the CNS, known to inhibit glycogen synthase via phosphorylation [<a href="#CR324" class="usa-link" aria-describedby="CR324">324</a>, <a href="#CR325" class="usa-link" aria-describedby="CR325">325</a>]. GSK3β is inactivated by insulin/IGF-1. The latter activates PDK1 (3-phosphoinositide-dependent protein kinase-1) which then activates protein kinase B that in turn inactivates GSK3β. However, PKC and MAPK are also known to inhibit GSK3β [<a href="#CR326" class="usa-link" aria-describedby="CR326">326</a>–<a href="#CR328" class="usa-link" aria-describedby="CR328">328</a>].</p>
<p id="Par85">Interestingly, activated GSK3β has been shown to increase Aβ production by interacting with APP, BACE1 or PS1 [<a href="#CR329" class="usa-link" aria-describedby="CR329">329</a>]. GSK3β has also been shown to be an upstream activator of Fyn leading to degradation of NRF2 [<a href="#CR330" class="usa-link" aria-describedby="CR330">330</a>]. Therefore, the GSK3β-dependent activation of Fyn might equally phosphorylate tau, as there is an increase in the presence of Fyn in neurons containing phosphorylated tau [<a href="#CR331" class="usa-link" aria-describedby="CR331">331</a>, <a href="#CR332" class="usa-link" aria-describedby="CR332">332</a>]. Fyn kinase is also known to phosphorylate NR2A/B subunits of NMDARs, thereby stabilising NMDAR at the synapse, possibly leading to excitotoxicity [<a href="#CR333" class="usa-link" aria-describedby="CR333">333</a>]. Fyn can also be activated by Aβ oligomers through a PrPc-specific signalling [<a href="#CR247" class="usa-link" aria-describedby="CR247">247</a>].</p>
<p id="Par86">At another level, the redistribution of Cu alone is another mechanism of action on its own. Cu is believed to stabilize Aβ oligomers, that can lead to the formation of pores in cells, thus increasing intracellular calcium levels, leading to cell toxicity. Equally, Aβ oligomers are known to lead to “over-activation” of NMDARs either by directly binding Cu or by instigating an “open” conformational switch, thereby increasing intraneuronal calcium levels. High levels of calcium are thought to activate Fyn or Cdk5, believed to phosphorylate tau [<a href="#CR251" class="usa-link" aria-describedby="CR251">251</a>, <a href="#CR252" class="usa-link" aria-describedby="CR252">252</a>]. Additionally, increase in labile Cu is also thought to be able to degrade LRP1 through PrPc-dependent <em>S</em>-nitrosylation [<a href="#CR304" class="usa-link" aria-describedby="CR304">304</a>]. This might be the cause of down-regulation of LRP1 in the capillaries of AD patients leading to accumulation of Aβ in the brain. Additionally, Cu increases Aβ production, reduces Aβ clearance and degradation in the brain parenchyma [<a href="#CR304" class="usa-link" aria-describedby="CR304">304</a>, <a href="#CR334" class="usa-link" aria-describedby="CR334">334</a>]. This shines light on the Aβ-Cu axis and brings up the notion of where in the brain Cu is toxic. We believe that this toxicity comes from both the decreased activity of Cu proteins and an increase in the extracellular labile Cu pool, therefore leading to ROS production. Therefore, Cu dyshomeostasis regulators may correct this toxicity by clearing labile Cu pool and restore normal Cu homeostasis.</p></section></section><section id="Sec17"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par87">Correct regulation of Cu levels in the CNS and in the body as a whole is vital. The dyshomeostasis of Cu as uncovered in AD likely plays a crucial role in the dysfunction of different brain cell populations. Neuronal hyperactivity precedes neuronal loss in AD [<a href="#CR335" class="usa-link" aria-describedby="CR335">335</a>]. This hyperactivation of neurons is thought to be in part due to sustained NMDAR activity leading to Ca<sup>2+</sup> imbalance [<a href="#CR336" class="usa-link" aria-describedby="CR336">336</a>]. It has been shown that Cu dyshomeostasis [<a href="#CR248" class="usa-link" aria-describedby="CR248">248</a>, <a href="#CR249" class="usa-link" aria-describedby="CR249">249</a>], Aβ and tau can all drive this phenomenon, as reviewed here [<a href="#CR336" class="usa-link" aria-describedby="CR336">336</a>]. Therefore, clearing excess extracellular Cu and redistributing it into neuronal cells may regulate NMDAR hyperactivity. This will also increase the resistance of these neurons to ROS, due to the role of Cu in oxidative defence. Another level where the redistribution of Cu from the outside to the inside of cells is important, is the microglia-activating property of extracellular Cu [<a href="#CR274" class="usa-link" aria-describedby="CR274">274</a>]. Cu is needed for IFN-activation and that IFN and Aβ together promote the microglial activation [<a href="#CR271" class="usa-link" aria-describedby="CR271">271</a>–<a href="#CR273" class="usa-link" aria-describedby="CR273">273</a>]. As well, hyperactive cells give an “eat me” signal to microglial cells, which can lead to sustained activation as seen in AD [<a href="#CR272" class="usa-link" aria-describedby="CR272">272</a>, <a href="#CR335" class="usa-link" aria-describedby="CR335">335</a>, <a href="#CR336" class="usa-link" aria-describedby="CR336">336</a>]. Therefore, depriving Cu from microglial cells could help reduce cytokine production and thus microglial activation. The simultaneous redistribution of non-physiological extracellular Cu and importation of Cu into neuronal cells, reduce Cu-induced microglial activation and could be an interesting therapeutic venture.</p>
<p id="Par88">New studies showing the effect of ionophores with selectivity towards Cu are emerging [<a href="#CR337" class="usa-link" aria-describedby="CR337">337</a>–<a href="#CR344" class="usa-link" aria-describedby="CR344">344</a>]. However, what is of note in this proposed therapy is that these new-generation Cu transporters should bind selectively and specifically to Cu<sup>2+</sup>, the extracellular form. They should also have a moderate affinity, as not to compete with physiological Cu chaperones or cuproproteins, but strong enough to withdraw Cu from promiscuous Cu ligands (e.g. Aβ), and importantly, with no secondary activities. Such potential Cu transporters include, for instance, peptide-based Cu shuttles capable of recovering Cu from Aβ aggregates, preventing cell toxicity and increasing bioavailable intracellular Cu levels [<a href="#CR328" class="usa-link" aria-describedby="CR328">328</a>, <a href="#CR331" class="usa-link" aria-describedby="CR331">331</a>], or molecules capable of retrieving Cu from Aβ but not endogenous ligand with similar affinity (ex: PrPc) [<a href="#CR345" class="usa-link" aria-describedby="CR345">345</a>]. Another important detail to take into account in the design of these Cu transporters is that excessive increase of Cu in neurons can lead to cuprotoxicity as seen for molecules such as elesclomol, GTSM, clioquinol, likely resulting from rapid increase in mitochondrial Cu levels [<a href="#CR321" class="usa-link" aria-describedby="CR321">321</a>]. Interestingly, different peptide-based Cu shuttles display different kinetics of Cu release, which may be of particular interest regarding this aspect [<a href="#CR331" class="usa-link" aria-describedby="CR331">331</a>]. Therefore, increase of Cu levels in compartment where it is useful (ex: Golgi, for incorporation in cuproproteins) and with an ideal kinetic, should be desired.</p>
<p id="Par89">Understanding how Cu dyshomeostasis is present in individual cell types or cell compartments is thus relevant, so as to be able to target specific cell types/compartments in re-equilibrating Cu levels in AD. Therefore, new studies will need to be carried out to answer this question, and new molecules capable of correcting Cu dyshomeostasis are needed. Another key aspect that will be needed to be taken into consideration in future clinical trials involving Cu-shuttles and metal transporters in general is to stratify AD patients for whom metal dyshomeostasis could contribute to the progression of the disease. Finally, like the most recent trial, these molecules are likely to work best before neuronal death and thus administered before the first symptoms are detected. Progress in early AD diagnosis and progress in Cu sensors are therefore also key to therapeutic progress.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Figures were designed with BIORENDER.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>α-syn</dt>
<dd><p id="Par2">α-Synuclein</p></dd>
<dt>α2M</dt>
<dd><p id="Par3">α-Macroglobulin</p></dd>
<dt>AD</dt>
<dd><p id="Par4">Alzheimer’s disease</p></dd>
<dt>ALS</dt>
<dd><p id="Par5">Amyotrophic lateral sclerosis</p></dd>
<dt>APP</dt>
<dd><p id="Par6">Amyloid precursor protein</p></dd>
<dt>AscH<sup>−</sup>
</dt>
<dd><p id="Par7">Ascorbate</p></dd>
<dt>ATOX1</dt>
<dd><p id="Par8">Antioxidant 1 Cu chaperone</p></dd>
<dt>Aβ</dt>
<dd><p id="Par9">Amyloid-β</p></dd>
<dt>BBB</dt>
<dd><p id="Par10">Blood–brain barrier</p></dd>
<dt>BCB</dt>
<dd><p id="Par11">Blood-cerebrospinal fluid barrier</p></dd>
<dt>CAA</dt>
<dd><p id="Par12">Cerebral amyloid angiopathy</p></dd>
<dt>CCS</dt>
<dd><p id="Par13">Copper chaperone for superoxide dismutase</p></dd>
<dt>COX</dt>
<dd><p id="Par14">Cytochrome C oxidase</p></dd>
<dt>CSF</dt>
<dd><p id="Par15">Cerebrospinal fluid</p></dd>
<dt>DβH</dt>
<dd><p id="Par16">Dopamine β-hydroxylase</p></dd>
<dt>GSH</dt>
<dd><p id="Par17">Glutathione</p></dd>
<dt>GTSM</dt>
<dd><p id="Par18">Glyoxal-bis N4-methylthiosemicarbazonato</p></dd>
<dt>PD</dt>
<dd><p id="Par19">Parkinson’s disease</p></dd>
<dt>PHFs</dt>
<dd><p id="Par20">Paired helical filaments</p></dd>
<dt>PrP</dt>
<dd><p id="Par21">Prion protein</p></dd>
<dt>ROS</dt>
<dd><p id="Par22">Reactive oxygen species</p></dd>
<dt>SOD</dt>
<dd><p id="Par23">Superoxide dismutase</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>All authors revised the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>The IdEx PhD program of the University of Strasbourg and the ITI Neurostra program (ANR-10-IDEX-0002) are providing the salary to MO. The University of Strasbourg is providing salary to PF. INSERM is providing the salary to NV.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>Not applicable.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethical approval and consent to participate</h3>
<p id="Par90">Not applicable.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par91">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Conflict of interest</h3>
<p id="Par92">The authors declare that they have no conflicts of interest with the contents of this article.</p></section></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Michael Okafor, Email: michael.okafor@icm-institute.org.</p>
<p>Nicolas Vitale, Email: vitalen@unistra.fr.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Stelzmann RA, Norman Schnitzlein H, Reed Murtagh F. An english translation of alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde.” Clin Anat. 1995;8:429–31.
</cite> [<a href="https://doi.org/10.1002/ca.980080612" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8713166/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stelzmann%20RA,%20Norman%20Schnitzlein%20H,%20Reed%20Murtagh%20F.%20An%20english%20translation%20of%20alzheimer%E2%80%99s%201907%20paper,%20%E2%80%9C%C3%BCber%20eine%20eigenartige%20erkankung%20der%20hirnrinde.%E2%80%9D%20Clin%20Anat.%201995;8:429%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Möller H-J, Graeber MB. The case described by Alois Alzheimer in 1911. Eur Arch Psychiatry Clin Neurosci. 1998;248:111–22.
</cite> [<a href="https://doi.org/10.1007/s004060050027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9728729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?M%C3%B6ller%20H-J,%20Graeber%20MB.%20The%20case%20described%20by%20Alois%20Alzheimer%20in%201911.%20Eur%20Arch%20Psychiatry%20Clin%20Neurosci.%201998;248:111%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Fuller SC. Alzheimer’s disease (senium præcox): the report of a case and review of published cases. J Nerv Ment Dis. 1912;39:440.</cite> [<a href="https://scholar.google.com/scholar_lookup?Fuller%20SC.%20Alzheimer%E2%80%99s%20disease%20(senium%20pr%C3%A6cox):%20the%20report%20of%20a%20case%20and%20review%20of%20published%20cases.%20J%20Nerv%20Ment%20Dis.%201912;39:440." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging. 1992;13:179–89.
</cite> [<a href="https://doi.org/10.1016/0197-4580(92)90027-u" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1311804/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dickson%20DW,%20Crystal%20HA,%20Mattiace%20LA,%20Masur%20DM,%20Blau%20AD,%20Davies%20P,%20et%20al.%20Identification%20of%20normal%20and%20pathological%20aging%20in%20prospectively%20studied%20nondemented%20elderly%20humans.%20Neurobiol%20Aging.%201992;13:179%E2%80%9389." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Saito S, Ihara M. Interaction between cerebrovascular disease and Alzheimer pathology. Curr Opin Psychiatry. 2016;29:168.
</cite> [<a href="https://doi.org/10.1097/YCO.0000000000000239" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26779861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saito%20S,%20Ihara%20M.%20Interaction%20between%20cerebrovascular%20disease%20and%20Alzheimer%20pathology.%20Curr%20Opin%20Psychiatry.%202016;29:168." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Saito S, Tanaka M, Satoh-Asahara N, Carare RO, Ihara M. Taxifolin: a potential therapeutic agent for cerebral amyloid angiopathy. Front Pharmacol. 2021. 10.3389/fphar.2021.643357.
</cite> [<a href="https://doi.org/10.3389/fphar.2021.643357" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7907591/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33643053/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saito%20S,%20Tanaka%20M,%20Satoh-Asahara%20N,%20Carare%20RO,%20Ihara%20M.%20Taxifolin:%20a%20potential%20therapeutic%20agent%20for%20cerebral%20amyloid%20angiopathy.%20Front%20Pharmacol.%202021.%2010.3389/fphar.2021.643357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Waziry R, Chibnik LB, Bos D, Ikram MK, Hofman A. Risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease. Neurology. 2020;94:265–72.
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000008924" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7136067/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31949087/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Waziry%20R,%20Chibnik%20LB,%20Bos%20D,%20Ikram%20MK,%20Hofman%20A.%20Risk%20of%20hemorrhagic%20and%20ischemic%20stroke%20in%20patients%20with%20Alzheimer%20disease.%20Neurology.%202020;94:265%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Braak H, Braak E. Staging of alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging. 1995;16:271–8.
</cite> [<a href="https://doi.org/10.1016/0197-4580(95)00021-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7566337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Braak%20H,%20Braak%20E.%20Staging%20of%20alzheimer%E2%80%99s%20disease-related%20neurofibrillary%20changes.%20Neurobiol%20Aging.%201995;16:271%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl). 1991;82:239–59.
</cite> [<a href="https://doi.org/10.1007/BF00308809" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1759558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Braak%20H,%20Braak%20E.%20Neuropathological%20stageing%20of%20Alzheimer-related%20changes.%20Acta%20Neuropathol%20(Berl).%201991;82:239%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Paterno G, Bell BM, Gorion K-MM, Prokop S, Giasson BI. Reassessment of neuronal tau distribution in adult human brain and implications for tau pathobiology. Acta Neuropathol Commun. 2022;10:94.
</cite> [<a href="https://doi.org/10.1186/s40478-022-01394-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9237980/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35765058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Paterno%20G,%20Bell%20BM,%20Gorion%20K-MM,%20Prokop%20S,%20Giasson%20BI.%20Reassessment%20of%20neuronal%20tau%20distribution%20in%20adult%20human%20brain%20and%20implications%20for%20tau%20pathobiology.%20Acta%20Neuropathol%20Commun.%202022;10:94." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Herukka S-K, Helisalmi S, Hallikainen M, Tervo S, Soininen H, Pirttilä T. CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI. Neurobiol Aging. 2007;28:507–14.
</cite> [<a href="https://doi.org/10.1016/j.neurobiolaging.2006.02.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16546302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Herukka%20S-K,%20Helisalmi%20S,%20Hallikainen%20M,%20Tervo%20S,%20Soininen%20H,%20Pirttil%C3%A4%20T.%20CSF%20Abeta42,%20Tau%20and%20phosphorylated%20Tau,%20APOE%20epsilon4%20allele%20and%20MCI%20type%20in%20progressive%20MCI.%20Neurobiol%20Aging.%202007;28:507%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Crowther RA. Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc Natl Acad Sci. 1991;88:2288–92.
</cite> [<a href="https://doi.org/10.1073/pnas.88.6.2288" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC51216/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1706519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Crowther%20RA.%20Straight%20and%20paired%20helical%20filaments%20in%20Alzheimer%20disease%20have%20a%20common%20structural%20unit.%20Proc%20Natl%20Acad%20Sci.%201991;88:2288%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Kozlov S, Afonin A, Evsyukov I, Bondarenko A. Alzheimer’s disease: as it was in the beginning. Rev Neurosci. 2017;28:825–43.
</cite> [<a href="https://doi.org/10.1515/revneuro-2017-0006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28704198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kozlov%20S,%20Afonin%20A,%20Evsyukov%20I,%20Bondarenko%20A.%20Alzheimer%E2%80%99s%20disease:%20as%20it%20was%20in%20the%20beginning.%20Rev%20Neurosci.%202017;28:825%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Castellani RJ, Smith MA. Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is “too big to fail.” J Pathol. 2011;224:147–52.
</cite> [<a href="https://doi.org/10.1002/path.2885" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21557219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Castellani%20RJ,%20Smith%20MA.%20Compounding%20artefacts%20with%20uncertainty,%20and%20an%20amyloid%20cascade%20hypothesis%20that%20is%20%E2%80%9Ctoo%20big%20to%20fail.%E2%80%9D%20J%20Pathol.%202011;224:147%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Deyts C, Thinakaran G, Parent AT. APP receptor? To be or not to be. Trends Pharmacol Sci. 2016;37:390–411.
</cite> [<a href="https://doi.org/10.1016/j.tips.2016.01.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4846520/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26837733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deyts%20C,%20Thinakaran%20G,%20Parent%20AT.%20APP%20receptor?%20To%20be%20or%20not%20to%20be.%20Trends%20Pharmacol%20Sci.%202016;37:390%E2%80%93411." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Zheng H, Jiang M, Trumbauer ME, Sirinathsinghji DJS, Hopkins R, Smith DW, et al. Β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell. 1995;81:525–31.
</cite> [<a href="https://doi.org/10.1016/0092-8674(95)90073-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7758106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20H,%20Jiang%20M,%20Trumbauer%20ME,%20Sirinathsinghji%20DJS,%20Hopkins%20R,%20Smith%20DW,%20et%20al.%20%CE%92-amyloid%20precursor%20protein-deficient%20mice%20show%20reactive%20gliosis%20and%20decreased%20locomotor%20activity.%20Cell.%201995;81:525%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Wang P, Yang G, Mosier DR, Chang P, Zaidi T, Gong Y-D, et al. Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-like protein 2. J Neurosci. 2005;25:1219–25.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.4660-04.2005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6725967/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15689559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20P,%20Yang%20G,%20Mosier%20DR,%20Chang%20P,%20Zaidi%20T,%20Gong%20Y-D,%20et%20al.%20Defective%20neuromuscular%20synapses%20in%20mice%20lacking%20amyloid%20precursor%20protein%20(APP)%20and%20APP-like%20protein%202.%20J%20Neurosci.%202005;25:1219%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Caldwell JH, Klevanski M, Saar M, Müller UC. Roles of the amyloid precursor protein family in the peripheral nervous system. Mech Dev. 2013;130:433–46.
</cite> [<a href="https://doi.org/10.1016/j.mod.2012.11.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23201910/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Caldwell%20JH,%20Klevanski%20M,%20Saar%20M,%20M%C3%BCller%20UC.%20Roles%20of%20the%20amyloid%20precursor%20protein%20family%20in%20the%20peripheral%20nervous%20system.%20Mech%20Dev.%202013;130:433%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Schneider A, Rajendran L, Honsho M, Gralle M, Donnert G, Wouters F, et al. Flotillin-dependent clustering of the amyloid precursor protein regulates its endocytosis and amyloidogenic processing in neurons. J Neurosci Off J Soc Neurosci. 2008;28:2874–82.</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.5345-07.2008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6670660/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18337418/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schneider%20A,%20Rajendran%20L,%20Honsho%20M,%20Gralle%20M,%20Donnert%20G,%20Wouters%20F,%20et%20al.%20Flotillin-dependent%20clustering%20of%20the%20amyloid%20precursor%20protein%20regulates%20its%20endocytosis%20and%20amyloidogenic%20processing%20in%20neurons.%20J%20Neurosci%20Off%20J%20Soc%20Neurosci.%202008;28:2874%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Vassar R, Kovacs DM, Yan R, Wong PC. The beta-secretase enzyme BACE in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential. J Neurosci Off J Soc Neurosci. 2009;29:12787–94.</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.3657-09.2009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2879048/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19828790/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vassar%20R,%20Kovacs%20DM,%20Yan%20R,%20Wong%20PC.%20The%20beta-secretase%20enzyme%20BACE%20in%20health%20and%20Alzheimer%E2%80%99s%20disease:%20regulation,%20cell%20biology,%20function,%20and%20therapeutic%20potential.%20J%20Neurosci%20Off%20J%20Soc%20Neurosci.%202009;29:12787%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Wang X, Zhou X, Li G, Zhang Y, Wu Y, Song W. Modifications and trafficking of APP in the pathogenesis of Alzheimer’s disease. Front Mol Neurosci. 2017. 10.3389/fnmol.2017.00294.
</cite> [<a href="https://doi.org/10.3389/fnmol.2017.00294" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5605621/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28966576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20X,%20Zhou%20X,%20Li%20G,%20Zhang%20Y,%20Wu%20Y,%20Song%20W.%20Modifications%20and%20trafficking%20of%20APP%20in%20the%20pathogenesis%20of%20Alzheimer%E2%80%99s%20disease.%20Front%20Mol%20Neurosci.%202017.%2010.3389/fnmol.2017.00294." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Furukawa K, Sopher BL, Rydel RE, Begley JG, Pham DG, Martin GM, et al. Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J Neurochem. 1996;67:1882–96.
</cite> [<a href="https://doi.org/10.1046/j.1471-4159.1996.67051882.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8863493/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Furukawa%20K,%20Sopher%20BL,%20Rydel%20RE,%20Begley%20JG,%20Pham%20DG,%20Martin%20GM,%20et%20al.%20Increased%20activity-regulating%20and%20neuroprotective%20efficacy%20of%20%CE%B1-secretase-derived%20secreted%20amyloid%20precursor%20protein%20conferred%20by%20a%20C-terminal%20heparin-binding%20domain.%20J%20Neurochem.%201996;67:1882%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Hampel H, Vassar R, De Strooper B, Hardy J, Willem M, Singh N, et al. The β-secretase BACE1 in Alzheimer’s disease. Biol Psychiatry. 2021;89:745–56.
</cite> [<a href="https://doi.org/10.1016/j.biopsych.2020.02.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7533042/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32223911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hampel%20H,%20Vassar%20R,%20De%20Strooper%20B,%20Hardy%20J,%20Willem%20M,%20Singh%20N,%20et%20al.%20The%20%CE%B2-secretase%20BACE1%20in%20Alzheimer%E2%80%99s%20disease.%20Biol%20Psychiatry.%202021;89:745%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Savonenko AV, Melnikova T, Li T, Price DL, Wong PC. Chapter 21—Alzheimer disease. In: Zigmond MJ, Rowland LP, Coyle JT, editors. Neurobiol Brain Disord. San Diego: Academic Press; 2015. p. 321–38.</cite> [<a href="https://scholar.google.com/scholar_lookup?Savonenko%20AV,%20Melnikova%20T,%20Li%20T,%20Price%20DL,%20Wong%20PC.%20Chapter%2021%E2%80%94Alzheimer%20disease.%20In:%20Zigmond%20MJ,%20Rowland%20LP,%20Coyle%20JT,%20editors.%20Neurobiol%20Brain%20Disord.%20San%20Diego:%20Academic%20Press;%202015.%20p.%20321%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Vieira SI, Rebelo S, Esselmann H, Wiltfang J, Lah J, Lane R, et al. Retrieval of the Alzheimer’s amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated. Mol Neurodegener. 2010;5:40.
</cite> [<a href="https://doi.org/10.1186/1750-1326-5-40" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2994555/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20937087/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vieira%20SI,%20Rebelo%20S,%20Esselmann%20H,%20Wiltfang%20J,%20Lah%20J,%20Lane%20R,%20et%20al.%20Retrieval%20of%20the%20Alzheimer%E2%80%99s%20amyloid%20precursor%20protein%20from%20the%20endosome%20to%20the%20TGN%20is%20S655%20phosphorylation%20state-dependent%20and%20retromer-mediated.%20Mol%20Neurodegener.%202010;5:40." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Suzuki T, Oishi M, Marshak Dr, Czernik Aj, Nairn Ac, Greengard P. Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J. 1994;13:1114–22.
</cite> [<a href="https://doi.org/10.1002/j.1460-2075.1994.tb06360.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC394920/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8131745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Suzuki%20T,%20Oishi%20M,%20Marshak%20Dr,%20Czernik%20Aj,%20Nairn%20Ac,%20Greengard%20P.%20Cell%20cycle-dependent%20regulation%20of%20the%20phosphorylation%20and%20metabolism%20of%20the%20Alzheimer%20amyloid%20precursor%20protein.%20EMBO%20J.%201994;13:1114%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Isohara T, Horiuchi A, Watanabe T, Ando K, Czernik AJ, Uno I, et al. Phosphorylation of the cytoplasmic domain of Alzheimer’s β-amyloid precursor protein at Ser655 by a novel protein kinase. Biochem Biophys Res Commun. 1999;258:300–5.
</cite> [<a href="https://doi.org/10.1006/bbrc.1999.0637" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10329382/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Isohara%20T,%20Horiuchi%20A,%20Watanabe%20T,%20Ando%20K,%20Czernik%20AJ,%20Uno%20I,%20et%20al.%20Phosphorylation%20of%20the%20cytoplasmic%20domain%20of%20Alzheimer%E2%80%99s%20%CE%B2-amyloid%20precursor%20protein%20at%20Ser655%20by%20a%20novel%20protein%20kinase.%20Biochem%20Biophys%20Res%20Commun.%201999;258:300%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Oishi M, Nairn AC, Czernik AJ, Lim GS, Isohara T, Gandy SE, et al. The cytoplasmic domain of Alzheimer’s amyloid precursor protein is phosphorylated at Thr654, Ser655, and Thr668 in adult rat brain and cultured cells. Mol Med. 1997;3:111–23.
</cite> [<a href="/articles/PMC2230054/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9085254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oishi%20M,%20Nairn%20AC,%20Czernik%20AJ,%20Lim%20GS,%20Isohara%20T,%20Gandy%20SE,%20et%20al.%20The%20cytoplasmic%20domain%20of%20Alzheimer%E2%80%99s%20amyloid%20precursor%20protein%20is%20phosphorylated%20at%20Thr654,%20Ser655,%20and%20Thr668%20in%20adult%20rat%20brain%20and%20cultured%20cells.%20Mol%20Med.%201997;3:111%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Muresan V, Muresan Z. A persistent stress response to impeded axonal transport leads to accumulation of amyloid-β in the endoplasmic reticulum, and is a probable cause of sporadic Alzheimer’s disease. Neurodegener Dis. 2012;10:60–3.
</cite> [<a href="https://doi.org/10.1159/000332815" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3363352/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22156573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Muresan%20V,%20Muresan%20Z.%20A%20persistent%20stress%20response%20to%20impeded%20axonal%20transport%20leads%20to%20accumulation%20of%20amyloid-%CE%B2%20in%20the%20endoplasmic%20reticulum,%20and%20is%20a%20probable%20cause%20of%20sporadic%20Alzheimer%E2%80%99s%20disease.%20Neurodegener%20Dis.%202012;10:60%E2%80%933." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Hernández-Sapiéns MA, Reza-Zaldívar EE, Márquez-Aguirre AL, Gómez-Pinedo U, Matias-Guiu J, Cevallos RR, et al. Presenilin mutations and their impact on neuronal differentiation in Alzheimer’s disease. Neural Regen Res. 2021;17:31–7.</cite> [<a href="https://doi.org/10.4103/1673-5374.313016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8451546/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34100423/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hern%C3%A1ndez-Sapi%C3%A9ns%20MA,%20Reza-Zald%C3%ADvar%20EE,%20M%C3%A1rquez-Aguirre%20AL,%20G%C3%B3mez-Pinedo%20U,%20Matias-Guiu%20J,%20Cevallos%20RR,%20et%20al.%20Presenilin%20mutations%20and%20their%20impact%20on%20neuronal%20differentiation%20in%20Alzheimer%E2%80%99s%20disease.%20Neural%20Regen%20Res.%202021;17:31%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Watanabe H, Shen J. Dominant negative mechanism of Presenilin-1 mutations in FAD. Proc Natl Acad Sci U S A. 2017;114:12635–7.
</cite> [<a href="https://doi.org/10.1073/pnas.1717180114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5715794/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29142009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Watanabe%20H,%20Shen%20J.%20Dominant%20negative%20mechanism%20of%20Presenilin-1%20mutations%20in%20FAD.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202017;114:12635%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Shen J, Kelleher RJ. The presenilin hypothesis of Alzheimer’s disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci. 2007;104:403–9.
</cite> [<a href="https://doi.org/10.1073/pnas.0608332104" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1766397/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17197420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shen%20J,%20Kelleher%20RJ.%20The%20presenilin%20hypothesis%20of%20Alzheimer%E2%80%99s%20disease:%20evidence%20for%20a%20loss-of-function%20pathogenic%20mechanism.%20Proc%20Natl%20Acad%20Sci.%202007;104:403%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Walker ES, Martinez M, Brunkan AL, Goate A. Presenilin 2 familial Alzheimer’s disease mutations result in partial loss of function and dramatic changes in Aβ 42/40 ratios. J Neurochem. 2005;92:294–301.
</cite> [<a href="https://doi.org/10.1111/j.1471-4159.2004.02858.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15663477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Walker%20ES,%20Martinez%20M,%20Brunkan%20AL,%20Goate%20A.%20Presenilin%202%20familial%20Alzheimer%E2%80%99s%20disease%20mutations%20result%20in%20partial%20loss%20of%20function%20and%20dramatic%20changes%20in%20A%CE%B2%2042/40%20ratios.%20J%20Neurochem.%202005;92:294%E2%80%93301." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Sun L, Zhou R, Yang G, Shi Y. Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase. Proc Natl Acad Sci. 2017;114:E476–85.
</cite> [<a href="https://doi.org/10.1073/pnas.1618657114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5278480/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27930341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20L,%20Zhou%20R,%20Yang%20G,%20Shi%20Y.%20Analysis%20of%20138%20pathogenic%20mutations%20in%20presenilin-1%20on%20the%20in%20vitro%20production%20of%20A%CE%B242%20and%20A%CE%B240%20peptides%20by%20%CE%B3-secretase.%20Proc%20Natl%20Acad%20Sci.%202017;114:E476%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, et al. Prevalence of Alzheimer’s disease in a community population of older persons.Higher than previously reported. JAMA. 1989;262:2551–6.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2810583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Evans%20DA,%20Funkenstein%20HH,%20Albert%20MS,%20Scherr%20PA,%20Cook%20NR,%20Chown%20MJ,%20et%20al.%20Prevalence%20of%20Alzheimer%E2%80%99s%20disease%20in%20a%20community%20population%20of%20older%20persons.Higher%20than%20previously%20reported.%20JAMA.%201989;262:2551%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Stozická Z, Zilka N, Novák M. Risk and protective factors for sporadic Alzheimer’s disease. Acta Virol. 2007;51:205–22.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/18197729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stozick%C3%A1%20Z,%20Zilka%20N,%20Nov%C3%A1k%20M.%20Risk%20and%20protective%20factors%20for%20sporadic%20Alzheimer%E2%80%99s%20disease.%20Acta%20Virol.%202007;51:205%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Karch CM, Goate AM. Alzheimer’s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry. 2015;77:43–51.
</cite> [<a href="https://doi.org/10.1016/j.biopsych.2014.05.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4234692/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24951455/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Karch%20CM,%20Goate%20AM.%20Alzheimer%E2%80%99s%20disease%20risk%20genes%20and%20mechanisms%20of%20disease%20pathogenesis.%20Biol%20Psychiatry.%202015;77:43%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Blumenfeld J, Yip O, Kim MJ, Huang Y. Cell type-specific roles of APOE4 in Alzheimer disease. Nat Rev Neurosci. 2024;25:91–110.
</cite> [<a href="https://doi.org/10.1038/s41583-023-00776-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11073858/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38191720/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Blumenfeld%20J,%20Yip%20O,%20Kim%20MJ,%20Huang%20Y.%20Cell%20type-specific%20roles%20of%20APOE4%20in%20Alzheimer%20disease.%20Nat%20Rev%20Neurosci.%202024;25:91%E2%80%93110." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Bertram L, Tanzi RE. Thirty years of Alzheimer’s disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci. 2008;9:768–78.
</cite> [<a href="https://doi.org/10.1038/nrn2494" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18802446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bertram%20L,%20Tanzi%20RE.%20Thirty%20years%20of%20Alzheimer%E2%80%99s%20disease%20genetics:%20the%20implications%20of%20systematic%20meta-analyses.%20Nat%20Rev%20Neurosci.%202008;9:768%E2%80%9378." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180–4.
</cite> [<a href="https://doi.org/10.1038/ng0694-180" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7920638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Corder%20EH,%20Saunders%20AM,%20Risch%20NJ,%20Strittmatter%20WJ,%20Schmechel%20DE,%20Gaskell%20PC,%20et%20al.%20Protective%20effect%20of%20apolipoprotein%20E%20type%202%20allele%20for%20late%20onset%20Alzheimer%20disease.%20Nat%20Genet.%201994;7:180%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci Off J Soc Neurosci. 2006;26:4985–94.</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.5476-05.2006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6674234/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16687490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20Q,%20Bernardo%20A,%20Walker%20D,%20Kanegawa%20T,%20Mahley%20RW,%20Huang%20Y.%20Profile%20and%20regulation%20of%20apolipoprotein%20E%20(ApoE)%20expression%20in%20the%20CNS%20in%20mice%20with%20targeting%20of%20green%20fluorescent%20protein%20gene%20to%20the%20ApoE%20locus.%20J%20Neurosci%20Off%20J%20Soc%20Neurosci.%202006;26:4985%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Xu P-T, Gilbert JR, Qiu H-L, Ervin J, Rothrock-Christian TR, Hulette C, et al. Specific regional transcription of apolipoprotein E in human brain neurons. Am J Pathol. 1999;154:601–11.
</cite> [<a href="https://doi.org/10.1016/S0002-9440(10)65305-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1850012/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10027417/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20P-T,%20Gilbert%20JR,%20Qiu%20H-L,%20Ervin%20J,%20Rothrock-Christian%20TR,%20Hulette%20C,%20et%20al.%20Specific%20regional%20transcription%20of%20apolipoprotein%20E%20in%20human%20brain%20neurons.%20Am%20J%20Pathol.%201999;154:601%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Flowers SA, Rebeck GW. APOE in the normal brain. Neurobiol Dis. 2020;136: 104724.
</cite> [<a href="https://doi.org/10.1016/j.nbd.2019.104724" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7002287/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31911114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Flowers%20SA,%20Rebeck%20GW.%20APOE%20in%20the%20normal%20brain.%20Neurobiol%20Dis.%202020;136:%20104724." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Michikawa M, Fan Q-W, Isobe I, Yanagisawa K. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem. 2000;74:1008–16.
</cite> [<a href="https://doi.org/10.1046/j.1471-4159.2000.0741008.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10693931/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Michikawa%20M,%20Fan%20Q-W,%20Isobe%20I,%20Yanagisawa%20K.%20Apolipoprotein%20E%20exhibits%20isoform-specific%20promotion%20of%20lipid%20efflux%20from%20astrocytes%20and%20neurons%20in%20culture.%20J%20Neurochem.%202000;74:1008%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Guo JL, Braun D, Fitzgerald GA, Hsieh Y-T, Rougé L, Litvinchuk A, et al. Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes. Cell. 2024;88(1):187–206.</cite> [<a href="https://doi.org/10.1016/j.cell.2024.10.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11724755/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39532095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20JL,%20Braun%20D,%20Fitzgerald%20GA,%20Hsieh%20Y-T,%20Roug%C3%A9%20L,%20Litvinchuk%20A,%20et%20al.%20Decreased%20lipidated%20ApoE-receptor%20interactions%20confer%20protection%20against%20pathogenicity%20of%20ApoE%20and%20its%20lipid%20cargoes%20in%20lysosomes.%20Cell.%202024;88(1):187%E2%80%93206." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Nagy Z, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, et al. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer’s disease. Neuroscience. 1995;69:757–61.
</cite> [<a href="https://doi.org/10.1016/0306-4522(95)00331-c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8596645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nagy%20Z,%20Esiri%20MM,%20Jobst%20KA,%20Johnston%20C,%20Litchfield%20S,%20Sim%20E,%20et%20al.%20Influence%20of%20the%20apolipoprotein%20E%20genotype%20on%20amyloid%20deposition%20and%20neurofibrillary%20tangle%20formation%20in%20Alzheimer%E2%80%99s%20disease.%20Neuroscience.%201995;69:757%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921–3.
</cite> [<a href="https://doi.org/10.1126/science.8346443" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8346443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Corder%20EH,%20Saunders%20AM,%20Strittmatter%20WJ,%20Schmechel%20DE,%20Gaskell%20PC,%20Small%20GW,%20et%20al.%20Gene%20dose%20of%20apolipoprotein%20E%20type%204%20allele%20and%20the%20risk%20of%20Alzheimer%E2%80%99s%20disease%20in%20late%20onset%20families.%20Science.%201993;261:921%E2%80%933." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Hou X, Zhang X, Zou H, Guan M, Fu C, Wang W, et al. Differential and substrate-specific inhibition of γ-secretase by the C-terminal region of ApoE2, ApoE3, and ApoE4. Neuron. 2023;111(12):1898–1913.e5.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2023.03.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37040764/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hou%20X,%20Zhang%20X,%20Zou%20H,%20Guan%20M,%20Fu%20C,%20Wang%20W,%20et%20al.%20Differential%20and%20substrate-specific%20inhibition%20of%20%CE%B3-secretase%20by%20the%20C-terminal%20region%20of%20ApoE2,%20ApoE3,%20and%20ApoE4.%20Neuron.%C2%A02023;111(12):1898%E2%80%931913.e5." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Zhao Y, Wu X, Li X, Jiang L-L, Gui X, Liu Y, et al. TREM2 is a receptor for β-amyloid that mediates microglial function. Neuron. 2018;97:1023–1031.e7.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2018.01.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5889092/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29518356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20Y,%20Wu%20X,%20Li%20X,%20Jiang%20L-L,%20Gui%20X,%20Liu%20Y,%20et%20al.%20TREM2%20is%20a%20receptor%20for%20%CE%B2-amyloid%20that%20mediates%20microglial%20function.%20Neuron.%202018;97:1023%E2%80%931031.e7." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Akhter R, Shao Y, Formica S, Khrestian M, Bekris LM. TREM2 alters the phagocytic, apoptotic and inflammatory response to Aβ42 in HMC3 cells. Mol Immunol. 2021;131:171–9.
</cite> [<a href="https://doi.org/10.1016/j.molimm.2020.12.035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8147571/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33461764/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Akhter%20R,%20Shao%20Y,%20Formica%20S,%20Khrestian%20M,%20Bekris%20LM.%20TREM2%20alters%20the%20phagocytic,%20apoptotic%20and%20inflammatory%20response%20to%20A%CE%B242%20in%20HMC3%20cells.%20Mol%20Immunol.%202021;131:171%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Ruiz A, Dols-Icardo O, Bullido MJ, Pastor P, Rodríguez-Rodríguez E, López de Munain A, et al. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer’s disease and frontotemporal dementia. Neurobiol Aging. 2014;35:444.e1-444.e4.
</cite> [<a href="https://doi.org/10.1016/j.neurobiolaging.2013.08.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24041969/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ruiz%20A,%20Dols-Icardo%20O,%20Bullido%20MJ,%20Pastor%20P,%20Rodr%C3%ADguez-Rodr%C3%ADguez%20E,%20L%C3%B3pez%20de%20Munain%20A,%20et%20al.%20Assessing%20the%20role%20of%20the%20TREM2%20p.R47H%20variant%20as%20a%20risk%20factor%20for%20Alzheimer%E2%80%99s%20disease%20and%20frontotemporal%20dementia.%20Neurobiol%20Aging.%202014;35:444.e1-444.e4." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Song W, Hooli B, Mullin K, Jin SC, Cella M, Ulland TK, et al. Alzheimer’s disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation. Alzheimers Dement. 2017;13:381–7.
</cite> [<a href="https://doi.org/10.1016/j.jalz.2016.07.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5299056/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27520774/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Song%20W,%20Hooli%20B,%20Mullin%20K,%20Jin%20SC,%20Cella%20M,%20Ulland%20TK,%20et%20al.%20Alzheimer%E2%80%99s%20disease-associated%20TREM2%20variants%20exhibit%20either%20decreased%20or%20increased%20ligand-dependent%20activation.%20Alzheimers%20Dement.%202017;13:381%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Thornton P, Sevalle J, Deery MJ, Fraser G, Zhou Y, Ståhl S, et al. TREM2 shedding by cleavage at the H157–S158 bond is accelerated for the Alzheimer’s disease-associated H157Y variant. EMBO Mol Med. 2017;9:1366–78.
</cite> [<a href="https://doi.org/10.15252/emmm.201707673" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5623839/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28855301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Thornton%20P,%20Sevalle%20J,%20Deery%20MJ,%20Fraser%20G,%20Zhou%20Y,%20St%C3%A5hl%20S,%20et%20al.%20TREM2%20shedding%20by%20cleavage%20at%20the%20H157%E2%80%93S158%20bond%20is%20accelerated%20for%20the%20Alzheimer%E2%80%99s%20disease-associated%20H157Y%20variant.%20EMBO%20Mol%20Med.%202017;9:1366%E2%80%9378." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Olufunmilayo EO, Holsinger RMD. Variant TREM2 signaling in Alzheimer’s disease. J Mol Biol. 2022;434: 167470.
</cite> [<a href="https://doi.org/10.1016/j.jmb.2022.167470" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35120968/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Olufunmilayo%20EO,%20Holsinger%20RMD.%20Variant%20TREM2%20signaling%20in%20Alzheimer%E2%80%99s%20disease.%20J%20Mol%20Biol.%202022;434:%20167470." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med. 2016;213:667–75.
</cite> [<a href="https://doi.org/10.1084/jem.20151948" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4854736/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27091843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Ulland%20TK,%20Ulrich%20JD,%20Song%20W,%20Tzaferis%20JA,%20Hole%20JT,%20et%20al.%20TREM2-mediated%20early%20microglial%20response%20limits%20diffusion%20and%20toxicity%20of%20amyloid%20plaques.%20J%20Exp%20Med.%202016;213:667%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90:724–39.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2016.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4898967/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27196974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yuan%20P,%20Condello%20C,%20Keene%20CD,%20Wang%20Y,%20Bird%20TD,%20Paul%20SM,%20et%20al.%20TREM2%20haplodeficiency%20in%20mice%20and%20humans%20impairs%20the%20microglia%20barrier%20function%20leading%20to%20decreased%20amyloid%20compaction%20and%20severe%20axonal%20dystrophy.%20Neuron.%202016;90:724%E2%80%9339." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Ulrich JD, Ulland TK, Mahan TE, Nyström S, Nilsson KP, Song WM, et al. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215:1047–58.
</cite> [<a href="https://doi.org/10.1084/jem.20171265" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5881464/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29483128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ulrich%20JD,%20Ulland%20TK,%20Mahan%20TE,%20Nystr%C3%B6m%20S,%20Nilsson%20KP,%20Song%20WM,%20et%20al.%20ApoE%20facilitates%20the%20microglial%20response%20to%20amyloid%20plaque%20pathology.%20J%20Exp%20Med.%202018;215:1047%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science. 1992;256:184–5.
</cite> [<a href="https://doi.org/10.1126/science.1566067" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1566067/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hardy%20JA,%20Higgins%20GA.%20Alzheimer%E2%80%99s%20disease:%20the%20amyloid%20cascade%20hypothesis.%20Science.%201992;256:184%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Tanzi RE, Bertram L. Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell. 2005;120:545–55.
</cite> [<a href="https://doi.org/10.1016/j.cell.2005.02.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15734686/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tanzi%20RE,%20Bertram%20L.%20Twenty%20years%20of%20the%20Alzheimer%E2%80%99s%20disease%20amyloid%20hypothesis:%20a%20genetic%20perspective.%20Cell.%202005;120:545%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Glenner GG, Wong CW. Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120:885–90.
</cite> [<a href="https://doi.org/10.1016/s0006-291x(84)80190-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6375662/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Glenner%20GG,%20Wong%20CW.%20Alzheimer%E2%80%99s%20disease:%20Initial%20report%20of%20the%20purification%20and%20characterization%20of%20a%20novel%20cerebrovascular%20amyloid%20protein.%20Biochem%20Biophys%20Res%20Commun.%201984;120:885%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Wang X, Sun Y, Li T, Cai Y, Han Y. Amyloid-β as a blood biomarker for Alzheimer’s disease: a review of recent literature. J Alzheimers Dis JAD. 2020;73:819–32.
</cite> [<a href="https://doi.org/10.3233/JAD-190714" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31868667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20X,%20Sun%20Y,%20Li%20T,%20Cai%20Y,%20Han%20Y.%20Amyloid-%CE%B2%20as%20a%20blood%20biomarker%20for%20Alzheimer%E2%80%99s%20disease:%20a%20review%20of%20recent%20literature.%20J%20Alzheimers%20Dis%20JAD.%202020;73:819%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Akiyama H, Kondo H, Ikeda K, Kato M, McGeer PL. Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition. Brain Res. 2001;902:277–81.
</cite> [<a href="https://doi.org/10.1016/s0006-8993(01)02390-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11384622/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Akiyama%20H,%20Kondo%20H,%20Ikeda%20K,%20Kato%20M,%20McGeer%20PL.%20Immunohistochemical%20localization%20of%20neprilysin%20in%20the%20human%20cerebral%20cortex:%20inverse%20association%20with%20vulnerability%20to%20amyloid%20beta-protein%20(Abeta)%20deposition.%20Brain%20Res.%202001;902:277%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Carpentier M, Robitaille Y, DesGroseillers L, Boileau G, Marcinkiewicz M. Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 2002;61:849–56.
</cite> [<a href="https://doi.org/10.1093/jnen/61.10.849" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12387451/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Carpentier%20M,%20Robitaille%20Y,%20DesGroseillers%20L,%20Boileau%20G,%20Marcinkiewicz%20M.%20Declining%20expression%20of%20neprilysin%20in%20Alzheimer%20disease%20vasculature:%20possible%20involvement%20in%20cerebral%20amyloid%20angiopathy.%20J%20Neuropathol%20Exp%20Neurol.%202002;61:849%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG. Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 2006;65:1012–21.
</cite> [<a href="https://doi.org/10.1097/01.jnen.0000240463.87886.9a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17021406/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miners%20JS,%20Van%20Helmond%20Z,%20Chalmers%20K,%20Wilcock%20G,%20Love%20S,%20Kehoe%20PG.%20Decreased%20expression%20and%20activity%20of%20neprilysin%20in%20Alzheimer%20disease%20are%20associated%20with%20cerebral%20amyloid%20angiopathy.%20J%20Neuropathol%20Exp%20Neurol.%202006;65:1012%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Miners JS, Baig S, Tayler H, Kehoe PG, Love S. Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity. J Neuropathol Exp Neurol. 2009;68:902–14.
</cite> [<a href="https://doi.org/10.1097/NEN.0b013e3181afe475" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19606063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miners%20JS,%20Baig%20S,%20Tayler%20H,%20Kehoe%20PG,%20Love%20S.%20Neprilysin%20and%20insulin-degrading%20enzyme%20levels%20are%20increased%20in%20Alzheimer%20disease%20in%20relation%20to%20disease%20severity.%20J%20Neuropathol%20Exp%20Neurol.%202009;68:902%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Shinohara M, Tachibana M, Kanekiyo T, Bu G. Role of LRP1 in the pathogenesis of Alzheimer’s disease: evidence from clinical and preclinical studies. J Lipid Res. 2017;58:1267–81.
</cite> [<a href="https://doi.org/10.1194/jlr.R075796" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5496044/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28381441/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shinohara%20M,%20Tachibana%20M,%20Kanekiyo%20T,%20Bu%20G.%20Role%20of%20LRP1%20in%20the%20pathogenesis%20of%20Alzheimer%E2%80%99s%20disease:%20evidence%20from%20clinical%20and%20preclinical%20studies.%20J%20Lipid%20Res.%202017;58:1267%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, et al. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest. 2008;118:4002–13.
</cite> [<a href="https://doi.org/10.1172/JCI36663" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2582453/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19033669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deane%20R,%20Sagare%20A,%20Hamm%20K,%20Parisi%20M,%20Lane%20S,%20Finn%20MB,%20et%20al.%20apoE%20isoform-specific%20disruption%20of%20amyloid%20beta%20peptide%20clearance%20from%20mouse%20brain.%20J%20Clin%20Invest.%202008;118:4002%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron. 2004;43:333–44.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2004.07.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15294142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deane%20R,%20Wu%20Z,%20Sagare%20A,%20Davis%20J,%20Du%20Yan%20S,%20Hamm%20K,%20et%20al.%20LRP/amyloid%20beta-peptide%20interaction%20mediates%20differential%20brain%20efflux%20of%20Abeta%20isoforms.%20Neuron.%202004;43:333%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Du Y, Ni B, Glinn M, Dodel RC, Bales KR, Zhang Z, et al. alpha2-Macroglobulin as a beta-amyloid peptide-binding plasma protein. J Neurochem. 1997;69:299–305.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9202323/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Du%20Y,%20Ni%20B,%20Glinn%20M,%20Dodel%20RC,%20Bales%20KR,%20Zhang%20Z,%20et%20al.%20alpha2-Macroglobulin%20as%20a%20beta-amyloid%20peptide-binding%20plasma%20protein.%20J%20Neurochem.%201997;69:299%E2%80%93305." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>May P, Reddy YK, Herz J. Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J Biol Chem. 2002;277:18736–43.
</cite> [<a href="https://doi.org/10.1074/jbc.M201979200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11907044/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?May%20P,%20Reddy%20YK,%20Herz%20J.%20Proteolytic%20processing%20of%20low%20density%20lipoprotein%20receptor-related%20protein%20mediates%20regulated%20release%20of%20its%20intracellular%20domain.%20J%20Biol%20Chem.%202002;277:18736%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>May P, Woldt E, Matz RL, Boucher P. The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann Med. 2007;39:219–28.
</cite> [<a href="https://doi.org/10.1080/07853890701214881" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17457719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?May%20P,%20Woldt%20E,%20Matz%20RL,%20Boucher%20P.%20The%20LDL%20receptor-related%20protein%20(LRP)%20family:%20an%20old%20family%20of%20proteins%20with%20new%20physiological%20functions.%20Ann%20Med.%202007;39:219%E2%80%9328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Ulery PG, Beers J, Mikhailenko I, Tanzi RE, Rebeck GW, Hyman BT, et al. Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer’s disease. J Biol Chem. 2000;275:7410–5.
</cite> [<a href="https://doi.org/10.1074/jbc.275.10.7410" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10702315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ulery%20PG,%20Beers%20J,%20Mikhailenko%20I,%20Tanzi%20RE,%20Rebeck%20GW,%20Hyman%20BT,%20et%20al.%20Modulation%20of%20beta-amyloid%20precursor%20protein%20processing%20by%20the%20low%20density%20lipoprotein%20receptor-related%20protein%20(LRP).%20Evidence%20that%20LRP%20contributes%20to%20the%20pathogenesis%20of%20Alzheimer%E2%80%99s%20disease.%20J%20Biol%20Chem.%202000;275:7410%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Cam JA, Zerbinatti CV, Li Y, Bu G. Rapid endocytosis of the low density lipoprotein receptor-related protein modulates cell surface distribution and processing of the beta-amyloid precursor protein. J Biol Chem. 2005;280:15464–70.
</cite> [<a href="https://doi.org/10.1074/jbc.M500613200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15705569/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cam%20JA,%20Zerbinatti%20CV,%20Li%20Y,%20Bu%20G.%20Rapid%20endocytosis%20of%20the%20low%20density%20lipoprotein%20receptor-related%20protein%20modulates%20cell%20surface%20distribution%20and%20processing%20of%20the%20beta-amyloid%20precursor%20protein.%20J%20Biol%20Chem.%202005;280:15464%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Trommsdorff M, Borg JP, Margolis B, Herz J. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J Biol Chem. 1998;273:33556–60.
</cite> [<a href="https://doi.org/10.1074/jbc.273.50.33556" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9837937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Trommsdorff%20M,%20Borg%20JP,%20Margolis%20B,%20Herz%20J.%20Interaction%20of%20cytosolic%20adaptor%20proteins%20with%20neuronal%20apolipoprotein%20E%20receptors%20and%20the%20amyloid%20precursor%20protein.%20J%20Biol%20Chem.%201998;273:33556%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Aldecoa I, Barroeta I, Carroll SL, Fortea J, Gilmore A, Ginsberg SD, et al. Down syndrome biobank consortium: a perspective. Alzheimers Dement J Alzheimers Assoc. 2024;20:2262–72.</cite> [<a href="https://doi.org/10.1002/alz.13692" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10984425/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38270275/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aldecoa%20I,%20Barroeta%20I,%20Carroll%20SL,%20Fortea%20J,%20Gilmore%20A,%20Ginsberg%20SD,%20et%20al.%20Down%20syndrome%20biobank%20consortium:%20a%20perspective.%20Alzheimers%20Dement%20J%20Alzheimers%20Assoc.%202024;20:2262%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Ossenkoppele R. Amyloid-β and tau PET scans predict clinical progression in cognitively unimpaired people. Nat Med. 2022;28:2267–8.
</cite> [<a href="https://doi.org/10.1038/s41591-022-02071-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36352264/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ossenkoppele%20R.%20Amyloid-%CE%B2%20and%20tau%20PET%20scans%20predict%20clinical%20progression%20in%20cognitively%20unimpaired%20people.%20Nat%20Med.%202022;28:2267%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, et al. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease. Sci Transl Med. 2016;8: 338ra66.
</cite> [<a href="https://doi.org/10.1126/scitranslmed.aaf2362" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5267531/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27169802/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brier%20MR,%20Gordon%20B,%20Friedrichsen%20K,%20McCarthy%20J,%20Stern%20A,%20Christensen%20J,%20et%20al.%20Tau%20and%20A%CE%B2%20imaging,%20CSF%20measures,%20and%20cognition%20in%20Alzheimer%E2%80%99s%20disease.%20Sci%20Transl%20Med.%202016;8:%20338ra66." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Tolar M, Hey J, Power A, Abushakra S. Neurotoxic soluble amyloid oligomers drive Alzheimer’s pathogenesis and represent a clinically validated target for slowing disease progression. Int J Mol Sci. 2021;22:6355.
</cite> [<a href="https://doi.org/10.3390/ijms22126355" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8231952/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34198582/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tolar%20M,%20Hey%20J,%20Power%20A,%20Abushakra%20S.%20Neurotoxic%20soluble%20amyloid%20oligomers%20drive%20Alzheimer%E2%80%99s%20pathogenesis%20and%20represent%20a%20clinically%20validated%20target%20for%20slowing%20disease%20progression.%20Int%20J%20Mol%20Sci.%202021;22:6355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Iqbal K, Alonso A, Gong C, Khatoon S, Kudo T, Singh T, et al. Molecular pathology of Alzheimer neurofibrillary degeneration. Acta Neurobiol Exp (Warsz). 1993;53:325–35.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8317268/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Iqbal%20K,%20Alonso%20A,%20Gong%20C,%20Khatoon%20S,%20Kudo%20T,%20Singh%20T,%20et%20al.%20Molecular%20pathology%20of%20Alzheimer%20neurofibrillary%20degeneration.%20Acta%20Neurobiol%20Exp%20(Warsz).%201993;53:325%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Imbimbo BP, Balducci C, Ippati S, Watling M. Initial failures of anti-tau antibodies in Alzheimer’s disease are reminiscent of the amyloid-β story. Neural Regen Res. 2022;18:117–8.</cite> [<a href="https://doi.org/10.4103/1673-5374.340409" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9241406/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35799522/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Imbimbo%20BP,%20Balducci%20C,%20Ippati%20S,%20Watling%20M.%20Initial%20failures%20of%20anti-tau%20antibodies%20in%20Alzheimer%E2%80%99s%20disease%20are%20reminiscent%20of%20the%20amyloid-%CE%B2%20story.%20Neural%20Regen%20Res.%202022;18:117%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Wennström M, Janelidze S, Nilsson KPR, Serrano GE, Beach TG, Dage JL, et al. Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels. Acta Neuropathol Commun. 2022;10:3.
</cite> [<a href="https://doi.org/10.1186/s40478-021-01307-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8734209/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34991721/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wennstr%C3%B6m%20M,%20Janelidze%20S,%20Nilsson%20KPR,%20Serrano%20GE,%20Beach%20TG,%20Dage%20JL,%20et%20al.%20Cellular%20localization%20of%20p-tau217%20in%20brain%20and%20its%20association%20with%20p-tau217%20plasma%20levels.%20Acta%20Neuropathol%20Commun.%202022;10:3." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Busciglio J, Lorenzo A, Yeh J, Yankner BA. Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 1995;14:879–88.
</cite> [<a href="https://doi.org/10.1016/0896-6273(95)90232-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7718249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Busciglio%20J,%20Lorenzo%20A,%20Yeh%20J,%20Yankner%20BA.%20Beta-amyloid%20fibrils%20induce%20tau%20phosphorylation%20and%20loss%20of%20microtubule%20binding.%20Neuron.%201995;14:879%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Ferreira A, Lu Q, Orecchio L, Kosik KS. Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta. Mol Cell Neurosci. 1997;9:220–34.
</cite> [<a href="https://doi.org/10.1006/mcne.1997.0615" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9245504/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ferreira%20A,%20Lu%20Q,%20Orecchio%20L,%20Kosik%20KS.%20Selective%20phosphorylation%20of%20adult%20tau%20isoforms%20in%20mature%20hippocampal%20neurons%20exposed%20to%20fibrillar%20A%20beta.%20Mol%20Cell%20Neurosci.%201997;9:220%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Gee MS, Son SH, Jeon SH, Do J, Kim N, Ju Y-J, et al. A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse. Alzheimers Res Ther. 2020;12:45.
</cite> [<a href="https://doi.org/10.1186/s13195-020-00617-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7175487/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32317025/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gee%20MS,%20Son%20SH,%20Jeon%20SH,%20Do%20J,%20Kim%20N,%20Ju%20Y-J,%20et%20al.%20A%20selective%20p38%CE%B1/%CE%B2%20MAPK%20inhibitor%20alleviates%20neuropathology%20and%20cognitive%20impairment,%20and%20modulates%20microglia%20function%20in%205XFAD%20mouse.%20Alzheimers%20Res%20Ther.%202020;12:45." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature. 2000;405:360–4.
</cite> [<a href="https://doi.org/10.1038/35012636" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10830966/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20MS,%20Kwon%20YT,%20Li%20M,%20Peng%20J,%20Friedlander%20RM,%20Tsai%20LH.%20Neurotoxicity%20induces%20cleavage%20of%20p35%20to%20p25%20by%20calpain.%20Nature.%202000;405:360%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR86">
<span class="label">86.</span><cite>Lopes JP, Oliveira CR, Agostinho P. Neurodegeneration in an Abeta-induced model of Alzheimer’s disease: the role of Cdk5. Aging Cell. 2010;9:64–77.
</cite> [<a href="https://doi.org/10.1111/j.1474-9726.2009.00536.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19895631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lopes%20JP,%20Oliveira%20CR,%20Agostinho%20P.%20Neurodegeneration%20in%20an%20Abeta-induced%20model%20of%20Alzheimer%E2%80%99s%20disease:%20the%20role%20of%20Cdk5.%20Aging%20Cell.%202010;9:64%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Yarza R, Vela S, Solas M, Ramirez MJ. c-Jun N-terminal Kinase (JNK) signaling as a therapeutic target for Alzheimer’s disease. Front Pharmacol. 2016;6:321.
</cite> [<a href="https://doi.org/10.3389/fphar.2015.00321" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4709475/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26793112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yarza%20R,%20Vela%20S,%20Solas%20M,%20Ramirez%20MJ.%20c-Jun%20N-terminal%20Kinase%20(JNK)%20signaling%20as%20a%20therapeutic%20target%20for%20Alzheimer%E2%80%99s%20disease.%20Front%20Pharmacol.%202016;6:321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Noble W, Hanger DP, Miller CCJ, Lovestone S. The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol. 2013;4: 83.
</cite> [<a href="https://doi.org/10.3389/fneur.2013.00083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3696910/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23847585/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Noble%20W,%20Hanger%20DP,%20Miller%20CCJ,%20Lovestone%20S.%20The%20importance%20of%20tau%20phosphorylation%20for%20neurodegenerative%20diseases.%20Front%20Neurol.%202013;4:%2083." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Alvarez G, Muñoz-Montaño JR, Satrústegui J, Avila J, Bogónez E, Díaz-Nido J. Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. FEBS Lett. 1999;453:260–4.
</cite> [<a href="https://doi.org/10.1016/s0014-5793(99)00685-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10405156/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alvarez%20G,%20Mu%C3%B1oz-Monta%C3%B1o%20JR,%20Satr%C3%BAstegui%20J,%20Avila%20J,%20Bog%C3%B3nez%20E,%20D%C3%ADaz-Nido%20J.%20Lithium%20protects%20cultured%20neurons%20against%20beta-amyloid-induced%20neurodegeneration.%20FEBS%20Lett.%201999;453:260%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Tamagno E, Robino G, Obbili A, Bardini P, Aragno M, Parola M, et al. H2O2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK. Exp Neurol. 2003;180:144–55.
</cite> [<a href="https://doi.org/10.1016/s0014-4886(02)00059-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12684028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tamagno%20E,%20Robino%20G,%20Obbili%20A,%20Bardini%20P,%20Aragno%20M,%20Parola%20M,%20et%20al.%20H2O2%20and%204-hydroxynonenal%20mediate%20amyloid%20beta-induced%20neuronal%20apoptosis%20by%20activating%20JNKs%20and%20p38MAPK.%20Exp%20Neurol.%202003;180:144%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Zheng W-H, Bastianetto S, Mennicken F, Ma W, Kar S. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience. 2002;115:201–11.
</cite> [<a href="https://doi.org/10.1016/s0306-4522(02)00404-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12401334/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20W-H,%20Bastianetto%20S,%20Mennicken%20F,%20Ma%20W,%20Kar%20S.%20Amyloid%20beta%20peptide%20induces%20tau%20phosphorylation%20and%20loss%20of%20cholinergic%20neurons%20in%20rat%20primary%20septal%20cultures.%20Neuroscience.%202002;115:201%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR92">
<span class="label">92.</span><cite>Selkoe DJ. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior. Behav Brain Res. 2008;192:106–13.
</cite> [<a href="https://doi.org/10.1016/j.bbr.2008.02.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2601528/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18359102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Selkoe%20DJ.%20Soluble%20oligomers%20of%20the%20amyloid%20%CE%B2-protein%20impair%20synaptic%20plasticity%20and%20behavior.%20Behav%20Brain%20Res.%202008;192:106%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR93">
<span class="label">93.</span><cite>Kuo YM, Emmerling MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, et al. Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem. 1996;271:4077–81.
</cite> [<a href="https://doi.org/10.1074/jbc.271.8.4077" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8626743/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kuo%20YM,%20Emmerling%20MR,%20Vigo-Pelfrey%20C,%20Kasunic%20TC,%20Kirkpatrick%20JB,%20Murdoch%20GH,%20et%20al.%20Water-soluble%20Abeta%20(N-40,%20N-42)%20oligomers%20in%20normal%20and%20Alzheimer%20disease%20brains.%20J%20Biol%20Chem.%201996;271:4077%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR94">
<span class="label">94.</span><cite>Liu P-P, Xie Y, Meng X-Y, Kang J-S. History and progress of hypotheses and clinical trials for Alzheimer’s disease. Signal Transduct Target Ther. 2019;4:1–22.
</cite> [<a href="https://doi.org/10.1038/s41392-019-0063-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6799833/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31637009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20P-P,%20Xie%20Y,%20Meng%20X-Y,%20Kang%20J-S.%20History%20and%20progress%20of%20hypotheses%20and%20clinical%20trials%20for%20Alzheimer%E2%80%99s%20disease.%20Signal%20Transduct%20Target%20Ther.%202019;4:1%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR95">
<span class="label">95.</span><cite>Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, et al. Randomized trial of Verubecestat for mild-to-moderate Alzheimer’s disease. N Engl J Med. 2018;378:1691–703.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1706441" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6776074/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29719179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Egan%20MF,%20Kost%20J,%20Tariot%20PN,%20Aisen%20PS,%20Cummings%20JL,%20Vellas%20B,%20et%20al.%20Randomized%20trial%20of%20Verubecestat%20for%20mild-to-moderate%20Alzheimer%E2%80%99s%20disease.%20N%20Engl%20J%20Med.%202018;378:1691%E2%80%93703." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR96">
<span class="label">96.</span><cite>Coric V, Salloway S, van Dyck CH, Dubois B, Andreasen N, Brody M, et al. Targeting prodromal Alzheimer disease with avagacestat: a randomized clinical trial. JAMA Neurol. 2015;72:1324–33.
</cite> [<a href="https://doi.org/10.1001/jamaneurol.2015.0607" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26414022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Coric%20V,%20Salloway%20S,%20van%20Dyck%20CH,%20Dubois%20B,%20Andreasen%20N,%20Brody%20M,%20et%20al.%20Targeting%20prodromal%20Alzheimer%20disease%20with%20avagacestat:%20a%20randomized%20clinical%20trial.%20JAMA%20Neurol.%202015;72:1324%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR97">
<span class="label">97.</span><cite>Sperling R, Henley D, Aisen PS, Raman R, Donohue MC, Ernstrom K, et al. Findings of efficacy, safety, and biomarker outcomes of atabecestat in preclinical Alzheimer disease: a truncated randomized phase 2b/3 clinical trial. JAMA Neurol. 2021;78:293–301.
</cite> [<a href="https://doi.org/10.1001/jamaneurol.2020.4857" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7816119/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33464300/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sperling%20R,%20Henley%20D,%20Aisen%20PS,%20Raman%20R,%20Donohue%20MC,%20Ernstrom%20K,%20et%20al.%20Findings%20of%20efficacy,%20safety,%20and%20biomarker%20outcomes%20of%20atabecestat%20in%20preclinical%20Alzheimer%20disease:%20a%20truncated%20randomized%20phase%202b/3%20clinical%20trial.%20JAMA%20Neurol.%202021;78:293%E2%80%93301." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR98">
<span class="label">98.</span><cite>Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. A phase 3 trial of semagacestat for treatment of Alzheimer’s disease. N Engl J Med. 2013;369:341–50.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1210951" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23883379/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Doody%20RS,%20Raman%20R,%20Farlow%20M,%20Iwatsubo%20T,%20Vellas%20B,%20Joffe%20S,%20et%20al.%20A%20phase%203%20trial%20of%20semagacestat%20for%20treatment%20of%20Alzheimer%E2%80%99s%20disease.%20N%20Engl%20J%20Med.%202013;369:341%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR99">
<span class="label">99.</span><cite>Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, et al. Two randomized phase 3 studies of aducanumab in early Alzheimer’s disease. J Prev Alzheimers Dis. 2022;9:197–210.
</cite> [<a href="https://doi.org/10.14283/jpad.2022.30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35542991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Budd%20Haeberlein%20S,%20Aisen%20PS,%20Barkhof%20F,%20Chalkias%20S,%20Chen%20T,%20Cohen%20S,%20et%20al.%20Two%20randomized%20phase%203%20studies%20of%20aducanumab%20in%20early%20Alzheimer%E2%80%99s%20disease.%20J%20Prev%20Alzheimers%20Dis.%202022;9:197%E2%80%93210." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR100">
<span class="label">100.</span><cite>Whitehouse P, Gandy S, Saini V, George DR, Larson EB, Alexander GC, et al. Making the case for accelerated withdrawal of aducanumab. J Alzheimers Dis JAD. 2022;87:1003–7.
</cite> [<a href="https://doi.org/10.3233/JAD-220262" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35404287/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Whitehouse%20P,%20Gandy%20S,%20Saini%20V,%20George%20DR,%20Larson%20EB,%20Alexander%20GC,%20et%20al.%20Making%20the%20case%20for%20accelerated%20withdrawal%20of%20aducanumab.%20J%20Alzheimers%20Dis%20JAD.%202022;87:1003%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR101">
<span class="label">101.</span><cite>Aduhelm | European Medicines Agency.. Available from: <a href="https://www.ema.europa.eu/en/medicines/human/EPAR/aduhelm" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ema.europa.eu/en/medicines/human/EPAR/aduhelm</a></cite>
</li>
<li id="CR102">
<span class="label">102.</span><cite>Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, et al. A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease. Alzheimers Res Ther. 2017;9:95.
</cite> [<a href="https://doi.org/10.1186/s13195-017-0318-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5723032/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29221491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ostrowitzki%20S,%20Lasser%20RA,%20Dorflinger%20E,%20Scheltens%20P,%20Barkhof%20F,%20Nikolcheva%20T,%20et%20al.%20A%20phase%20III%20randomized%20trial%20of%20gantenerumab%20in%20prodromal%20Alzheimer%E2%80%99s%20disease.%20Alzheimers%20Res%20Ther.%202017;9:95." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR103">
<span class="label">103.</span><cite>Filippi M, Cecchetti G, Spinelli EG, Vezzulli P, Falini A, Agosta F. Amyloid-related imaging abnormalities and β-amyloid-targeting antibodies: a systematic review. JAMA Neurol. 2022;79:291–304.
</cite> [<a href="https://doi.org/10.1001/jamaneurol.2021.5205" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35099507/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Filippi%20M,%20Cecchetti%20G,%20Spinelli%20EG,%20Vezzulli%20P,%20Falini%20A,%20Agosta%20F.%20Amyloid-related%20imaging%20abnormalities%20and%20%CE%B2-amyloid-targeting%20antibodies:%20a%20systematic%20review.%20JAMA%20Neurol.%202022;79:291%E2%80%93304." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR104">
<span class="label">104.</span><cite>Roytman M, Mashriqi F, Al-Tawil K, Schulz PE, Zaharchuk G, Benzinger TLS, et al. Amyloid-related imaging abnormalities: an update. Am J Roentgenol. 2023;220:562–74.
</cite> [<a href="https://doi.org/10.2214/AJR.22.28461" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36321981/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Roytman%20M,%20Mashriqi%20F,%20Al-Tawil%20K,%20Schulz%20PE,%20Zaharchuk%20G,%20Benzinger%20TLS,%20et%20al.%20Amyloid-related%20imaging%20abnormalities:%20an%20update.%20Am%20J%20Roentgenol.%202023;220:562%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR105">
<span class="label">105.</span><cite>Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, et al. Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol. 2022;79:13–21.
</cite> [<a href="https://doi.org/10.1001/jamaneurol.2021.4161" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8609465/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34807243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Salloway%20S,%20Chalkias%20S,%20Barkhof%20F,%20Burkett%20P,%20Barakos%20J,%20Purcell%20D,%20et%20al.%20Amyloid-related%20imaging%20abnormalities%20in%202%20phase%203%20studies%20evaluating%20aducanumab%20in%20patients%20with%20early%20Alzheimer%20disease.%20JAMA%20Neurol.%202022;79:13%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR106">
<span class="label">106.</span><cite>van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer’s disease. N Engl J Med. 2023;388:9–21.
</cite> [<a href="https://doi.org/10.1056/NEJMoa2212948" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36449413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Dyck%20CH,%20Swanson%20CJ,%20Aisen%20P,%20Bateman%20RJ,%20Chen%20C,%20Gee%20M,%20et%20al.%20Lecanemab%20in%20early%20Alzheimer%E2%80%99s%20disease.%20N%20Engl%20J%20Med.%202023;388:9%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR107">
<span class="label">107.</span><cite>Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330:512–27.
</cite> [<a href="https://doi.org/10.1001/jama.2023.13239" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10352931/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37459141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sims%20JR,%20Zimmer%20JA,%20Evans%20CD,%20Lu%20M,%20Ardayfio%20P,%20Sparks%20J,%20et%20al.%20Donanemab%20in%20early%20symptomatic%20Alzheimer%20disease:%20the%20TRAILBLAZER-ALZ%202%20randomized%20clinical%20trial.%20JAMA.%202023;330:512%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR108">
<span class="label">108.</span><cite>Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody. Alzheimers Res Ther. 2021;13:80.
</cite> [<a href="https://doi.org/10.1186/s13195-021-00813-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8053280/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33865446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Swanson%20CJ,%20Zhang%20Y,%20Dhadda%20S,%20Wang%20J,%20Kaplow%20J,%20Lai%20RYK,%20et%20al.%20A%20randomized,%20double-blind,%20phase%202b%20proof-of-concept%20clinical%20trial%20in%20early%20Alzheimer%E2%80%99s%20disease%20with%20lecanemab,%20an%20anti-A%CE%B2%20protofibril%20antibody.%20Alzheimers%20Res%20Ther.%202021;13:80." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR109">
<span class="label">109.</span><cite>Kim B-H, Kim S, Nam Y, Park YH, Shin SM, Moon M. Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives. Transl Neurodegener. 2025;14:6.
</cite> [<a href="https://doi.org/10.1186/s40035-025-00465-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11771116/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39865265/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20B-H,%20Kim%20S,%20Nam%20Y,%20Park%20YH,%20Shin%20SM,%20Moon%20M.%20Second-generation%20anti-amyloid%20monoclonal%20antibodies%20for%20Alzheimer%E2%80%99s%20disease:%20current%20landscape%20and%20future%20perspectives.%20Transl%20Neurodegener.%202025;14:6." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR110">
<span class="label">110.</span><cite>Antolini L, DiFrancesco JC, Zedde M, Basso G, Arighi A, Shima A, et al. Spontaneous ARIA-like events in cerebral amyloid angiopathy–related inflammation: a multicenter prospective longitudinal cohort study. Neurology. 2021;97: e1809.
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000012778" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8610623/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34531298/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Antolini%20L,%20DiFrancesco%20JC,%20Zedde%20M,%20Basso%20G,%20Arighi%20A,%20Shima%20A,%20et%20al.%20Spontaneous%20ARIA-like%20events%20in%20cerebral%20amyloid%20angiopathy%E2%80%93related%20inflammation:%20a%20multicenter%20prospective%20longitudinal%20cohort%20study.%20Neurology.%202021;97:%20e1809." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR111">
<span class="label">111.</span><cite>Sperling RA, Jack CR, Black SE, Frosch MP, Greenberg SM, Hyman BT, et al. Amyloid related imaging abnormalities (aria) in amyloid modifying therapeutic trials: recommendations from the Alzheimer’s Association Research Roundtable Workgroup. Alzheimers Dement J Alzheimers Assoc. 2011;7:367–85.</cite> [<a href="https://doi.org/10.1016/j.jalz.2011.05.2351" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3693547/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21784348/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sperling%20RA,%20Jack%20CR,%20Black%20SE,%20Frosch%20MP,%20Greenberg%20SM,%20Hyman%20BT,%20et%20al.%20Amyloid%20related%20imaging%20abnormalities%20(aria)%20in%20amyloid%20modifying%20therapeutic%20trials:%20recommendations%20from%20the%20Alzheimer%E2%80%99s%20Association%20Research%20Roundtable%20Workgroup.%20Alzheimers%20Dement%20J%20Alzheimers%20Assoc.%202011;7:367%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR112">
<span class="label">112.</span><cite>DiFrancesco JC, Brioschi M, Brighina L, Ruffmann C, Saracchi E, Costantino G, et al. Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report. Neurology. 2011;76:842–4.
</cite> [<a href="https://doi.org/10.1212/WNL.0b013e31820e773c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21357837/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?DiFrancesco%20JC,%20Brioschi%20M,%20Brighina%20L,%20Ruffmann%20C,%20Saracchi%20E,%20Costantino%20G,%20et%20al.%20Anti-A%CE%B2%20autoantibodies%20in%20the%20CSF%20of%20a%20patient%20with%20CAA-related%20inflammation:%20a%20case%20report.%20Neurology.%202011;76:842%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR113">
<span class="label">113.</span><cite>Scientists tie third clinical trial death to experimental Alzheimer’s drug.. Available from: <a href="https://www.science.org/content/article/scientists-tie-third-clinical-trial-death-experimental-alzheimer-s-drug" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.science.org/content/article/scientists-tie-third-clinical-trial-death-experimental-alzheimer-s-drug</a></cite>
</li>
<li id="CR114">
<span class="label">114.</span><cite>Jomova K, Makova M, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, et al. Essential metals in health and disease. Chem Biol Interact. 2022;367: 110173.
</cite> [<a href="https://doi.org/10.1016/j.cbi.2022.110173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36152810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jomova%20K,%20Makova%20M,%20Alomar%20SY,%20Alwasel%20SH,%20Nepovimova%20E,%20Kuca%20K,%20et%20al.%20Essential%20metals%20in%20health%20and%20disease.%20Chem%20Biol%20Interact.%202022;367:%20110173." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR115">
<span class="label">115.</span><cite>Riordan JF, Vallee BL. The functional roles of metals in metalloenzymes. Protein-Met Interact. Boston: Springer; 1974. p. 33–57.</cite> [<a href="https://doi.org/10.1007/978-1-4684-0943-7_2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/4215300/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Riordan%20JF,%20Vallee%20BL.%20The%20functional%20roles%20of%20metals%20in%20metalloenzymes.%20Protein-Met%20Interact.%20Boston:%20Springer;%201974.%20p.%2033%E2%80%9357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR116">
<span class="label">116.</span><cite>Bai R, Guo J, Ye X-Y, Xie Y, Xie T. Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease. Ageing Res Rev. 2022;77: 101619.
</cite> [<a href="https://doi.org/10.1016/j.arr.2022.101619" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35395415/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bai%20R,%20Guo%20J,%20Ye%20X-Y,%20Xie%20Y,%20Xie%20T.%20Oxidative%20stress:%20The%20core%20pathogenesis%20and%20mechanism%20of%20Alzheimer%E2%80%99s%20disease.%20Ageing%20Res%20Rev.%202022;77:%20101619." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR117">
<span class="label">117.</span><cite>Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol. 2017;14:450–64.
</cite> [<a href="https://doi.org/10.1016/j.redox.2017.10.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5680523/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29080524/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheignon%20C,%20Tomas%20M,%20Bonnefont-Rousselot%20D,%20Faller%20P,%20Hureau%20C,%20Collin%20F.%20Oxidative%20stress%20and%20the%20amyloid%20beta%20peptide%20in%20Alzheimer%E2%80%99s%20disease.%20Redox%20Biol.%202017;14:450%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR118">
<span class="label">118.</span><cite>Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer’s disease senile plaques. J Neurol Sci. 1998;158:47–52.
</cite> [<a href="https://doi.org/10.1016/s0022-510x(98)00092-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9667777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lovell%20MA,%20Robertson%20JD,%20Teesdale%20WJ,%20Campbell%20JL,%20Markesbery%20WR.%20Copper,%20iron%20and%20zinc%20in%20Alzheimer%E2%80%99s%20disease%20senile%20plaques.%20J%20Neurol%20Sci.%201998;158:47%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR119">
<span class="label">119.</span><cite>Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease. Mol Neurodegener. 2020;15: 40.
</cite> [<a href="https://doi.org/10.1186/s13024-020-00391-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7364557/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32677986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20T,%20Zhang%20D,%20Zeng%20Y,%20Huang%20TY,%20Xu%20H,%20Zhao%20Y.%20Molecular%20and%20cellular%20mechanisms%20underlying%20the%20pathogenesis%20of%20Alzheimer%E2%80%99s%20disease.%20Mol%20Neurodegener.%202020;15:%2040." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR120">
<span class="label">120.</span><cite>Miller LM, Wang Q, Telivala TP, Smith RJ, Lanzirotti A, Miklossy J. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer’s disease. J Struct Biol. 2006;155:30–7.
</cite> [<a href="https://doi.org/10.1016/j.jsb.2005.09.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16325427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miller%20LM,%20Wang%20Q,%20Telivala%20TP,%20Smith%20RJ,%20Lanzirotti%20A,%20Miklossy%20J.%20Synchrotron-based%20infrared%20and%20X-ray%20imaging%20shows%20focalized%20accumulation%20of%20Cu%20and%20Zn%20co-localized%20with%20beta-amyloid%20deposits%20in%20Alzheimer%E2%80%99s%20disease.%20J%20Struct%20Biol.%202006;155:30%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR121">
<span class="label">121.</span><cite>Schrag M, Mueller C, Oyoyo U, Smith MA, Kirsch WM. Iron, zinc and copper in the Alzheimer’s disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Prog Neurobiol. 2011;94:296–306.
</cite> [<a href="https://doi.org/10.1016/j.pneurobio.2011.05.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3134620/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21600264/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schrag%20M,%20Mueller%20C,%20Oyoyo%20U,%20Smith%20MA,%20Kirsch%20WM.%20Iron,%20zinc%20and%20copper%20in%20the%20Alzheimer%E2%80%99s%20disease%20brain:%20a%20quantitative%20meta-analysis.%20Some%20insight%20on%20the%20influence%20of%20citation%20bias%20on%20scientific%20opinion.%20Prog%20Neurobiol.%202011;94:296%E2%80%93306." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR122">
<span class="label">122.</span><cite>Cheli VT, Correale J, Paez PM, Pasquini JM. Iron metabolism in oligodendrocytes and astrocytes, implications for myelination and remyelination. ASN Neuro. 2020;12: 1759091420962681.
</cite> [<a href="https://doi.org/10.1177/1759091420962681" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7545512/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32993319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheli%20VT,%20Correale%20J,%20Paez%20PM,%20Pasquini%20JM.%20Iron%20metabolism%20in%20oligodendrocytes%20and%20astrocytes,%20implications%20for%20myelination%20and%20remyelination.%20ASN%20Neuro.%202020;12:%201759091420962681." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR123">
<span class="label">123.</span><cite>Espinosa de los Monteros A, Chiapelli F, Fisher RS, de Vellis J. Transferrin: an early marker of oligodendrocytes in culture. Int J Dev Neurosci Off J Int Soc Dev Neurosci. 1988;6:167–75.</cite> [<a href="https://doi.org/10.1016/0736-5748(88)90042-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3213576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Espinosa%20de%20los%20Monteros%20A,%20Chiapelli%20F,%20Fisher%20RS,%20de%20Vellis%20J.%20Transferrin:%20an%20early%20marker%20of%20oligodendrocytes%20in%20culture.%20Int%20J%20Dev%20Neurosci%20Off%20J%20Int%20Soc%20Dev%20Neurosci.%201988;6:167%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR124">
<span class="label">124.</span><cite>Connor JR, Menzies SL, St. Martin SM, Mufson EJ. A histochemical study of iron, transferrin, and ferritin in Alzheimer’s diseased brains. J Neurosci Res. 1992;31:75–83.
</cite> [<a href="https://doi.org/10.1002/jnr.490310111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1613823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Connor%20JR,%20Menzies%20SL,%20St.%20Martin%20SM,%20Mufson%20EJ.%20A%20histochemical%20study%20of%20iron,%20transferrin,%20and%20ferritin%20in%20Alzheimer%E2%80%99s%20diseased%20brains.%20J%20Neurosci%20Res.%201992;31:75%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR125">
<span class="label">125.</span><cite>Grundke-Iqbal I, Fleming J, Tung Y-C, Lassmann H, Iqbal K, Joshi JG. Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol (Berl). 1990;81:105–10.
</cite> [<a href="https://doi.org/10.1007/BF00334497" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2082650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grundke-Iqbal%20I,%20Fleming%20J,%20Tung%20Y-C,%20Lassmann%20H,%20Iqbal%20K,%20Joshi%20JG.%20Ferritin%20is%20a%20component%20of%20the%20neuritic%20(senile)%20plaque%20in%20Alzheimer%20dementia.%20Acta%20Neuropathol%20(Berl).%201990;81:105%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR126">
<span class="label">126.</span><cite>Bodovitz S, Falduto MT, Frail DE, Klein WL. Iron levels modulate alpha-secretase cleavage of amyloid precursor protein. J Neurochem. 1995;64:307–15.
</cite> [<a href="https://doi.org/10.1046/j.1471-4159.1995.64010307.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7798927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bodovitz%20S,%20Falduto%20MT,%20Frail%20DE,%20Klein%20WL.%20Iron%20levels%20modulate%20alpha-secretase%20cleavage%20of%20amyloid%20precursor%20protein.%20J%20Neurochem.%201995;64:307%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR127">
<span class="label">127.</span><cite>Chen Y, Chen W, Huang X, Xu Y, Zhang H. Iron dysregulates APP processing accompanying with sAPPα cellular retention and β-secretase inhibition in rat cortical neurons. Acta Pharmacol Sin. 2018;39:177–83.
</cite> [<a href="https://doi.org/10.1038/aps.2017.113" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5800463/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28836584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20Y,%20Chen%20W,%20Huang%20X,%20Xu%20Y,%20Zhang%20H.%20Iron%20dysregulates%20APP%20processing%20accompanying%20with%20sAPP%CE%B1%20cellular%20retention%20and%20%CE%B2-secretase%20inhibition%20in%20rat%20cortical%20neurons.%20Acta%20Pharmacol%20Sin.%202018;39:177%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR128">
<span class="label">128.</span><cite>Rogers J, Bush A, Cho H-H, Smith D, Thomson A, Friedlich A, et al. Iron and the translation of the amyloid precursor protein (APP) and ferritin. Biochem Soc Trans. 2008;36:1282–7.
</cite> [<a href="https://doi.org/10.1042/BST0361282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2746665/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19021541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rogers%20J,%20Bush%20A,%20Cho%20H-H,%20Smith%20D,%20Thomson%20A,%20Friedlich%20A,%20et%20al.%20Iron%20and%20the%20translation%20of%20the%20amyloid%20precursor%20protein%20(APP)%20and%20ferritin.%20Biochem%20Soc%20Trans.%202008;36:1282%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR129">
<span class="label">129.</span><cite>Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, et al. Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer’s disease. Cell. 2010;142:857–67.
</cite> [<a href="https://doi.org/10.1016/j.cell.2010.08.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2943017/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20817278/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Duce%20JA,%20Tsatsanis%20A,%20Cater%20MA,%20James%20SA,%20Robb%20E,%20Wikhe%20K,%20et%20al.%20Iron-export%20ferroxidase%20activity%20of%20%CE%B2-amyloid%20precursor%20protein%20is%20inhibited%20by%20zinc%20in%20Alzheimer%E2%80%99s%20disease.%20Cell.%202010;142:857%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR130">
<span class="label">130.</span><cite>Tsatsanis A, Dickens S, Kwok JCF, Wong BX, Duce JA. Post translational modulation of β-amyloid precursor protein trafficking to the cell surface alters neuronal iron homeostasis. Neurochem Res. 2019;44:1367–74.
</cite> [<a href="https://doi.org/10.1007/s11064-019-02747-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6525264/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30796750/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsatsanis%20A,%20Dickens%20S,%20Kwok%20JCF,%20Wong%20BX,%20Duce%20JA.%20Post%20translational%20modulation%20of%20%CE%B2-amyloid%20precursor%20protein%20trafficking%20to%20the%20cell%20surface%20alters%20neuronal%20iron%20homeostasis.%20Neurochem%20Res.%202019;44:1367%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR131">
<span class="label">131.</span><cite>Zecca L, Youdim MBH, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004;5:863–73.
</cite> [<a href="https://doi.org/10.1038/nrn1537" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15496864/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zecca%20L,%20Youdim%20MBH,%20Riederer%20P,%20Connor%20JR,%20Crichton%20RR.%20Iron,%20brain%20ageing%20and%20neurodegenerative%20disorders.%20Nat%20Rev%20Neurosci.%202004;5:863%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR132">
<span class="label">132.</span><cite>Ayton S, Portbury S, Kalinowski P, Agarwal P, Diouf I, Schneider JA, et al. Regional brain iron associated with deterioration in Alzheimer’s disease: a large cohort study and theoretical significance. Alzheimers Dement. 2021;17:1244–56.
</cite> [<a href="https://doi.org/10.1002/alz.12282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9701539/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33491917/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ayton%20S,%20Portbury%20S,%20Kalinowski%20P,%20Agarwal%20P,%20Diouf%20I,%20Schneider%20JA,%20et%20al.%20Regional%20brain%20iron%20associated%20with%20deterioration%20in%20Alzheimer%E2%80%99s%20disease:%20a%20large%20cohort%20study%20and%20theoretical%20significance.%20Alzheimers%20Dement.%202021;17:1244%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR133">
<span class="label">133.</span><cite>Drago D, Bolognin S, Zatta P. Role of metal ions in the Aβ oligomerization in Alzheimers disease and in other neurological disorders. Curr Alzheimer Res. 2008;5:500–7.
</cite> [<a href="https://doi.org/10.2174/156720508786898479" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19075576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Drago%20D,%20Bolognin%20S,%20Zatta%20P.%20Role%20of%20metal%20ions%20in%20the%20A%CE%B2%20oligomerization%20in%20Alzheimers%20disease%20and%20in%20other%20neurological%20disorders.%20Curr%20Alzheimer%20Res.%202008;5:500%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR134">
<span class="label">134.</span><cite>Rezaei-Ghaleh N, Giller K, Becker S, Zweckstetter M. Effect of zinc binding on β-amyloid structure and dynamics: implications for Aβ aggregation. Biophys J. 2011;101:1202–11.
</cite> [<a href="https://doi.org/10.1016/j.bpj.2011.06.062" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3164126/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21889458/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rezaei-Ghaleh%20N,%20Giller%20K,%20Becker%20S,%20Zweckstetter%20M.%20Effect%20of%20zinc%20binding%20on%20%CE%B2-amyloid%20structure%20and%20dynamics:%20implications%20for%20A%CE%B2%20aggregation.%20Biophys%20J.%202011;101:1202%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR135">
<span class="label">135.</span><cite>Sharma AK, Pavlova ST, Kim J, Kim J, Mirica LM. The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity. Metallomics. 2013;5:1529–36.
</cite> [<a href="https://doi.org/10.1039/c3mt00161j" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4060528/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23995980/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sharma%20AK,%20Pavlova%20ST,%20Kim%20J,%20Kim%20J,%20Mirica%20LM.%20The%20effect%20of%20Cu2+%20and%20Zn2+%20on%20the%20A%CE%B242%20peptide%20aggregation%20and%20cellular%20toxicity.%20Metallomics.%202013;5:1529%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR136">
<span class="label">136.</span><cite>Craven KM, Kochen WR, Hernandez CM, Flinn JM. Zinc exacerbates tau pathology in a tau mouse model. J Alzheimers Dis JAD. 2018;64:617–30.
</cite> [<a href="https://doi.org/10.3233/JAD-180151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29914030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Craven%20KM,%20Kochen%20WR,%20Hernandez%20CM,%20Flinn%20JM.%20Zinc%20exacerbates%20tau%20pathology%20in%20a%20tau%20mouse%20model.%20J%20Alzheimers%20Dis%20JAD.%202018;64:617%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR137">
<span class="label">137.</span><cite>Huang Y, Wu Z, Cao Y, Lang M, Lu B, Zhou B. Zinc binding directly regulates tau toxicity independent of tau hyperphosphorylation. Cell Rep. 2014;8(3):831–42.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2014.06.047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4306234/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25066125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20Y,%20Wu%20Z,%20Cao%20Y,%20Lang%20M,%20Lu%20B,%20Zhou%20B.%20Zinc%20binding%20directly%20regulates%20tau%20toxicity%20independent%20of%20tau%20hyperphosphorylation.%20Cell%20Rep.%202014;8(3):831%E2%80%9342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR138">
<span class="label">138.</span><cite>Zhang L-H, Wang X, Stoltenberg M, Danscher G, Huang L, Wang Z-Y. Abundant expression of zinc transporters in the amyloid plaques of Alzheimer’s disease brain. Brain Res Bull. 2008;77:55–60.
</cite> [<a href="https://doi.org/10.1016/j.brainresbull.2008.03.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18639746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20L-H,%20Wang%20X,%20Stoltenberg%20M,%20Danscher%20G,%20Huang%20L,%20Wang%20Z-Y.%20Abundant%20expression%20of%20zinc%20transporters%20in%20the%20amyloid%20plaques%20of%20Alzheimer%E2%80%99s%20disease%20brain.%20Brain%20Res%20Bull.%202008;77:55%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR139">
<span class="label">139.</span><cite>Lovell MA, Smith JL, Xiong S, Markesbery WR. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer’s disease. Neurotox Res. 2005;7:265–71.
</cite> [<a href="https://doi.org/10.1007/BF03033884" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16179263/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lovell%20MA,%20Smith%20JL,%20Xiong%20S,%20Markesbery%20WR.%20Alterations%20in%20zinc%20transporter%20protein-1%20(ZnT-1)%20in%20the%20brain%20of%20subjects%20with%20mild%20cognitive%20impairment,%20early,%20and%20late-stage%20Alzheimer%E2%80%99s%20disease.%20Neurotox%20Res.%202005;7:265%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR140">
<span class="label">140.</span><cite>Lyubartseva G, Smith JL, Markesbery WR, Lovell MA. Alterations of zinc transporter proteins ZnT-1, ZnT-4 and ZnT-6 in preclinical Alzheimer’s disease brain. Brain Pathol Zurich Switz. 2010;20:343–50.</cite> [<a href="https://doi.org/10.1111/j.1750-3639.2009.00283.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3175637/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19371353/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lyubartseva%20G,%20Smith%20JL,%20Markesbery%20WR,%20Lovell%20MA.%20Alterations%20of%20zinc%20transporter%20proteins%20ZnT-1,%20ZnT-4%20and%20ZnT-6%20in%20preclinical%20Alzheimer%E2%80%99s%20disease%20brain.%20Brain%20Pathol%20Zurich%20Switz.%202010;20:343%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR141">
<span class="label">141.</span><cite>Lee J-Y, Cole TB, Palmiter RD, Suh SW, Koh J-Y. Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci U S A. 2002;99:7705–10.
</cite> [<a href="https://doi.org/10.1073/pnas.092034699" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC124328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12032347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20J-Y,%20Cole%20TB,%20Palmiter%20RD,%20Suh%20SW,%20Koh%20J-Y.%20Contribution%20by%20synaptic%20zinc%20to%20the%20gender-disparate%20plaque%20formation%20in%20human%20Swedish%20mutant%20APP%20transgenic%20mice.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202002;99:7705%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR142">
<span class="label">142.</span><cite>Li D-D, Zhang W, Wang Z-Y, Zhao P. Serum copper, zinc, and iron levels in patients with Alzheimer’s disease: a meta-analysis of case-control studies. Front Aging Neurosci. 2017;9:300.
</cite> [<a href="https://doi.org/10.3389/fnagi.2017.00300" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5605551/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28966592/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20D-D,%20Zhang%20W,%20Wang%20Z-Y,%20Zhao%20P.%20Serum%20copper,%20zinc,%20and%20iron%20levels%20in%20patients%20with%20Alzheimer%E2%80%99s%20disease:%20a%20meta-analysis%20of%20case-control%20studies.%20Front%20Aging%20Neurosci.%202017;9:300." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR143">
<span class="label">143.</span><cite>Ventriglia M, Brewer GJ, Simonelli I, Mariani S, Siotto M, Bucossi S, et al. Zinc in Alzheimer’s disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies. J Alzheimers Dis. 2015;46:75–87.
</cite> [<a href="https://doi.org/10.3233/JAD-141296" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25697706/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ventriglia%20M,%20Brewer%20GJ,%20Simonelli%20I,%20Mariani%20S,%20Siotto%20M,%20Bucossi%20S,%20et%20al.%20Zinc%20in%20Alzheimer%E2%80%99s%20disease:%20a%20meta-analysis%20of%20serum,%20plasma,%20and%20cerebrospinal%20fluid%20studies.%20J%20Alzheimers%20Dis.%202015;46:75%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR144">
<span class="label">144.</span><cite>Sharp PA. Ctr1 and its role in body copper homeostasis. Int J Biochem Cell Biol. 2003;35:288–91.
</cite> [<a href="https://doi.org/10.1016/s1357-2725(02)00134-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12531240/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sharp%20PA.%20Ctr1%20and%20its%20role%20in%20body%20copper%20homeostasis.%20Int%20J%20Biochem%20Cell%20Biol.%202003;35:288%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR145">
<span class="label">145.</span><cite>Falcone E, Okafor M, Vitale N, Raibaut L, Sour A, Faller P. Extracellular Cu2+ pools and their detection: from current knowledge to next-generation probes. Coord Chem Rev. 2021;433: 213727.</cite> [<a href="https://scholar.google.com/scholar_lookup?Falcone%20E,%20Okafor%20M,%20Vitale%20N,%20Raibaut%20L,%20Sour%20A,%20Faller%20P.%20Extracellular%20Cu2+%20pools%20and%20their%20detection:%20from%20current%20knowledge%20to%20next-generation%20probes.%20Coord%20Chem%20Rev.%202021;433:%20213727." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR146">
<span class="label">146.</span><cite>La Fontaine S, Ackland ML, Mercer JFB. Mammalian copper-transporting P-type ATPases, ATP7A and ATP7B: emerging roles. Int J Biochem Cell Biol. 2010;42:206–9.
</cite> [<a href="https://doi.org/10.1016/j.biocel.2009.11.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2846448/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19922814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?La%20Fontaine%20S,%20Ackland%20ML,%20Mercer%20JFB.%20Mammalian%20copper-transporting%20P-type%20ATPases,%20ATP7A%20and%20ATP7B:%20emerging%20roles.%20Int%20J%20Biochem%20Cell%20Biol.%202010;42:206%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR147">
<span class="label">147.</span><cite>Hatori Y, Lutsenko S. The role of copper chaperone Atox1 in coupling redox homeostasis to intracellular copper distribution. Antioxidants. 2016;5:25.
</cite> [<a href="https://doi.org/10.3390/antiox5030025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5039574/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27472369/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hatori%20Y,%20Lutsenko%20S.%20The%20role%20of%20copper%20chaperone%20Atox1%20in%20coupling%20redox%20homeostasis%20to%20intracellular%20copper%20distribution.%20Antioxidants.%202016;5:25." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR148">
<span class="label">148.</span><cite>Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY. Function and regulation of human copper-transporting ATPases. Physiol Rev. 2007;87:1011–46.
</cite> [<a href="https://doi.org/10.1152/physrev.00004.2006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17615395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lutsenko%20S,%20Barnes%20NL,%20Bartee%20MY,%20Dmitriev%20OY.%20Function%20and%20regulation%20of%20human%20copper-transporting%20ATPases.%20Physiol%20Rev.%202007;87:1011%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR149">
<span class="label">149.</span><cite>Veldhuis NA, Valova VA, Gaeth AP, Palstra N, Hannan KM, Michell BJ, et al. Phosphorylation regulates copper-responsive trafficking of the Menkes copper transporting P-type ATPase. Int J Biochem Cell Biol. 2009;41:2403–12.
</cite> [<a href="https://doi.org/10.1016/j.biocel.2009.06.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19576997/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Veldhuis%20NA,%20Valova%20VA,%20Gaeth%20AP,%20Palstra%20N,%20Hannan%20KM,%20Michell%20BJ,%20et%20al.%20Phosphorylation%20regulates%20copper-responsive%20trafficking%20of%20the%20Menkes%20copper%20transporting%20P-type%20ATPase.%20Int%20J%20Biochem%20Cell%20Biol.%202009;41:2403%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR150">
<span class="label">150.</span><cite>D’Ambrosi N, Rossi L. Copper at synapse: release, binding and modulation of neurotransmission. Neurochem Int. 2015;90:36–45.
</cite> [<a href="https://doi.org/10.1016/j.neuint.2015.07.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26187063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?D%E2%80%99Ambrosi%20N,%20Rossi%20L.%20Copper%20at%20synapse:%20release,%20binding%20and%20modulation%20of%20neurotransmission.%20Neurochem%20Int.%202015;90:36%E2%80%9345." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR151">
<span class="label">151.</span><cite>Telianidis J, Hung YH, Materia S, Fontaine SL. Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis. Front Aging Neurosci. 2013;5:44.
</cite> [<a href="https://doi.org/10.3389/fnagi.2013.00044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3750203/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23986700/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Telianidis%20J,%20Hung%20YH,%20Materia%20S,%20Fontaine%20SL.%20Role%20of%20the%20P-Type%20ATPases,%20ATP7A%20and%20ATP7B%20in%20brain%20copper%20homeostasis.%20Front%20Aging%20Neurosci.%202013;5:44." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR152">
<span class="label">152.</span><cite>White C, Kambe T, Fulcher YG, Sachdev SW, Bush AI, Fritsche K, et al. Copper transport into the secretory pathway is regulated by oxygen in macrophages. J Cell Sci. 2009;122:1315–21.
</cite> [<a href="https://doi.org/10.1242/jcs.043216" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2671928/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19351718/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?White%20C,%20Kambe%20T,%20Fulcher%20YG,%20Sachdev%20SW,%20Bush%20AI,%20Fritsche%20K,%20et%20al.%20Copper%20transport%20into%20the%20secretory%20pathway%20is%20regulated%20by%20oxygen%20in%20macrophages.%20J%20Cell%20Sci.%202009;122:1315%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR153">
<span class="label">153.</span><cite>Qin Z, Itoh S, Jeney V, Ushio-Fukai M, Fukai T. Essential role for the Menkes ATPase in activation of extracellular superoxide dismutase: implication for vascular oxidative stress. FASEB J Off Publ Fed Am Soc Exp Biol. 2006;20:334–6.</cite> [<a href="https://doi.org/10.1096/fj.05-4564fje" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16371425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qin%20Z,%20Itoh%20S,%20Jeney%20V,%20Ushio-Fukai%20M,%20Fukai%20T.%20Essential%20role%20for%20the%20Menkes%20ATPase%20in%20activation%20of%20extracellular%20superoxide%20dismutase:%20implication%20for%20vascular%20oxidative%20stress.%20FASEB%20J%20Off%20Publ%20Fed%20Am%20Soc%20Exp%20Biol.%202006;20:334%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR154">
<span class="label">154.</span><cite>Nyasae L, Bustos R, Braiterman L, Eipper B, Hubbard A. Dynamics of endogenous ATP7A (Menkes protein) in intestinal epithelial cells: copper-dependent redistribution between two intracellular sites. Am J Physiol-Gastrointest Liver Physiol. 2007;292:G1181–94.
</cite> [<a href="https://doi.org/10.1152/ajpgi.00472.2006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17158254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nyasae%20L,%20Bustos%20R,%20Braiterman%20L,%20Eipper%20B,%20Hubbard%20A.%20Dynamics%20of%20endogenous%20ATP7A%20(Menkes%20protein)%20in%20intestinal%20epithelial%20cells:%20copper-dependent%20redistribution%20between%20two%20intracellular%20sites.%20Am%20J%20Physiol-Gastrointest%20Liver%20Physiol.%202007;292:G1181%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR155">
<span class="label">155.</span><cite>Weiss KH, Wurz J, Gotthardt D, Merle U, Stremmel W, Füllekrug J. Localization of the Wilson disease protein in murine intestine. J Anat. 2008;213:232–40.
</cite> [<a href="https://doi.org/10.1111/j.1469-7580.2008.00954.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2732049/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18673401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Weiss%20KH,%20Wurz%20J,%20Gotthardt%20D,%20Merle%20U,%20Stremmel%20W,%20F%C3%BCllekrug%20J.%20Localization%20of%20the%20Wilson%20disease%20protein%20in%20murine%20intestine.%20J%20Anat.%202008;213:232%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR156">
<span class="label">156.</span><cite>Polishchuk EV, Concilli M, Iacobacci S, Chesi G, Pastore N, Piccolo P, et al. Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis. Dev Cell. 2014;29:686–700.
</cite> [<a href="https://doi.org/10.1016/j.devcel.2014.04.033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4070386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24909901/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Polishchuk%20EV,%20Concilli%20M,%20Iacobacci%20S,%20Chesi%20G,%20Pastore%20N,%20Piccolo%20P,%20et%20al.%20Wilson%20disease%20protein%20ATP7B%20utilizes%20lysosomal%20exocytosis%20to%20maintain%20copper%20homeostasis.%20Dev%20Cell.%202014;29:686%E2%80%93700." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR157">
<span class="label">157.</span><cite>Opazo CM, Greenough MA, Bush AI. Copper: from neurotransmission to neuroproteostasis. Front Aging Neurosci. 2014;6:143.
</cite> [<a href="https://doi.org/10.3389/fnagi.2014.00143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4080678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25071552/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Opazo%20CM,%20Greenough%20MA,%20Bush%20AI.%20Copper:%20from%20neurotransmission%20to%20neuroproteostasis.%20Front%20Aging%20Neurosci.%202014;6:143." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR158">
<span class="label">158.</span><cite>Lutsenko S, Bhattacharjee A, Hubbard AL. Copper handling machinery of the brain. Metallomics. 2010;2:596–608.
</cite> [<a href="https://doi.org/10.1039/c0mt00006j" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21072351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lutsenko%20S,%20Bhattacharjee%20A,%20Hubbard%20AL.%20Copper%20handling%20machinery%20of%20the%20brain.%20Metallomics.%202010;2:596%E2%80%93608." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR159">
<span class="label">159.</span><cite>Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, Gallorini M, et al. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci U S A. 2004;101:9843–8.
</cite> [<a href="https://doi.org/10.1073/pnas.0403495101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC470762/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15210960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zecca%20L,%20Stroppolo%20A,%20Gatti%20A,%20Tampellini%20D,%20Toscani%20M,%20Gallorini%20M,%20et%20al.%20The%20role%20of%20iron%20and%20copper%20molecules%20in%20the%20neuronal%20vulnerability%20of%20locus%20coeruleus%20and%20substantia%20nigra%20during%20aging.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202004;101:9843%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR160">
<span class="label">160.</span><cite>Davies KM, Hare DJ, Cottam V, Chen N, Hilgers L, Halliday G, et al. Localization of copper and copper transporters in the human brain†. Metallomics. 2013;5(1):43–51.
</cite> [<a href="https://doi.org/10.1039/c2mt20151h" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23076575/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Davies%20KM,%20Hare%20DJ,%20Cottam%20V,%20Chen%20N,%20Hilgers%20L,%20Halliday%20G,%20et%20al.%20Localization%20of%20copper%20and%20copper%20transporters%20in%20the%20human%20brain%E2%80%A0.%20Metallomics.%202013;5(1):43%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR161">
<span class="label">161.</span><cite>Trapani G, Satriano C, Mendola DL. Peptides and their metal complexes in neurodegenerative diseases: from structural studies to nanomedicine prospects. Curr Med Chem. 2018;25:715–47.
</cite> [<a href="https://doi.org/10.2174/0929867324666171026163144" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29076411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Trapani%20G,%20Satriano%20C,%20Mendola%20DL.%20Peptides%20and%20their%20metal%20complexes%20in%20neurodegenerative%20diseases:%20from%20structural%20studies%20to%20nanomedicine%20prospects.%20Curr%20Med%20Chem.%202018;25:715%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR162">
<span class="label">162.</span><cite>Witt B, Schaumlöffel D, Schwerdtle T. Subcellular localization of copper—cellular bioimaging with focus on neurological disorders. Int J Mol Sci. 2020;21: 2341.
</cite> [<a href="https://doi.org/10.3390/ijms21072341" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7178132/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32231018/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Witt%20B,%20Schauml%C3%B6ffel%20D,%20Schwerdtle%20T.%20Subcellular%20localization%20of%20copper%E2%80%94cellular%20bioimaging%20with%20focus%20on%20neurological%20disorders.%20Int%20J%20Mol%20Sci.%202020;21:%202341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR163">
<span class="label">163.</span><cite>Perrin L, Roudeau S, Carmona A, Domart F, Petersen JD, Bohic S, et al. Zinc and copper effects on stability of tubulin and actin networks in dendrites and spines of hippocampal neurons. ACS Chem Neurosci. 2017;8:1490–9.
</cite> [<a href="https://doi.org/10.1021/acschemneuro.6b00452" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28323401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Perrin%20L,%20Roudeau%20S,%20Carmona%20A,%20Domart%20F,%20Petersen%20JD,%20Bohic%20S,%20et%20al.%20Zinc%20and%20copper%20effects%20on%20stability%20of%20tubulin%20and%20actin%20networks%20in%20dendrites%20and%20spines%20of%20hippocampal%20neurons.%20ACS%20Chem%20Neurosci.%202017;8:1490%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR164">
<span class="label">164.</span><cite>Dahms SO, Könnig I, Roeser D, Gührs K-H, Mayer MC, Kaden D, et al. Metal binding dictates conformation and function of the amyloid precursor protein (APP) E2 domain. J Mol Biol. 2012;416:438–52.
</cite> [<a href="https://doi.org/10.1016/j.jmb.2011.12.057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22245578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dahms%20SO,%20K%C3%B6nnig%20I,%20Roeser%20D,%20G%C3%BChrs%20K-H,%20Mayer%20MC,%20Kaden%20D,%20et%20al.%20Metal%20binding%20dictates%20conformation%20and%20function%20of%20the%20amyloid%20precursor%20protein%20(APP)%20E2%20domain.%20J%20Mol%20Biol.%202012;416:438%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR165">
<span class="label">165.</span><cite>Acevedo KM, Hung YH, Dalziel AH, Li Q-X, Laughton K, Wikhe K, et al. Copper promotes the trafficking of the amyloid precursor protein. J Biol Chem. 2011;286:8252–62.
</cite> [<a href="https://doi.org/10.1074/jbc.M110.128512" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3048711/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21177866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Acevedo%20KM,%20Hung%20YH,%20Dalziel%20AH,%20Li%20Q-X,%20Laughton%20K,%20Wikhe%20K,%20et%20al.%20Copper%20promotes%20the%20trafficking%20of%20the%20amyloid%20precursor%20protein.%20J%20Biol%20Chem.%202011;286:8252%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR166">
<span class="label">166.</span><cite>White AR, Reyes R, Mercer JFB, Camakaris J, Zheng H, Bush AI, et al. Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res. 1999;842:439–44.
</cite> [<a href="https://doi.org/10.1016/s0006-8993(99)01861-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10526140/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?White%20AR,%20Reyes%20R,%20Mercer%20JFB,%20Camakaris%20J,%20Zheng%20H,%20Bush%20AI,%20et%20al.%20Copper%20levels%20are%20increased%20in%20the%20cerebral%20cortex%20and%20liver%20of%20APP%20and%20APLP2%20knockout%20mice.%20Brain%20Res.%201999;842:439%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR167">
<span class="label">167.</span><cite>Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, et al. The Aβ peptide of Alzheimer’s disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 1999;38:7609–16.
</cite> [<a href="https://doi.org/10.1021/bi990438f" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10386999/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20X,%20Atwood%20CS,%20Hartshorn%20MA,%20Multhaup%20G,%20Goldstein%20LE,%20Scarpa%20RC,%20et%20al.%20The%20A%CE%B2%20peptide%20of%20Alzheimer%E2%80%99s%20disease%20directly%20produces%20hydrogen%20peroxide%20through%20metal%20ion%20reduction.%20Biochemistry.%201999;38:7609%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR168">
<span class="label">168.</span><cite>Scholefield M, Church SJ, Xu J, Kassab S, Gardiner NJ, Roncaroli F, et al. Evidence that levels of nine essential metals in post-mortem human-Alzheimer’s-brain and <em>ex vivo</em> rat-brain tissues are unaffected by differences in post-mortem delay, age, disease staging, and brain bank location†. Metallomics. 2020;12:952–62.
</cite> [<a href="https://doi.org/10.1039/d0mt00048e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32373908/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Scholefield%20M,%20Church%20SJ,%20Xu%20J,%20Kassab%20S,%20Gardiner%20NJ,%20Roncaroli%20F,%20et%20al.%20Evidence%20that%20levels%20of%20nine%20essential%20metals%20in%20post-mortem%20human-Alzheimer%E2%80%99s-brain%20and%20ex%20vivo%20rat-brain%20tissues%20are%20unaffected%20by%20differences%20in%20post-mortem%20delay,%20age,%20disease%20staging,%20and%20brain%20bank%20location%E2%80%A0.%20Metallomics.%202020;12:952%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR169">
<span class="label">169.</span><cite>Wang L, Yin Y-L, Liu X-Z, Shen P, Zheng Y-G, Lan X-R, et al. Current understanding of metal ions in the pathogenesis of Alzheimer’s disease. Transl Neurodegener. 2020;9: 10.
</cite> [<a href="https://doi.org/10.1186/s40035-020-00189-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7119290/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32266063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20L,%20Yin%20Y-L,%20Liu%20X-Z,%20Shen%20P,%20Zheng%20Y-G,%20Lan%20X-R,%20et%20al.%20Current%20understanding%20of%20metal%20ions%20in%20the%20pathogenesis%20of%20Alzheimer%E2%80%99s%20disease.%20Transl%20Neurodegener.%202020;9:%2010." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR170">
<span class="label">170.</span><cite>James SA, Volitakis I, Adlard PA, Duce JA, Masters CL, Cherny RA, et al. Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. Free Radic Biol Med. 2012;52(2):298–302.
</cite> [<a href="https://doi.org/10.1016/j.freeradbiomed.2011.10.446" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22080049/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?James%20SA,%20Volitakis%20I,%20Adlard%20PA,%20Duce%20JA,%20Masters%20CL,%20Cherny%20RA,%20et%20al.%20Elevated%20labile%20Cu%20is%20associated%20with%20oxidative%20pathology%20in%20Alzheimer%20disease.%20Free%20Radic%20Biol%20Med.%202012;52(2):298%E2%80%93302." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR171">
<span class="label">171.</span><cite>Rembach A, Hare DJ, Lind M, Fowler CJ, Cherny RA, McLean C, et al. Decreased copper in Alzheimer’s disease brain is predominantly in the soluble extractable fraction. Int J Alzheimer’s Dis. 2013;2013:e623241.</cite> [<a href="https://doi.org/10.1155/2013/623241" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3818847/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24228186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rembach%20A,%20Hare%20DJ,%20Lind%20M,%20Fowler%20CJ,%20Cherny%20RA,%20McLean%20C,%20et%20al.%20Decreased%20copper%20in%20Alzheimer%E2%80%99s%20disease%20brain%20is%20predominantly%20in%20the%20soluble%20extractable%20fraction.%20Int%20J%20Alzheimer%E2%80%99s%20Dis.%202013;2013:e623241." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR172">
<span class="label">172.</span><cite>Squitti R, Catalli C, Gigante L, Marianetti M, Rosari M, Mariani S, et al. Non-ceruloplasmin copper identifies a subtype of Alzheimer’s disease (CuAD): characterization of the cognitive profile and case of a CuAD patient carrying an RGS7 stop-loss variant. Int J Mol Sci. 2023;24(7):6377.
</cite> [<a href="https://doi.org/10.3390/ijms24076377" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10094789/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37047347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Squitti%20R,%20Catalli%20C,%20Gigante%20L,%20Marianetti%20M,%20Rosari%20M,%20Mariani%20S,%20et%20al.%20Non-ceruloplasmin%20copper%20identifies%20a%20subtype%20of%20Alzheimer%E2%80%99s%20disease%20(CuAD):%20characterization%20of%20the%20cognitive%20profile%20and%20case%20of%20a%20CuAD%20patient%20carrying%20an%20RGS7%20stop-loss%20variant.%20Int%20J%20Mol%20Sci.%202023;24(7):6377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR173">
<span class="label">173.</span><cite>Squitti R, Ventriglia M, Simonelli I, Bonvicini C, Costa A, Perini G, et al. Copper imbalance in Alzheimer’s disease: meta-analysis of serum, plasma, and brain specimens, and replication study evaluating ATP7B gene variants. Biomolecules. 2021;11: 960.
</cite> [<a href="https://doi.org/10.3390/biom11070960" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8301962/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34209820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Squitti%20R,%20Ventriglia%20M,%20Simonelli%20I,%20Bonvicini%20C,%20Costa%20A,%20Perini%20G,%20et%20al.%20Copper%20imbalance%20in%20Alzheimer%E2%80%99s%20disease:%20meta-analysis%20of%20serum,%20plasma,%20and%20brain%20specimens,%20and%20replication%20study%20evaluating%20ATP7B%20gene%20variants.%20Biomolecules.%202021;11:%20960." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR174">
<span class="label">174.</span><cite>Sparks DL, Schreurs BG. Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer’s disease. Proc Natl Acad Sci U S A. 2003;100:11065–9.
</cite> [<a href="https://doi.org/10.1073/pnas.1832769100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC196927/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12920183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sparks%20DL,%20Schreurs%20BG.%20Trace%20amounts%20of%20copper%20in%20water%20induce%20beta-amyloid%20plaques%20and%20learning%20deficits%20in%20a%20rabbit%20model%20of%20Alzheimer%E2%80%99s%20disease.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202003;100:11065%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR175">
<span class="label">175.</span><cite>Mercer SW, Wang J, Burke R. In vivo modeling of the pathogenic effect of copper transporter mutations that cause Menkes and Wilson diseases, motor neuropathy, and susceptibility to Alzheimer’s disease. J Biol Chem. 2017;292:4113–22.
</cite> [<a href="https://doi.org/10.1074/jbc.M116.756163" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5354492/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28119449/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mercer%20SW,%20Wang%20J,%20Burke%20R.%20In%20vivo%20modeling%20of%20the%20pathogenic%20effect%20of%20copper%20transporter%20mutations%20that%20cause%20Menkes%20and%20Wilson%20diseases,%20motor%20neuropathy,%20and%20susceptibility%20to%20Alzheimer%E2%80%99s%20disease.%20J%20Biol%20Chem.%202017;292:4113%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR176">
<span class="label">176.</span><cite>Squitti R, Polimanti R, Siotto M, Bucossi S, Ventriglia M, Mariani S, et al. ATP7B variants as modulators of copper dyshomeostasis in Alzheimer’s disease. NeuroMolecular Med. 2013;15:515–22.
</cite> [<a href="https://doi.org/10.1007/s12017-013-8237-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23760784/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Squitti%20R,%20Polimanti%20R,%20Siotto%20M,%20Bucossi%20S,%20Ventriglia%20M,%20Mariani%20S,%20et%20al.%20ATP7B%20variants%20as%20modulators%20of%20copper%20dyshomeostasis%20in%20Alzheimer%E2%80%99s%20disease.%20NeuroMolecular%20Med.%202013;15:515%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR177">
<span class="label">177.</span><cite>Hedera P. Wilson’s disease: a master of disguise. Parkinsonism Relat Disord. 2019;59:140–5.
</cite> [<a href="https://doi.org/10.1016/j.parkreldis.2019.02.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30797706/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hedera%20P.%20Wilson%E2%80%99s%20disease:%20a%20master%20of%20disguise.%20Parkinsonism%20Relat%20Disord.%202019;59:140%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR178">
<span class="label">178.</span><cite>Nagral A, Sarma MS, Matthai J, Kukkle PL, Devarbhavi H, Sinha S, et al. Wilson’s disease: clinical practice guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India. J Clin Exp Hepatol. 2019;9:74–98.
</cite> [<a href="https://doi.org/10.1016/j.jceh.2018.08.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6363961/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30765941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nagral%20A,%20Sarma%20MS,%20Matthai%20J,%20Kukkle%20PL,%20Devarbhavi%20H,%20Sinha%20S,%20et%20al.%20Wilson%E2%80%99s%20disease:%20clinical%20practice%20guidelines%20of%20the%20Indian%20National%20Association%20for%20Study%20of%20the%20Liver,%20the%20Indian%20Society%20of%20Pediatric%20Gastroenterology,%20Hepatology%20and%20Nutrition,%20and%20the%20Movement%20Disorders%20Society%20of%20India.%20J%20Clin%20Exp%20Hepatol.%202019;9:74%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR179">
<span class="label">179.</span><cite>Pfeiffenberger J, Lohse CM, Gotthardt D, Rupp C, Weiler M, Teufel U, et al. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment. J Inherit Metab Dis. 2019;42:371–80.
</cite> [<a href="https://doi.org/10.1002/jimd.12046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30746719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pfeiffenberger%20J,%20Lohse%20CM,%20Gotthardt%20D,%20Rupp%20C,%20Weiler%20M,%20Teufel%20U,%20et%20al.%20Long-term%20evaluation%20of%20urinary%20copper%20excretion%20and%20non-caeruloplasmin%20associated%20copper%20in%20Wilson%20disease%20patients%20under%20medical%20treatment.%20J%20Inherit%20Metab%20Dis.%202019;42:371%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR180">
<span class="label">180.</span><cite>Bucossi S, Ventriglia M, Panetta V, Salustri C, Pasqualetti P, Mariani S, et al. Copper in Alzheimer’s disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies. J Alzheimers Dis JAD. 2011;24:175–85.
</cite> [<a href="https://doi.org/10.3233/JAD-2010-101473" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21187586/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bucossi%20S,%20Ventriglia%20M,%20Panetta%20V,%20Salustri%20C,%20Pasqualetti%20P,%20Mariani%20S,%20et%20al.%20Copper%20in%20Alzheimer%E2%80%99s%20disease:%20a%20meta-analysis%20of%20serum,plasma,%20and%20cerebrospinal%20fluid%20studies.%20J%20Alzheimers%20Dis%20JAD.%202011;24:175%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR181">
<span class="label">181.</span><cite>Capo CR, Arciello M, Squitti R, Cassetta E, Rossini PM, Calabrese L, et al. Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer’s disease patients. Biometals. 2008;21:367–72.
</cite> [<a href="https://doi.org/10.1007/s10534-007-9125-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18060472/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Capo%20CR,%20Arciello%20M,%20Squitti%20R,%20Cassetta%20E,%20Rossini%20PM,%20Calabrese%20L,%20et%20al.%20Features%20of%20ceruloplasmin%20in%20the%20cerebrospinal%20fluid%20of%20Alzheimer%E2%80%99s%20disease%20patients.%20Biometals.%202008;21:367%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR182">
<span class="label">182.</span><cite>Tórsdóttir G, Kristinsson J, Hreidarsson S, Snaedal J, Jóhannesson T. Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down’s syndrome. Pharmacol Toxicol. 2001;89:320–5.
</cite> [<a href="https://doi.org/10.1034/j.1600-0773.2001.d01-168.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11903959/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?T%C3%B3rsd%C3%B3ttir%20G,%20Kristinsson%20J,%20Hreidarsson%20S,%20Snaedal%20J,%20J%C3%B3hannesson%20T.%20Copper,%20ceruloplasmin%20and%20superoxide%20dismutase%20(SOD1)%20in%20patients%20with%20Down%E2%80%99s%20syndrome.%20Pharmacol%20Toxicol.%202001;89:320%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR183">
<span class="label">183.</span><cite>Jeong SY, David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem. 2003;278:27144–8.
</cite> [<a href="https://doi.org/10.1074/jbc.M301988200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12743117/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jeong%20SY,%20David%20S.%20Glycosylphosphatidylinositol-anchored%20ceruloplasmin%20is%20required%20for%20iron%20efflux%20from%20cells%20in%20the%20central%20nervous%20system.%20J%20Biol%20Chem.%202003;278:27144%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR184">
<span class="label">184.</span><cite>Young TR, Kirchner A, Wedd AG, Xiao Z. An integrated study of the affinities of the Aβ16 peptide for Cu(I) and Cu(II): implications for the catalytic production of reactive oxygen species. Metallomics. 2014;6:505–17.
</cite> [<a href="https://doi.org/10.1039/c4mt00001c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24493126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Young%20TR,%20Kirchner%20A,%20Wedd%20AG,%20Xiao%20Z.%20An%20integrated%20study%20of%20the%20affinities%20of%20the%20A%CE%B216%20peptide%20for%20Cu(I)%20and%20Cu(II):%20implications%20for%20the%20catalytic%20production%20of%20reactive%20oxygen%20species.%20Metallomics.%202014;6:505%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR185">
<span class="label">185.</span><cite>Conte-Daban A, Borghesani V, Sayen S, Guillon E, Journaux Y, Gontard G, et al. Link between affinity and Cu(II) binding sites to amyloid-β peptides evaluated by a new water-soluble UV-visible ratiometric dye with a moderate Cu(II) affinity. Anal Chem. 2017;89:2155–62.
</cite> [<a href="https://doi.org/10.1021/acs.analchem.6b04979" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5714188/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28208266/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Conte-Daban%20A,%20Borghesani%20V,%20Sayen%20S,%20Guillon%20E,%20Journaux%20Y,%20Gontard%20G,%20et%20al.%20Link%20between%20affinity%20and%20Cu(II)%20binding%20sites%20to%20amyloid-%CE%B2%20peptides%20evaluated%20by%20a%20new%20water-soluble%20UV-visible%20ratiometric%20dye%20with%20a%20moderate%20Cu(II)%20affinity.%20Anal%20Chem.%202017;89:2155%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR186">
<span class="label">186.</span><cite>Sarell CJ, Syme CD, Rigby SEJ, Viles JH. Copper(II) binding to amyloid-beta fibrils of Alzheimer’s disease reveals a picomolar affinity: stoichiometry and coordination geometry are independent of Abeta oligomeric form. Biochemistry. 2009;48:4388–402.
</cite> [<a href="https://doi.org/10.1021/bi900254n" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19338344/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sarell%20CJ,%20Syme%20CD,%20Rigby%20SEJ,%20Viles%20JH.%20Copper(II)%20binding%20to%20amyloid-beta%20fibrils%20of%20Alzheimer%E2%80%99s%20disease%20reveals%20a%20picomolar%20affinity:%20stoichiometry%20and%20coordination%20geometry%20are%20independent%20of%20Abeta%20oligomeric%20form.%20Biochemistry.%202009;48:4388%E2%80%93402." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR187">
<span class="label">187.</span><cite>Atrián-Blasco E, Gonzalez P, Santoro A, Alies B, Faller P, Hureau C. Cu and Zn coordination to amyloid peptides: from fascinating chemistry to debated pathological relevance. Coord Chem Rev. 2018;371:38–55.</cite> [<a href="https://doi.org/10.1016/j.ccr.2018.04.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6152896/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30262932/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Atri%C3%A1n-Blasco%20E,%20Gonzalez%20P,%20Santoro%20A,%20Alies%20B,%20Faller%20P,%20Hureau%20C.%20Cu%20and%20Zn%20coordination%20to%20amyloid%20peptides:%20from%20fascinating%20chemistry%20to%20debated%20pathological%20relevance.%20Coord%20Chem%20Rev.%202018;371:38%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR188">
<span class="label">188.</span><cite>Faller P. Copper and zinc binding to Amyloid-β: coordination, dynamics, aggregation, reactivity and metal-ion transfer. ChemBioChem. 2009;10:2837–45.
</cite> [<a href="https://doi.org/10.1002/cbic.200900321" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19877000/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Faller%20P.%20Copper%20and%20zinc%20binding%20to%20Amyloid-%CE%B2:%20coordination,%20dynamics,%20aggregation,%20reactivity%20and%20metal-ion%20transfer.%20ChemBioChem.%202009;10:2837%E2%80%9345." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR189">
<span class="label">189.</span><cite>Drew SC, Noble CJ, Masters CL, Hanson GR, Barnham KJ. Pleomorphic copper coordination by Alzheimer’s disease amyloid-beta peptide. J Am Chem Soc. 2009;131:1195–207.
</cite> [<a href="https://doi.org/10.1021/ja808073b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19119811/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Drew%20SC,%20Noble%20CJ,%20Masters%20CL,%20Hanson%20GR,%20Barnham%20KJ.%20Pleomorphic%20copper%20coordination%20by%20Alzheimer%E2%80%99s%20disease%20amyloid-beta%20peptide.%20J%20Am%20Chem%20Soc.%202009;131:1195%E2%80%93207." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR190">
<span class="label">190.</span><cite>Dorlet P, Gambarelli S, Faller P, Hureau C. Pulse EPR spectroscopy reveals the coordination sphere of copper(ii) ions in the 1–16 amyloid-β peptide: a key role of the first two N-terminus residues. Angew Chem Int Ed. 2009;48:9273–6.</cite> [<a href="https://doi.org/10.1002/anie.200904567" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19894241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dorlet%20P,%20Gambarelli%20S,%20Faller%20P,%20Hureau%20C.%20Pulse%20EPR%20spectroscopy%20reveals%20the%20coordination%20sphere%20of%20copper(ii)%20ions%20in%20the%201%E2%80%9316%20amyloid-%CE%B2%20peptide:%20a%20key%20role%20of%20the%20first%20two%20N-terminus%20residues.%20Angew%20Chem%20Int%20Ed.%202009;48:9273%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR191">
<span class="label">191.</span><cite>Pham AN, Waite TD. Cu(II)-catalyzed oxidation of dopamine in aqueous solutions: mechanism and kinetics. J Inorg Biochem. 2014;137:74–84.
</cite> [<a href="https://doi.org/10.1016/j.jinorgbio.2014.03.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24815905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pham%20AN,%20Waite%20TD.%20Cu(II)-catalyzed%20oxidation%20of%20dopamine%20in%20aqueous%20solutions:%20mechanism%20and%20kinetics.%20J%20Inorg%20Biochem.%202014;137:74%E2%80%9384." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR192">
<span class="label">192.</span><cite>Falcone E, Nobili G, Okafor M, Proux O, Rossi G, Morante S, et al. Chasing the Elusive “In-Between” State of the Copper-Amyloidβ Complex by X-ray Absorption through Partial Thermal Relaxation after Photoreduction. Angew Chem Int Ed.;n/a:e202217791.</cite> [<a href="https://doi.org/10.1002/anie.202217791" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36869617/" class="usa-link">PubMed</a>]</li>
<li id="CR193">
<span class="label">193.</span><cite>Cheignon C, Hureau C, Collin F. Real-time evolution of Aβ40 metal-catalyzed oxidation reveals Asp1 as the main target and a dependence on metal binding site. Inorganica Chim Acta. 2018;472:111–8.</cite> [<a href="https://scholar.google.com/scholar_lookup?Cheignon%20C,%20Hureau%20C,%20Collin%20F.%20Real-time%20evolution%20of%20A%CE%B240%20metal-catalyzed%20oxidation%20reveals%20Asp1%20as%20the%20main%20target%20and%20a%20dependence%20on%20metal%20binding%20site.%20Inorganica%20Chim%20Acta.%202018;472:111%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR194">
<span class="label">194.</span><cite>Gunn AP, Roberts BR, Bush AI. Rapid generation of dityrosine cross-linked Aβ oligomers via Cu-redox cycling. In: Sigurdsson EM, Calero M, Gasset M, editors. Amyloid Proteins: Methods and Protocols. Totowa, NJ: Humana Press; 2012;p. 3–10.</cite> [<a href="https://doi.org/10.1007/978-1-61779-551-0_1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22528079/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gunn%20AP,%20Roberts%20BR,%20Bush%20AI.%20Rapid%20generation%20of%20dityrosine%20cross-linked%20A%CE%B2%20oligomers%20via%20Cu-redox%20cycling.%20In:%20Sigurdsson%20EM,%20Calero%20M,%20Gasset%20M,%20editors.%20Amyloid%20Proteins:%20Methods%20and%20Protocols.%20Totowa,%20NJ:%20Humana%20Press;%202012;p.%203%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR195">
<span class="label">195.</span><cite>Atwood CS, Perry G, Zeng H, Kato Y, Jones WD, Ling K-Q, et al. Copper mediates dityrosine cross-linking of Alzheimer’s amyloid-β. Biochemistry. 2004;43:560–8.
</cite> [<a href="https://doi.org/10.1021/bi0358824" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14717612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Atwood%20CS,%20Perry%20G,%20Zeng%20H,%20Kato%20Y,%20Jones%20WD,%20Ling%20K-Q,%20et%20al.%20Copper%20mediates%20dityrosine%20cross-linking%20of%20Alzheimer%E2%80%99s%20amyloid-%CE%B2.%20Biochemistry.%202004;43:560%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR196">
<span class="label">196.</span><cite>Matheou CJ, Younan ND, Viles JH. Cu2+ accentuates distinct misfolding of Aβ(1–40) and Aβ(1–42) peptides, and potentiates membrane disruption. Biochem J. 2015;466:233–42.
</cite> [<a href="https://doi.org/10.1042/BJ20141168" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25471541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Matheou%20CJ,%20Younan%20ND,%20Viles%20JH.%20Cu2+%20accentuates%20distinct%20misfolding%20of%20A%CE%B2(1%E2%80%9340)%20and%20A%CE%B2(1%E2%80%9342)%20peptides,%20and%20potentiates%20membrane%20disruption.%20Biochem%20J.%202015;466:233%E2%80%9342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR197">
<span class="label">197.</span><cite>Tian Y, Shang Q, Liang R, Viles JH. Copper(II) can kinetically trap arctic and Italian amyloid-β40 as toxic oligomers, mimicking Cu(II) binding to wild-type amyloid-β42: implications for familial Alzheimer’s disease. JACS Au. 2024;4:578–91.
</cite> [<a href="https://doi.org/10.1021/jacsau.3c00687" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10900208/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38425915/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tian%20Y,%20Shang%20Q,%20Liang%20R,%20Viles%20JH.%20Copper(II)%20can%20kinetically%20trap%20arctic%20and%20Italian%20amyloid-%CE%B240%20as%20toxic%20oligomers,%20mimicking%20Cu(II)%20binding%20to%20wild-type%20amyloid-%CE%B242:%20implications%20for%20familial%20Alzheimer%E2%80%99s%20disease.%20JACS%20Au.%202024;4:578%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR198">
<span class="label">198.</span><cite>Weibull MGM, Simonsen S, Oksbjerg CR, Tiwari MK, Hemmingsen L. Effects of Cu(II) on the aggregation of amyloid-β. J Biol Inorg Chem. 2019;24:1197–215.
</cite> [<a href="https://doi.org/10.1007/s00775-019-01727-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31602542/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Weibull%20MGM,%20Simonsen%20S,%20Oksbjerg%20CR,%20Tiwari%20MK,%20Hemmingsen%20L.%20Effects%20of%20Cu(II)%20on%20the%20aggregation%20of%20amyloid-%CE%B2.%20J%20Biol%20Inorg%20Chem.%202019;24:1197%E2%80%93215." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR199">
<span class="label">199.</span><cite>Pedersen JT, Teilum K, Heegaard NHH, Østergaard J, Adolph H-W, Hemmingsen L. Rapid formation of a preoligomeric peptide–metal–peptide complex following copper(II) binding to amyloid β peptides. Angew Chem Int Ed. 2011;50:2532–5.</cite> [<a href="https://doi.org/10.1002/anie.201006335" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21370331/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pedersen%20JT,%20Teilum%20K,%20Heegaard%20NHH,%20%C3%98stergaard%20J,%20Adolph%20H-W,%20Hemmingsen%20L.%20Rapid%20formation%20of%20a%20preoligomeric%20peptide%E2%80%93metal%E2%80%93peptide%20complex%20following%20copper(II)%20binding%20to%20amyloid%20%CE%B2%20peptides.%20Angew%20Chem%20Int%20Ed.%202011;50:2532%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR200">
<span class="label">200.</span><cite>Miravalle L, Calero M, Takao M, Roher AE, Ghetti B, Vidal R. Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. Biochemistry. 2005;44:10810–21.
</cite> [<a href="https://doi.org/10.1021/bi0508237" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16086583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miravalle%20L,%20Calero%20M,%20Takao%20M,%20Roher%20AE,%20Ghetti%20B,%20Vidal%20R.%20Amino-terminally%20truncated%20Abeta%20peptide%20species%20are%20the%20main%20component%20of%20cotton%20wool%20plaques.%20Biochemistry.%202005;44:10810%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR201">
<span class="label">201.</span><cite>Barritt JD, Younan ND, Viles JH. N-terminally truncated amyloid-β(11–40/42) cofibrillizes with its full-length counterpart: implications for Alzheimer’s disease. Angew Chem Int Ed Engl. 2017;56:9816–9.
</cite> [<a href="https://doi.org/10.1002/anie.201704618" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28609583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Barritt%20JD,%20Younan%20ND,%20Viles%20JH.%20N-terminally%20truncated%20amyloid-%CE%B2(11%E2%80%9340/42)%20cofibrillizes%20with%20its%20full-length%20counterpart:%20implications%20for%20Alzheimer%E2%80%99s%20disease.%20Angew%20Chem%20Int%20Ed%20Engl.%202017;56:9816%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR202">
<span class="label">202.</span><cite>Sullivan CP, Berg EA, Elliott-Bryant R, Fishman JB, McKee AC, Morin PJ, et al. Pyroglutamate-Aβ 3 and 11 colocalize in amyloid plaques in Alzheimer’s disease cerebral cortex with pyroglutamate-Aβ 11 forming the central core. Neurosci Lett. 2011;505:109–12.
</cite> [<a href="https://doi.org/10.1016/j.neulet.2011.09.071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3253715/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22001577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sullivan%20CP,%20Berg%20EA,%20Elliott-Bryant%20R,%20Fishman%20JB,%20McKee%20AC,%20Morin%20PJ,%20et%20al.%20Pyroglutamate-A%CE%B2%203%20and%2011%20colocalize%20in%20amyloid%20plaques%20in%20Alzheimer%E2%80%99s%20disease%20cerebral%20cortex%20with%20pyroglutamate-A%CE%B2%2011%20forming%20the%20central%20core.%20Neurosci%20Lett.%202011;505:109%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR203">
<span class="label">203.</span><cite>Teng X, Stefaniak E, Girvan P, Kotuniak R, Płonka D, Bal W, et al. Hierarchical binding of copperII to N-truncated Aβ4-16 peptide. Metallomics. 2020;12:470–3.
</cite> [<a href="https://doi.org/10.1039/c9mt00299e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32236192/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Teng%20X,%20Stefaniak%20E,%20Girvan%20P,%20Kotuniak%20R,%20P%C5%82onka%20D,%20Bal%20W,%20et%20al.%20Hierarchical%20binding%20of%20copperII%20to%20N-truncated%20A%CE%B24-16%20peptide.%20Metallomics.%202020;12:470%E2%80%933." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR204">
<span class="label">204.</span><cite>Mital M, Wezynfeld NE, Frączyk T, Wiloch MZ, Wawrzyniak UE, Bonna A, et al. A functional role for Aβ in metal homeostasis? N-truncation and high-affinity copper binding. Angew Chem Int Ed Engl. 2015;54:10460–4.
</cite> [<a href="https://doi.org/10.1002/anie.201502644" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26178596/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mital%20M,%20Wezynfeld%20NE,%20Fr%C4%85czyk%20T,%20Wiloch%20MZ,%20Wawrzyniak%20UE,%20Bonna%20A,%20et%20al.%20A%20functional%20role%20for%20A%CE%B2%20in%20metal%20homeostasis?%20N-truncation%20and%20high-affinity%20copper%20binding.%20Angew%20Chem%20Int%20Ed%20Engl.%202015;54:10460%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR205">
<span class="label">205.</span><cite>Barritt JD, Viles JH. Truncated amyloid-β(11–40/42) from Alzheimer disease binds Cu2+ with a femtomolar affinity and influences fiber assembly. J Biol Chem. 2015;290:27791–802.
</cite> [<a href="https://doi.org/10.1074/jbc.M115.684084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4646025/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26408196/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Barritt%20JD,%20Viles%20JH.%20Truncated%20amyloid-%CE%B2(11%E2%80%9340/42)%20from%20Alzheimer%20disease%20binds%20Cu2+%20with%20a%20femtomolar%20affinity%20and%20influences%20fiber%20assembly.%20J%20Biol%20Chem.%202015;290:27791%E2%80%93802." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR206">
<span class="label">206.</span><cite>Domingo G, Benussi L, Saraceno C, Bertuzzi M, Nicsanu R, Longobardi A, et al. N-terminally truncated and pyroglutamate-modified Aβ forms are measurable in human cerebrospinal fluid and are potential markers of disease progression in Alzheimer’s disease. Front Neurosci. 2021;15: 708119.
</cite> [<a href="https://doi.org/10.3389/fnins.2021.708119" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8358181/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34393717/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Domingo%20G,%20Benussi%20L,%20Saraceno%20C,%20Bertuzzi%20M,%20Nicsanu%20R,%20Longobardi%20A,%20et%20al.%20N-terminally%20truncated%20and%20pyroglutamate-modified%20A%CE%B2%20forms%20are%20measurable%20in%20human%20cerebrospinal%20fluid%20and%20are%20potential%20markers%20of%20disease%20progression%20in%20Alzheimer%E2%80%99s%20disease.%20Front%20Neurosci.%202021;15:%20708119." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR207">
<span class="label">207.</span><cite>Stefaniak E, Bal W. CuII binding properties of N-truncated Aβ peptides: in search of biological function. Inorg Chem. 2019;58:13561–77.
</cite> [<a href="https://doi.org/10.1021/acs.inorgchem.9b01399" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31304745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stefaniak%20E,%20Bal%20W.%20CuII%20binding%20properties%20of%20N-truncated%20A%CE%B2%20peptides:%20in%20search%20of%20biological%20function.%20Inorg%20Chem.%202019;58:13561%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR208">
<span class="label">208.</span><cite>Faller P, Hureau C. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-β peptide. Dalton Trans. 2009;7:1080–94.</cite> [<a href="https://doi.org/10.1039/b813398k" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19322475/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Faller%20P,%20Hureau%20C.%20Bioinorganic%20chemistry%20of%20copper%20and%20zinc%20ions%20coordinated%20to%20amyloid-%CE%B2%20peptide.%20Dalton%20Trans.%202009;7:1080%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR209">
<span class="label">209.</span><cite>Pelvig DP, Pakkenberg H, Stark AK, Pakkenberg B. Neocortical glial cell numbers in human brains. Neurobiol Aging. 2008;29:1754–62.
</cite> [<a href="https://doi.org/10.1016/j.neurobiolaging.2007.04.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17544173/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pelvig%20DP,%20Pakkenberg%20H,%20Stark%20AK,%20Pakkenberg%20B.%20Neocortical%20glial%20cell%20numbers%20in%20human%20brains.%20Neurobiol%20Aging.%202008;29:1754%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR210">
<span class="label">210.</span><cite>Cuestas Torres DM, Cardenas FP. Synaptic plasticity in Alzheimer’s disease and healthy aging. Rev Neurosci. 2020;31:245–68.
</cite> [<a href="https://doi.org/10.1515/revneuro-2019-0058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32250284/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cuestas%20Torres%20DM,%20Cardenas%20FP.%20Synaptic%20plasticity%20in%20Alzheimer%E2%80%99s%20disease%20and%20healthy%20aging.%20Rev%20Neurosci.%202020;31:245%E2%80%9368." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR211">
<span class="label">211.</span><cite>Ansorge O, Daniel SE, Pearce RK. Neuronal loss and plasticity in the supraoptic nucleus in Parkinson’s disease. Neurology. 1997;49:610–3.
</cite> [<a href="https://doi.org/10.1212/wnl.49.2.610" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9270609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ansorge%20O,%20Daniel%20SE,%20Pearce%20RK.%20Neuronal%20loss%20and%20plasticity%20in%20the%20supraoptic%20nucleus%20in%20Parkinson%E2%80%99s%20disease.%20Neurology.%201997;49:610%E2%80%933." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR212">
<span class="label">212.</span><cite>Pilato F, Profice P, Ranieri F, Capone F, Di Iorio R, Florio L, et al. Synaptic plasticity in neurodegenerative diseases evaluated and modulated by in vivo neurophysiological techniques. Mol Neurobiol. 2012;46:563–71.
</cite> [<a href="https://doi.org/10.1007/s12035-012-8302-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22821187/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pilato%20F,%20Profice%20P,%20Ranieri%20F,%20Capone%20F,%20Di%20Iorio%20R,%20Florio%20L,%20et%20al.%20Synaptic%20plasticity%20in%20neurodegenerative%20diseases%20evaluated%20and%20modulated%20by%20in%20vivo%20neurophysiological%20techniques.%20Mol%20Neurobiol.%202012;46:563%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR213">
<span class="label">213.</span><cite>Cajal SRY. Degeneration of Interrupted Nerves. In: Cajal SR, y, DeFelipe J, Jones EG, May RM, editors. Cajal's Degeneration and Regeneration of the Nervous System. Oxford: Oxford University Press; 1991.</cite> [<a href="https://scholar.google.com/scholar_lookup?Cajal%20SRY.%20Degeneration%20of%20Interrupted%20Nerves.%20In:%20Cajal%20SR,%20y,%20DeFelipe%20J,%20Jones%20EG,%20May%20RM,%20editors.%20Cajal's%20Degeneration%20and%20Regeneration%20of%20the%20Nervous%20System.%20Oxford:%20Oxford%20University%20Press;%201991." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR214">
<span class="label">214.</span><cite>Hebb DO. The organization of behavior: a neuropsychological theory. Oxford, England: Wiley; 1949. p. xix, 335.</cite>
</li>
<li id="CR215">
<span class="label">215.</span><cite>von Bartheld CS, Bahney J, Herculano-Houzel S. The search for true numbers of neurons and glial cells in the human brain: a review of 150 years of cell counting. J Comp Neurol. 2016;524:3865–95.
</cite> [<a href="https://doi.org/10.1002/cne.24040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5063692/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27187682/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?von%20Bartheld%20CS,%20Bahney%20J,%20Herculano-Houzel%20S.%20The%20search%20for%20true%20numbers%20of%20neurons%20and%20glial%20cells%20in%20the%20human%20brain:%20a%20review%20of%20150%20years%20of%20cell%20counting.%20J%20Comp%20Neurol.%202016;524:3865%E2%80%9395." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR216">
<span class="label">216.</span><cite>Andrade-Moraes CH, Oliveira-Pinto AV, Castro-Fonseca E, da Silva CG, Guimarães DM, Szczupak D, et al. Cell number changes in Alzheimer’s disease relate to dementia, not to plaques and tangles. Brain. 2013;136:3738–52.
</cite> [<a href="https://doi.org/10.1093/brain/awt273" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3859218/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24136825/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Andrade-Moraes%20CH,%20Oliveira-Pinto%20AV,%20Castro-Fonseca%20E,%20da%20Silva%20CG,%20Guimar%C3%A3es%20DM,%20Szczupak%20D,%20et%20al.%20Cell%20number%20changes%20in%20Alzheimer%E2%80%99s%20disease%20relate%20to%20dementia,%20not%20to%20plaques%20and%20tangles.%20Brain.%202013;136:3738%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR217">
<span class="label">217.</span><cite>Simić G, Kostović I, Winblad B, Bogdanović N. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer’s disease. J Comp Neurol. 1997;379:482–94.
</cite> [<a href="https://doi.org/10.1002/(sici)1096-9861(19970324)379:4&lt;482::aid-cne2&gt;3.0.co;2-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9067838/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Simi%C4%87%20G,%20Kostovi%C4%87%20I,%20Winblad%20B,%20Bogdanovi%C4%87%20N.%20Volume%20and%20number%20of%20neurons%20of%20the%20human%20hippocampal%20formation%20in%20normal%20aging%20and%20Alzheimer%E2%80%99s%20disease.%20J%20Comp%20Neurol.%201997;379:482%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR218">
<span class="label">218.</span><cite>Whitehouse P, Price D, Struble R, Clark A, Coyle J, DeLong MR. Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science. 1982;215:1237–9.
</cite> [<a href="https://doi.org/10.1126/science.7058341" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7058341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Whitehouse%20P,%20Price%20D,%20Struble%20R,%20Clark%20A,%20Coyle%20J,%20DeLong%20MR.%20Alzheimer%E2%80%99s%20disease%20and%20senile%20dementia:%20loss%20of%20neurons%20in%20the%20basal%20forebrain.%20Science.%201982;215:1237%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR219">
<span class="label">219.</span><cite>Lagarde J, Olivieri P, Tonietto M, Noiray C, Lehericy S, Valabrègue R, et al. Combined in vivo MRI assessment of locus coeruleus and nucleus basalis of Meynert integrity in amnestic Alzheimer’s disease, suspected-LATE and frontotemporal dementia. Alzheimers Res Ther. 2024;16: 97.
</cite> [<a href="https://doi.org/10.1186/s13195-024-01466-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11067144/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38702802/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lagarde%20J,%20Olivieri%20P,%20Tonietto%20M,%20Noiray%20C,%20Lehericy%20S,%20Valabr%C3%A8gue%20R,%20et%20al.%20Combined%20in%20vivo%20MRI%20assessment%20of%20locus%20coeruleus%20and%20nucleus%20basalis%20of%20Meynert%20integrity%20in%20amnestic%20Alzheimer%E2%80%99s%20disease,%20suspected-LATE%20and%20frontotemporal%20dementia.%20Alzheimers%20Res%20Ther.%202024;16:%2097." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR220">
<span class="label">220.</span><cite>Bueichekú E, Diez I, Kim C-M, Becker JA, Koops EA, Kwong K, et al. Spatiotemporal patterns of locus coeruleus integrity predict cortical tau and cognition. Nat Aging. 2024;4:625–37.
</cite> [<a href="https://doi.org/10.1038/s43587-024-00626-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11108787/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38664576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bueichek%C3%BA%20E,%20Diez%20I,%20Kim%20C-M,%20Becker%20JA,%20Koops%20EA,%20Kwong%20K,%20et%20al.%20Spatiotemporal%20patterns%20of%20locus%20coeruleus%20integrity%20predict%20cortical%20tau%20and%20cognition.%20Nat%20Aging.%202024;4:625%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR221">
<span class="label">221.</span><cite>Thal DR, Del Tredici K, Ludolph AC, Hoozemans JJM, Rozemuller AJ, Braak H, et al. Stages of granulovacuolar degeneration: their relation to Alzheimer’s disease and chronic stress response. Acta Neuropathol (Berl). 2011;122:577–89.
</cite> [<a href="https://doi.org/10.1007/s00401-011-0871-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21935637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Thal%20DR,%20Del%20Tredici%20K,%20Ludolph%20AC,%20Hoozemans%20JJM,%20Rozemuller%20AJ,%20Braak%20H,%20et%20al.%20Stages%20of%20granulovacuolar%20degeneration:%20their%20relation%20to%20Alzheimer%E2%80%99s%20disease%20and%20chronic%20stress%20response.%20Acta%20Neuropathol%20(Berl).%202011;122:577%E2%80%9389." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR222">
<span class="label">222.</span><cite>Jorge-Oliva M, Smits JFM, Wiersma VI, Hoozemans JJM, Scheper W. Granulovacuolar degeneration bodies are independently induced by tau and α-synuclein pathology. Alzheimers Res Ther. 2022;14: 187.
</cite> [<a href="https://doi.org/10.1186/s13195-022-01128-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9749177/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36517915/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jorge-Oliva%20M,%20Smits%20JFM,%20Wiersma%20VI,%20Hoozemans%20JJM,%20Scheper%20W.%20Granulovacuolar%20degeneration%20bodies%20are%20independently%20induced%20by%20tau%20and%20%CE%B1-synuclein%20pathology.%20Alzheimers%20Res%20Ther.%202022;14:%20187." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR223">
<span class="label">223.</span><cite>Xu J, Church SJ, Patassini S, Begley P, Waldvogel HJ, Curtis MA, et al. Evidence for widespread, severe brain copper deficiency in Alzheimer’s dementia†. Metallomics. 2017;9:1106–19.
</cite> [<a href="https://doi.org/10.1039/c7mt00074j" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28654115/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20J,%20Church%20SJ,%20Patassini%20S,%20Begley%20P,%20Waldvogel%20HJ,%20Curtis%20MA,%20et%20al.%20Evidence%20for%20widespread,%20severe%20brain%20copper%20deficiency%20in%20Alzheimer%E2%80%99s%20dementia%E2%80%A0.%20Metallomics.%202017;9:1106%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR224">
<span class="label">224.</span><cite>Voss K, Harris C, Ralle M, Duffy M, Murchison C, Quinn JF. Modulation of tau phosphorylation by environmental copper. Transl Neurodegener. 2014;3: 24.
</cite> [<a href="https://doi.org/10.1186/2047-9158-3-24" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4322670/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25671100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Voss%20K,%20Harris%20C,%20Ralle%20M,%20Duffy%20M,%20Murchison%20C,%20Quinn%20JF.%20Modulation%20of%20tau%20phosphorylation%20by%20environmental%20copper.%20Transl%20Neurodegener.%202014;3:%2024." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR225">
<span class="label">225.</span><cite>Swerdlow RH, Khan SM. A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease. Med Hypotheses. 2004;63:8–20.
</cite> [<a href="https://doi.org/10.1016/j.mehy.2003.12.045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15193340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Swerdlow%20RH,%20Khan%20SM.%20A%20%E2%80%9Cmitochondrial%20cascade%20hypothesis%E2%80%9D%20for%20sporadic%20Alzheimer%E2%80%99s%20disease.%20Med%20Hypotheses.%202004;63:8%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR226">
<span class="label">226.</span><cite>Sebők-Nagy K, Blastyák A, Juhász G, Páli T. Reversible binding of divalent cations to Ductin protein assemblies—a putative new regulatory mechanism of membrane traffic processes. Front Mol Biosci. 2023. 10.3389/fmolb.2023.1195010.
</cite> [<a href="https://doi.org/10.3389/fmolb.2023.1195010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10203432/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37228584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Seb%C5%91k-Nagy%20K,%20Blasty%C3%A1k%20A,%20Juh%C3%A1sz%20G,%20P%C3%A1li%20T.%20Reversible%20binding%20of%20divalent%20cations%20to%20Ductin%20protein%20assemblies%E2%80%94a%20putative%20new%20regulatory%20mechanism%20of%20membrane%20traffic%20processes.%20Front%20Mol%20Biosci.%202023.%2010.3389/fmolb.2023.1195010." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR227">
<span class="label">227.</span><cite>Poëa-Guyon S, Ammar MR, Erard M, Amar M, Moreau AW, Fossier P, et al. The V-ATPase membrane domain is a sensor of granular pH that controls the exocytotic machinery. J Cell Biol. 2013;203:283–98.
</cite> [<a href="https://doi.org/10.1083/jcb.201303104" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3812966/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24165939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Po%C3%ABa-Guyon%20S,%20Ammar%20MR,%20Erard%20M,%20Amar%20M,%20Moreau%20AW,%20Fossier%20P,%20et%20al.%20The%20V-ATPase%20membrane%20domain%20is%20a%20sensor%20of%20granular%20pH%20that%20controls%20the%20exocytotic%20machinery.%20J%20Cell%20Biol.%202013;203:283%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR228">
<span class="label">228.</span><cite>Koch G, Di Lorenzo F, Bonnì S, Ponzo V, Caltagirone C, Martorana A. Impaired LTP- but not LTD-like cortical plasticity in Alzheimer’s disease patients. J Alzheimers Dis JAD. 2012;31:593–9.
</cite> [<a href="https://doi.org/10.3233/JAD-2012-120532" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22647254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Koch%20G,%20Di%20Lorenzo%20F,%20Bonn%C3%AC%20S,%20Ponzo%20V,%20Caltagirone%20C,%20Martorana%20A.%20Impaired%20LTP-%20but%20not%20LTD-like%20cortical%20plasticity%20in%20Alzheimer%E2%80%99s%20disease%20patients.%20J%20Alzheimers%20Dis%20JAD.%202012;31:593%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR229">
<span class="label">229.</span><cite>Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416:535–9.
</cite> [<a href="https://doi.org/10.1038/416535a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11932745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Walsh%20DM,%20Klyubin%20I,%20Fadeeva%20JV,%20Cullen%20WK,%20Anwyl%20R,%20Wolfe%20MS,%20et%20al.%20Naturally%20secreted%20oligomers%20of%20amyloid%20%CE%B2%20protein%20potently%20inhibit%20hippocampal%20long-term%20potentiation%20in%20vivo.%20Nature.%202002;416:535%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR230">
<span class="label">230.</span><cite>Prieto GA, Trieu BH, Dang CT, Bilousova T, Gylys KH, Berchtold NC, et al. Pharmacological rescue of long-term potentiation in Alzheimer diseased synapses. J Neurosci. 2017;37:1197–212.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.2774-16.2016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5296796/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27986924/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Prieto%20GA,%20Trieu%20BH,%20Dang%20CT,%20Bilousova%20T,%20Gylys%20KH,%20Berchtold%20NC,%20et%20al.%20Pharmacological%20rescue%20of%20long-term%20potentiation%20in%20Alzheimer%20diseased%20synapses.%20J%20Neurosci.%202017;37:1197%E2%80%93212." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR231">
<span class="label">231.</span><cite>Meloni G, Sonois V, Delaine T, Guilloreau L, Gillet A, Teissié J, et al. Metal swap between Zn7-metallothionein-3 and amyloid-beta-Cu protects against amyloid-beta toxicity. Nat Chem Biol. 2008;4:366–72.
</cite> [<a href="https://doi.org/10.1038/nchembio.89" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18454142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Meloni%20G,%20Sonois%20V,%20Delaine%20T,%20Guilloreau%20L,%20Gillet%20A,%20Teissi%C3%A9%20J,%20et%20al.%20Metal%20swap%20between%20Zn7-metallothionein-3%20and%20amyloid-beta-Cu%20protects%20against%20amyloid-beta%20toxicity.%20Nat%20Chem%20Biol.%202008;4:366%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR232">
<span class="label">232.</span><cite>Santoro A, Ewa Wezynfeld N, Vašák M, Bal W, Faller P. Cysteine and glutathione trigger the Cu–Zn swap between Cu(ii)-amyloid-β4-16 peptide and Zn7-metallothionein-3. Chem Commun Camb Engl. 2017;53:11634–7.</cite> [<a href="https://doi.org/10.1039/c7cc06802f" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28948272/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Santoro%20A,%20Ewa%20Wezynfeld%20N,%20Va%C5%A1%C3%A1k%20M,%20Bal%20W,%20Faller%20P.%20Cysteine%20and%20glutathione%20trigger%20the%20Cu%E2%80%93Zn%20swap%20between%20Cu(ii)-amyloid-%CE%B24-16%20peptide%20and%20Zn7-metallothionein-3.%20Chem%20Commun%20Camb%20Engl.%202017;53:11634%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR233">
<span class="label">233.</span><cite>Mandal PK, Saharan S, Tripathi M, Murari G. Brain glutathione levels – a novel biomarker for mild cognitive impairment and Alzheimer’s disease. Biol Psychiatry. 2015;78:702–10.
</cite> [<a href="https://doi.org/10.1016/j.biopsych.2015.04.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26003861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mandal%20PK,%20Saharan%20S,%20Tripathi%20M,%20Murari%20G.%20Brain%20glutathione%20levels%20%E2%80%93%20a%20novel%20biomarker%20for%20mild%20cognitive%20impairment%20and%20Alzheimer%E2%80%99s%20disease.%20Biol%20Psychiatry.%202015;78:702%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR234">
<span class="label">234.</span><cite>Walsh DM, Tseng BP, Rydel RE, Podlisny MB, Selkoe DJ. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry. 2000;39:10831–9.
</cite> [<a href="https://doi.org/10.1021/bi001048s" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10978169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Walsh%20DM,%20Tseng%20BP,%20Rydel%20RE,%20Podlisny%20MB,%20Selkoe%20DJ.%20The%20oligomerization%20of%20amyloid%20beta-protein%20begins%20intracellularly%20in%20cells%20derived%20from%20human%20brain.%20Biochemistry.%202000;39:10831%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR235">
<span class="label">235.</span><cite>Greenfield JP, Tsai J, Gouras GK, Hai B, Thinakaran G, Checler F, et al. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc Natl Acad Sci U S A. 1999;96:742–7.
</cite> [<a href="https://doi.org/10.1073/pnas.96.2.742" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC15207/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9892704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Greenfield%20JP,%20Tsai%20J,%20Gouras%20GK,%20Hai%20B,%20Thinakaran%20G,%20Checler%20F,%20et%20al.%20Endoplasmic%20reticulum%20and%20trans-Golgi%20network%20generate%20distinct%20populations%20of%20Alzheimer%20beta-amyloid%20peptides.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%201999;96:742%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR236">
<span class="label">236.</span><cite>Hartmann T, Bieger SC, Brühl B, Tienari PJ, Ida N, Allsop D, et al. Distinct sites of intracellular production for Alzheimer’s disease A beta40/42 amyloid peptides. Nat Med. 1997;3:1016–20.
</cite> [<a href="https://doi.org/10.1038/nm0997-1016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9288729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hartmann%20T,%20Bieger%20SC,%20Br%C3%BChl%20B,%20Tienari%20PJ,%20Ida%20N,%20Allsop%20D,%20et%20al.%20Distinct%20sites%20of%20intracellular%20production%20for%20Alzheimer%E2%80%99s%20disease%20A%20beta40/42%20amyloid%20peptides.%20Nat%20Med.%201997;3:1016%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR237">
<span class="label">237.</span><cite>Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, et al. Intraneuronal Aβ42 accumulation in human brain. Am J Pathol. 2000;156:15–20.
</cite> [<a href="https://doi.org/10.1016/s0002-9440(10)64700-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1868613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10623648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gouras%20GK,%20Tsai%20J,%20Naslund%20J,%20Vincent%20B,%20Edgar%20M,%20Checler%20F,%20et%20al.%20Intraneuronal%20A%CE%B242%20accumulation%20in%20human%20brain.%20Am%20J%20Pathol.%202000;156:15%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR238">
<span class="label">238.</span><cite>Angeletti B, Waldron KJ, Freeman KB, Bawagan H, Hussain I, Miller CCJ, et al. BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper. J Biol Chem. 2005;280:17930–7.
</cite> [<a href="https://doi.org/10.1074/jbc.M412034200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15722349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Angeletti%20B,%20Waldron%20KJ,%20Freeman%20KB,%20Bawagan%20H,%20Hussain%20I,%20Miller%20CCJ,%20et%20al.%20BACE1%20cytoplasmic%20domain%20interacts%20with%20the%20copper%20chaperone%20for%20superoxide%20dismutase-1%20and%20binds%20copper.%20J%20Biol%20Chem.%202005;280:17930%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR239">
<span class="label">239.</span><cite>Kitazawa M, Cheng D, Laferla FM. Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD. J Neurochem. 2009;108:1550–60.
</cite> [<a href="https://doi.org/10.1111/j.1471-4159.2009.05901.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4096128/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19183260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kitazawa%20M,%20Cheng%20D,%20Laferla%20FM.%20Chronic%20copper%20exposure%20exacerbates%20both%20amyloid%20and%20tau%20pathology%20and%20selectively%20dysregulates%20cdk5%20in%20a%20mouse%20model%20of%20AD.%20J%20Neurochem.%202009;108:1550%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR240">
<span class="label">240.</span><cite>Acevedo KM, Opazo CM, Norrish D, Challis LM, Li Q-X, White AR, et al. Phosphorylation of amyloid precursor protein at threonine 668 is essential for its copper-responsive trafficking in SH-SY5Y neuroblastoma cells. J Biol Chem. 2014;289:11007–19.
</cite> [<a href="https://doi.org/10.1074/jbc.M113.538710" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4036242/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24610780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Acevedo%20KM,%20Opazo%20CM,%20Norrish%20D,%20Challis%20LM,%20Li%20Q-X,%20White%20AR,%20et%20al.%20Phosphorylation%20of%20amyloid%20precursor%20protein%20at%20threonine%20668%20is%20essential%20for%20its%20copper-responsive%20trafficking%20in%20SH-SY5Y%20neuroblastoma%20cells.%20J%20Biol%20Chem.%202014;289:11007%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR241">
<span class="label">241.</span><cite>Crouch PJ, Hung LW, Adlard PA, Cortes M, Lal V, Filiz G, et al. Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation. Proc Natl Acad Sci U S A. 2009;106:381–6.
</cite> [<a href="https://doi.org/10.1073/pnas.0809057106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2626711/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19122148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Crouch%20PJ,%20Hung%20LW,%20Adlard%20PA,%20Cortes%20M,%20Lal%20V,%20Filiz%20G,%20et%20al.%20Increasing%20Cu%20bioavailability%20inhibits%20Abeta%20oligomers%20and%20tau%20phosphorylation.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202009;106:381%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR242">
<span class="label">242.</span><cite>Wirths O, Multhaup G, Bayer TA. A modified β-amyloid hypothesis: intraneuronal accumulation of the β-amyloid peptide – the first step of a fatal cascade. J Neurochem. 2004;91:513–20.
</cite> [<a href="https://doi.org/10.1111/j.1471-4159.2004.02737.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15485483/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wirths%20O,%20Multhaup%20G,%20Bayer%20TA.%20A%20modified%20%CE%B2-amyloid%20hypothesis:%20intraneuronal%20accumulation%20of%20the%20%CE%B2-amyloid%20peptide%20%E2%80%93%20the%20first%20step%20of%20a%20fatal%20cascade.%20J%20Neurochem.%202004;91:513%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR243">
<span class="label">243.</span><cite>Ittner LM, Götz J. Amyloid-β and tau — a toxic pas de deux in Alzheimer’s disease. Nat Rev Neurosci. 2011;12:67–72.</cite> [<a href="https://doi.org/10.1038/nrn2967" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21193853/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ittner%20LM,%20G%C3%B6tz%20J.%20Amyloid-%CE%B2%20and%20tau%20%E2%80%94%20a%20toxic%20pas%20de%20deux%20in%20Alzheimer%E2%80%99s%20disease.%20Nat%20Rev%20Neurosci.%202011;12:67%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR244">
<span class="label">244.</span><cite>Lee H, Casadesus G, Zhu X, Castellani RJ, McShea A, Perry G, et al. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer’s disease. Neurochem Int. 2009;54:84–8.
</cite> [<a href="https://doi.org/10.1016/j.neuint.2008.10.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2792898/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19114068/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20H,%20Casadesus%20G,%20Zhu%20X,%20Castellani%20RJ,%20McShea%20A,%20Perry%20G,%20et%20al.%20Cell%20cycle%20re-entry%20mediated%20neurodegeneration%20and%20its%20treatment%20role%20in%20the%20pathogenesis%20of%20Alzheimer%E2%80%99s%20disease.%20Neurochem%20Int.%202009;54:84%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR245">
<span class="label">245.</span><cite>Folch J, Junyent F, Verdaguer E, Auladell C, Pizarro JG, Beas-Zarate C, et al. Role of cell cycle re-entry in neurons: a common apoptotic mechanism of neuronal cell death. Neurotox Res. 2012;22:195–207.
</cite> [<a href="https://doi.org/10.1007/s12640-011-9277-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21965004/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Folch%20J,%20Junyent%20F,%20Verdaguer%20E,%20Auladell%20C,%20Pizarro%20JG,%20Beas-Zarate%20C,%20et%20al.%20Role%20of%20cell%20cycle%20re-entry%20in%20neurons:%20a%20common%20apoptotic%20mechanism%20of%20neuronal%20cell%20death.%20Neurotox%20Res.%202012;22:195%E2%80%93207." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR246">
<span class="label">246.</span><cite>Chen S, Yadav SP, Surewicz WK. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues. J Biol Chem. 2010;285:26377–83.
</cite> [<a href="https://doi.org/10.1074/jbc.M110.145516" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2924066/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20576610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20S,%20Yadav%20SP,%20Surewicz%20WK.%20Interaction%20between%20human%20prion%20protein%20and%20amyloid-beta%20(Abeta)%20oligomers:%20role%20OF%20N-terminal%20residues.%20J%20Biol%20Chem.%202010;285:26377%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR247">
<span class="label">247.</span><cite>Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature. 2009;457:1128–32.
</cite> [<a href="https://doi.org/10.1038/nature07761" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2748841/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19242475/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Laur%C3%A9n%20J,%20Gimbel%20DA,%20Nygaard%20HB,%20Gilbert%20JW,%20Strittmatter%20SM.%20Cellular%20prion%20protein%20mediates%20impairment%20of%20synaptic%20plasticity%20by%20amyloid-beta%20oligomers.%20Nature.%202009;457:1128%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR248">
<span class="label">248.</span><cite>Black SAG, Stys PK, Zamponi GW, Tsutsui S. Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity. Front Cell Dev Biol. 2014;2: 45.
</cite> [<a href="https://doi.org/10.3389/fcell.2014.00045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4207032/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25364752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Black%20SAG,%20Stys%20PK,%20Zamponi%20GW,%20Tsutsui%20S.%20Cellular%20prion%20protein%20and%20NMDA%20receptor%20modulation:%20protecting%20against%20excitotoxicity.%20Front%20Cell%20Dev%20Biol.%202014;2:%2045." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR249">
<span class="label">249.</span><cite>Gasperini L, Meneghetti E, Pastore B, Benetti F, Legname G. Prion protein and copper cooperatively protect neurons by modulating NMDA receptor through S-nitrosylation. Antioxid Redox Signal. 2015;22:772–84.
</cite> [<a href="https://doi.org/10.1089/ars.2014.6032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4361008/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25490055/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gasperini%20L,%20Meneghetti%20E,%20Pastore%20B,%20Benetti%20F,%20Legname%20G.%20Prion%20protein%20and%20copper%20cooperatively%20protect%20neurons%20by%20modulating%20NMDA%20receptor%20through%20S-nitrosylation.%20Antioxid%20Redox%20Signal.%202015;22:772%E2%80%9384." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR250">
<span class="label">250.</span><cite>Schlief ML, Craig AM, Gitlin JD. NMDA receptor activation mediates copper homeostasis in hippocampal neurons. J Neurosci. 2005;25:239–46.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.3699-04.2005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6725203/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15634787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schlief%20ML,%20Craig%20AM,%20Gitlin%20JD.%20NMDA%20receptor%20activation%20mediates%20copper%20homeostasis%20in%20hippocampal%20neurons.%20J%20Neurosci.%202005;25:239%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR251">
<span class="label">251.</span><cite>Hernandez P, Lee G, Sjoberg M, Maccioni RB. Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25–35): involvement of lipid rafts. J Alzheimers Dis. 2009;16:149–56.
</cite> [<a href="https://doi.org/10.3233/JAD-2009-0933" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19158430/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hernandez%20P,%20Lee%20G,%20Sjoberg%20M,%20Maccioni%20RB.%20Tau%20phosphorylation%20by%20cdk5%20and%20Fyn%20in%20response%20to%20amyloid%20peptide%20Abeta%20(25%E2%80%9335):%20involvement%20of%20lipid%20rafts.%20J%20Alzheimers%20Dis.%202009;16:149%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR252">
<span class="label">252.</span><cite>Zheng Y-L, Kesavapany S, Gravell M, Hamilton RS, Schubert M, Amin N, et al. A cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J. 2005;24:209–20.
</cite> [<a href="https://doi.org/10.1038/sj.emboj.7600441" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC544899/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15592431/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20Y-L,%20Kesavapany%20S,%20Gravell%20M,%20Hamilton%20RS,%20Schubert%20M,%20Amin%20N,%20et%20al.%20A%20cdk5%20inhibitory%20peptide%20reduces%20tau%20hyperphosphorylation%20and%20apoptosis%20in%20neurons.%20EMBO%20J.%202005;24:209%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR253">
<span class="label">253.</span><cite>Dedkova EN, Blatter LA. Nitric oxide inhibits capacitative Ca2+ entry and enhances endoplasmic reticulum Ca2+ uptake in bovine vascular endothelial cells. J Physiol. 2002;539:77–91.
</cite> [<a href="https://doi.org/10.1113/jphysiol.2001.013258" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2290138/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11850503/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dedkova%20EN,%20Blatter%20LA.%20Nitric%20oxide%20inhibits%20capacitative%20Ca2+%20entry%20and%20enhances%20endoplasmic%20reticulum%20Ca2+%20uptake%20in%20bovine%20vascular%20endothelial%20cells.%20J%20Physiol.%202002;539:77%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR254">
<span class="label">254.</span><cite>Dubey H, Gulati K, Ray A. Alzheimer’s disease: a contextual link with nitric oxide synthase. Curr Mol Med. 2020;20:505–15.
</cite> [<a href="https://doi.org/10.2174/1566524019666191129103117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31782366/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dubey%20H,%20Gulati%20K,%20Ray%20A.%20Alzheimer%E2%80%99s%20disease:%20a%20contextual%20link%20with%20nitric%20oxide%20synthase.%20Curr%20Mol%20Med.%202020;20:505%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR255">
<span class="label">255.</span><cite>Lüth HJ, Holzer M, Gärtner U, Staufenbiel M, Arendt T. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer’s disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. Brain Res. 2001;913:57–67.
</cite> [<a href="https://doi.org/10.1016/s0006-8993(01)02758-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11532247/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?L%C3%BCth%20HJ,%20Holzer%20M,%20G%C3%A4rtner%20U,%20Staufenbiel%20M,%20Arendt%20T.%20Expression%20of%20endothelial%20and%20inducible%20NOS-isoforms%20is%20increased%20in%20Alzheimer%E2%80%99s%20disease,%20in%20APP23%20transgenic%20mice%20and%20after%20experimental%20brain%20lesion%20in%20rat:%20evidence%20for%20an%20induction%20by%20amyloid%20pathology.%20Brain%20Res.%202001;913:57%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR256">
<span class="label">256.</span><cite>Love S, Miners JS. Cerebral hypoperfusion and the energy deficit in Alzheimer’s disease. Brain Pathol. 2016;26:607–17.
</cite> [<a href="https://doi.org/10.1111/bpa.12401" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8028913/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27327656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Love%20S,%20Miners%20JS.%20Cerebral%20hypoperfusion%20and%20the%20energy%20deficit%20in%20Alzheimer%E2%80%99s%20disease.%20Brain%20Pathol.%202016;26:607%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR257">
<span class="label">257.</span><cite>Carrick JB, Begg AP. Peripheral blood leukocytes. Vet Clin North Am Equine Pract. 2008;24:239–59.
</cite> [<a href="https://doi.org/10.1016/j.cveq.2008.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18652954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Carrick%20JB,%20Begg%20AP.%20Peripheral%20blood%20leukocytes.%20Vet%20Clin%20North%20Am%20Equine%20Pract.%202008;24:239%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR258">
<span class="label">258.</span><cite>Nayak D, Roth TL, McGavern DB. Microglia development and function. Annu Rev Immunol. 2014;32:367–402.
</cite> [<a href="https://doi.org/10.1146/annurev-immunol-032713-120240" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5001846/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24471431/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nayak%20D,%20Roth%20TL,%20McGavern%20DB.%20Microglia%20development%20and%20function.%20Annu%20Rev%20Immunol.%202014;32:367%E2%80%93402." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR259">
<span class="label">259.</span><cite>Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330:841–5.
</cite> [<a href="https://doi.org/10.1126/science.1194637" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3719181/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20966214/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ginhoux%20F,%20Greter%20M,%20Leboeuf%20M,%20Nandi%20S,%20See%20P,%20Gokhan%20S,%20et%20al.%20Fate%20mapping%20analysis%20reveals%20that%20adult%20microglia%20derive%20from%20primitive%20macrophages.%20Science.%202010;330:841%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR260">
<span class="label">260.</span><cite>Sominsky L, De Luca S, Spencer SJ. Microglia: key players in neurodevelopment and neuronal plasticity. Int J Biochem Cell Biol. 2018;94:56–60.
</cite> [<a href="https://doi.org/10.1016/j.biocel.2017.11.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29197626/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sominsky%20L,%20De%20Luca%20S,%20Spencer%20SJ.%20Microglia:%20key%20players%20in%20neurodevelopment%20and%20neuronal%20plasticity.%20Int%20J%20Biochem%20Cell%20Biol.%202018;94:56%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR261">
<span class="label">261.</span><cite>Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456–8.
</cite> [<a href="https://doi.org/10.1126/science.1202529" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21778362/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Paolicelli%20RC,%20Bolasco%20G,%20Pagani%20F,%20Maggi%20L,%20Scianni%20M,%20Panzanelli%20P,%20et%20al.%20Synaptic%20pruning%20by%20microglia%20is%20necessary%20for%20normal%20brain%20development.%20Science.%202011;333:1456%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR262">
<span class="label">262.</span><cite>Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308:1314–8.
</cite> [<a href="https://doi.org/10.1126/science.1110647" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15831717/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nimmerjahn%20A,%20Kirchhoff%20F,%20Helmchen%20F.%20Resting%20microglial%20cells%20are%20highly%20dynamic%20surveillants%20of%20brain%20parenchyma%20in%20vivo.%20Science.%202005;308:1314%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR263">
<span class="label">263.</span><cite>Orihuela R, McPherson CA, Harry GJ. Microglial M1/M2 polarization and metabolic states. Br J Pharmacol. 2016;173:649–65.
</cite> [<a href="https://doi.org/10.1111/bph.13139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4742299/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25800044/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Orihuela%20R,%20McPherson%20CA,%20Harry%20GJ.%20Microglial%20M1/M2%20polarization%20and%20metabolic%20states.%20Br%20J%20Pharmacol.%202016;173:649%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR264">
<span class="label">264.</span><cite>Lang R, Patel D, Morris JJ, Rutschman RL, Murray PJ. Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol Baltim Md. 1950;2002(169):2253–63.</cite> [<a href="https://doi.org/10.4049/jimmunol.169.5.2253" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12193690/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lang%20R,%20Patel%20D,%20Morris%20JJ,%20Rutschman%20RL,%20Murray%20PJ.%20Shaping%20gene%20expression%20in%20activated%20and%20resting%20primary%20macrophages%20by%20IL-10.%20J%20Immunol%20Baltim%20Md.%201950;2002(169):2253%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR265">
<span class="label">265.</span><cite>Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009;27:451–83.
</cite> [<a href="https://doi.org/10.1146/annurev.immunol.021908.132532" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19105661/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Martinez%20FO,%20Helming%20L,%20Gordon%20S.%20Alternative%20activation%20of%20macrophages:%20an%20immunologic%20functional%20perspective.%20Annu%20Rev%20Immunol.%202009;27:451%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR266">
<span class="label">266.</span><cite>Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19:987–91.
</cite> [<a href="https://doi.org/10.1038/nn.4338" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27459405/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ransohoff%20RM.%20A%20polarizing%20question:%20do%20M1%20and%20M2%20microglia%20exist?%20Nat%20Neurosci.%202016;19:987%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR267">
<span class="label">267.</span><cite>Deczkowska A, Keren-Shaul H, Weiner A, Colonna M, Schwartz M, Amit I. Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell. 2018;173:1073–81.
</cite> [<a href="https://doi.org/10.1016/j.cell.2018.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29775591/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deczkowska%20A,%20Keren-Shaul%20H,%20Weiner%20A,%20Colonna%20M,%20Schwartz%20M,%20Amit%20I.%20Disease-associated%20microglia:%20a%20universal%20immune%20sensor%20of%20neurodegeneration.%20Cell.%202018;173:1073%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR268">
<span class="label">268.</span><cite>Rangaraju S, Dammer EB, Raza SA, Rathakrishnan P, Xiao H, Gao T, et al. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease. Mol Neurodegener. 2018;13: 24.
</cite> [<a href="https://doi.org/10.1186/s13024-018-0254-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5963076/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29784049/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rangaraju%20S,%20Dammer%20EB,%20Raza%20SA,%20Rathakrishnan%20P,%20Xiao%20H,%20Gao%20T,%20et%20al.%20Identification%20and%20therapeutic%20modulation%20of%20a%20pro-inflammatory%20subset%20of%20disease-associated-microglia%20in%20Alzheimer%E2%80%99s%20disease.%20Mol%20Neurodegener.%202018;13:%2024." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR269">
<span class="label">269.</span><cite>Fan Z, Brooks DJ, Okello A, Edison P. An early and late peak in microglial activation in Alzheimer’s disease trajectory. Brain J Neurol. 2017;140:792–803.</cite> [<a href="https://doi.org/10.1093/brain/aww349" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5837520/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28122877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fan%20Z,%20Brooks%20DJ,%20Okello%20A,%20Edison%20P.%20An%20early%20and%20late%20peak%20in%20microglial%20activation%20in%20Alzheimer%E2%80%99s%20disease%20trajectory.%20Brain%20J%20Neurol.%202017;140:792%E2%80%93803." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR270">
<span class="label">270.</span><cite>Shi Y, Holtzman DM. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat Rev Immunol. 2018;18:759–72.
</cite> [<a href="https://doi.org/10.1038/s41577-018-0051-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6425488/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30140051/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shi%20Y,%20Holtzman%20DM.%20Interplay%20between%20innate%20immunity%20and%20Alzheimer%20disease:%20APOE%20and%20TREM2%20in%20the%20spotlight.%20Nat%20Rev%20Immunol.%202018;18:759%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR271">
<span class="label">271.</span><cite>Zheng Z, White C, Lee J, Peterson TS, Bush AI, Sun G, et al. Altered microglial copper homeostasis in a mouse model of Alzheimer’s diseasE. J Neurochem. 2010;114:1630–8.
</cite> [<a href="https://doi.org/10.1111/j.1471-4159.2010.06888.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2945454/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20626553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20Z,%20White%20C,%20Lee%20J,%20Peterson%20TS,%20Bush%20AI,%20Sun%20G,%20et%20al.%20Altered%20microglial%20copper%20homeostasis%20in%20a%20mouse%20model%20of%20Alzheimer%E2%80%99s%20diseasE.%20J%20Neurochem.%202010;114:1630%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR272">
<span class="label">272.</span><cite>Meda L, Cassatella MA, Szendrei GI, Otvos L, Baron P, Villalba M, et al. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature. 1995;374:647–50.
</cite> [<a href="https://doi.org/10.1038/374647a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7715705/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Meda%20L,%20Cassatella%20MA,%20Szendrei%20GI,%20Otvos%20L,%20Baron%20P,%20Villalba%20M,%20et%20al.%20Activation%20of%20microglial%20cells%20by%20%CE%B2-amyloid%20protein%20and%20interferon-%CE%B3.%20Nature.%201995;374:647%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR273">
<span class="label">273.</span><cite>Belkhelfa M, Rafa H, Medjeber O, Arroul-Lammali A, Behairi N, Abada-Bendib M, et al. IFN-γ and TNF-α are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients. J Interferon Cytokine Res. 2014;34:839–47.</cite> [<a href="https://doi.org/10.1089/jir.2013.0085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24831467/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Belkhelfa%20M,%20Rafa%20H,%20Medjeber%20O,%20Arroul-Lammali%20A,%20Behairi%20N,%20Abada-Bendib%20M,%20et%20al.%20IFN-%CE%B3%20and%20TNF-%CE%B1%20are%20involved%20during%20Alzheimer%20disease%20progression%20and%20correlate%20with%20nitric%20oxide%20production:%20a%20study%20in%20Algerian%20patients.%C2%A0J%20Interferon%20Cytokine%20Res.%202014;34:839%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR274">
<span class="label">274.</span><cite>Hu Z, Yu F, Gong P, Qiu Y, Zhou W, Cui Y, et al. Subneurotoxic copper(II)-induced NF-κB-dependent microglial activation is associated with mitochondrial ROS. Toxicol Appl Pharmacol. 2014;276:95–103.
</cite> [<a href="https://doi.org/10.1016/j.taap.2014.01.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24530511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20Z,%20Yu%20F,%20Gong%20P,%20Qiu%20Y,%20Zhou%20W,%20Cui%20Y,%20et%20al.%20Subneurotoxic%20copper(II)-induced%20NF-%CE%BAB-dependent%20microglial%20activation%20is%20associated%20with%20mitochondrial%20ROS.%20Toxicol%20Appl%20Pharmacol.%202014;276:95%E2%80%93103." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR275">
<span class="label">275.</span><cite>Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, et al. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res. 2002;62:4854–9.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/12208730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pan%20Q,%20Kleer%20CG,%20van%20Golen%20KL,%20Irani%20J,%20Bottema%20KM,%20Bias%20C,%20et%20al.%20Copper%20deficiency%20induced%20by%20tetrathiomolybdate%20suppresses%20tumor%20growth%20and%20angiogenesis.%20Cancer%20Res.%202002;62:4854%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR276">
<span class="label">276.</span><cite>Mandinov L, Mandinova A, Kyurkchiev S, Kyurkchiev D, Kehayov I, Kolev V, et al. Copper chelation represses the vascular response to injury. Proc Natl Acad Sci U S A. 2003;100:6700–5.
</cite> [<a href="https://doi.org/10.1073/pnas.1231994100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC164510/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12754378/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mandinov%20L,%20Mandinova%20A,%20Kyurkchiev%20S,%20Kyurkchiev%20D,%20Kehayov%20I,%20Kolev%20V,%20et%20al.%20Copper%20chelation%20represses%20the%20vascular%20response%20to%20injury.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202003;100:6700%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR277">
<span class="label">277.</span><cite>Schlief ML, West T, Craig AM, Holtzman DM, Gitlin JD. Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity. Proc Natl Acad Sci. 2006;103:14919–24.
</cite> [<a href="https://doi.org/10.1073/pnas.0605390103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1578502/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17003121/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schlief%20ML,%20West%20T,%20Craig%20AM,%20Holtzman%20DM,%20Gitlin%20JD.%20Role%20of%20the%20Menkes%20copper-transporting%20ATPase%20in%20NMDA%20receptor-mediated%20neuronal%20toxicity.%20Proc%20Natl%20Acad%20Sci.%202006;103:14919%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR278">
<span class="label">278.</span><cite>Bagheri S, Saboury AA, Haertlé T, Rongioletti M, Saso L. Probable reasons for neuron copper deficiency in the brain of patients with Alzheimer’s disease: the complex role of amyloid. Inorganics. 2022;10:6.</cite> [<a href="https://scholar.google.com/scholar_lookup?Bagheri%20S,%20Saboury%20AA,%20Haertl%C3%A9%20T,%20Rongioletti%20M,%20Saso%20L.%20Probable%20reasons%20for%20neuron%20copper%20deficiency%20in%20the%20brain%20of%20patients%20with%20Alzheimer%E2%80%99s%20disease:%20the%20complex%20role%20of%20amyloid.%20Inorganics.%202022;10:6." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR279">
<span class="label">279.</span><cite>Maryon EB, Molloy SA, Kaplan JH. Cellular glutathione plays a key role in copper uptake mediated by human copper transporter 1. Am J Physiol Cell Physiol. 2013;304:C768–79.
</cite> [<a href="https://doi.org/10.1152/ajpcell.00417.2012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3625801/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23426973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maryon%20EB,%20Molloy%20SA,%20Kaplan%20JH.%20Cellular%20glutathione%20plays%20a%20key%20role%20in%20copper%20uptake%20mediated%20by%20human%20copper%20transporter%201.%20Am%20J%20Physiol%20Cell%20Physiol.%202013;304:C768%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR280">
<span class="label">280.</span><cite>Brown GC, St George-Hyslop P. Does soluble TREM2 protect against Alzheimer’s disease? Front Aging Neurosci. 2022. 10.3389/fnagi.2021.834697.
</cite> [<a href="https://doi.org/10.3389/fnagi.2021.834697" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8831327/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35153729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brown%20GC,%20St%20George-Hyslop%20P.%20Does%20soluble%20TREM2%20protect%20against%20Alzheimer%E2%80%99s%20disease?%20Front%20Aging%20Neurosci.%202022.%2010.3389/fnagi.2021.834697." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR281">
<span class="label">281.</span><cite>Dong J, Wang X, Xu C, Gao M, Wang S, Zhang J, et al. Inhibiting NLRP3 inflammasome activation prevents copper-induced neuropathology in a murine model of Wilson’s disease. Cell Death Dis. 2021;12:1–12.
</cite> [<a href="https://doi.org/10.1038/s41419-021-03397-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7813851/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33462188/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dong%20J,%20Wang%20X,%20Xu%20C,%20Gao%20M,%20Wang%20S,%20Zhang%20J,%20et%20al.%20Inhibiting%20NLRP3%20inflammasome%20activation%20prevents%20copper-induced%20neuropathology%20in%20a%20murine%20model%20of%20Wilson%E2%80%99s%20disease.%20Cell%20Death%20Dis.%202021;12:1%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR282">
<span class="label">282.</span><cite>Liang T, Zhang Y, Wu S, Chen Q, Wang L. The role of NLRP3 inflammasome in Alzheimer’s disease and potential therapeutic targets. Front Pharmacol. 2022;13: 845185.
</cite> [<a href="https://doi.org/10.3389/fphar.2022.845185" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8889079/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35250595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liang%20T,%20Zhang%20Y,%20Wu%20S,%20Chen%20Q,%20Wang%20L.%20The%20role%20of%20NLRP3%20inflammasome%20in%20Alzheimer%E2%80%99s%20disease%20and%20potential%20therapeutic%20targets.%20Front%20Pharmacol.%202022;13:%20845185." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR283">
<span class="label">283.</span><cite>Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, et al. Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease. Nature. 2017;552:355–61.
</cite> [<a href="https://doi.org/10.1038/nature25158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29293211/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Venegas%20C,%20Kumar%20S,%20Franklin%20BS,%20Dierkes%20T,%20Brinkschulte%20R,%20Tejera%20D,%20et%20al.%20Microglia-derived%20ASC%20specks%20cross-seed%20amyloid-%CE%B2%20in%20Alzheimer%E2%80%99s%20disease.%20Nature.%202017;552:355%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR284">
<span class="label">284.</span><cite>Schitine C, Nogaroli L, Costa MR, Hedin-Pereira C. Astrocyte heterogeneity in the brain: from development to disease. Front Cell Neurosci. 2015;9: 76.
</cite> [<a href="https://doi.org/10.3389/fncel.2015.00076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4367182/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25852472/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schitine%20C,%20Nogaroli%20L,%20Costa%20MR,%20Hedin-Pereira%20C.%20Astrocyte%20heterogeneity%20in%20the%20brain:%20from%20development%20to%20disease.%20Front%20Cell%20Neurosci.%202015;9:%2076." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR285">
<span class="label">285.</span><cite>Vasile F, Dossi E, Rouach N. Human astrocytes: structure and functions in the healthy brain. Brain Struct Funct. 2017;222:2017–29.
</cite> [<a href="https://doi.org/10.1007/s00429-017-1383-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5504258/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28280934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vasile%20F,%20Dossi%20E,%20Rouach%20N.%20Human%20astrocytes:%20structure%20and%20functions%20in%20the%20healthy%20brain.%20Brain%20Struct%20Funct.%202017;222:2017%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR286">
<span class="label">286.</span><cite>Verkhratsky A, Nedergaard M. Physiology of astroglia. Physiol Rev. 2018;98:239–389.
</cite> [<a href="https://doi.org/10.1152/physrev.00042.2016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6050349/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29351512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Verkhratsky%20A,%20Nedergaard%20M.%20Physiology%20of%20astroglia.%20Physiol%20Rev.%202018;98:239%E2%80%93389." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR287">
<span class="label">287.</span><cite>Clément T, Lee JB, Ichkova A, Rodriguez-Grande B, Fournier M-L, Aussudre J, et al. Juvenile mild traumatic brain injury elicits distinct spatiotemporal astrocyte responses. Glia. 2020;68:528–42.
</cite> [<a href="https://doi.org/10.1002/glia.23736" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31670865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cl%C3%A9ment%20T,%20Lee%20JB,%20Ichkova%20A,%20Rodriguez-Grande%20B,%20Fournier%20M-L,%20Aussudre%20J,%20et%20al.%20Juvenile%20mild%20traumatic%20brain%20injury%20elicits%20distinct%20spatiotemporal%20astrocyte%20responses.%20Glia.%202020;68:528%E2%80%9342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR288">
<span class="label">288.</span><cite>Mahmoud S, Gharagozloo M, Simard C, Gris D. Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release. Cells. 2019;8:184.
</cite> [<a href="https://doi.org/10.3390/cells8020184" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6406900/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30791579/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mahmoud%20S,%20Gharagozloo%20M,%20Simard%20C,%20Gris%20D.%20Astrocytes%20maintain%20glutamate%20homeostasis%20in%20the%20CNS%20by%20controlling%20the%20balance%20between%20glutamate%20uptake%20and%20release.%20Cells.%202019;8:184." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR289">
<span class="label">289.</span><cite>Bak LK, Schousboe A, Waagepetersen HS. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem. 2006;98:641–53.
</cite> [<a href="https://doi.org/10.1111/j.1471-4159.2006.03913.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16787421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bak%20LK,%20Schousboe%20A,%20Waagepetersen%20HS.%20The%20glutamate/GABA-glutamine%20cycle:%20aspects%20of%20transport,%20neurotransmitter%20homeostasis%20and%20ammonia%20transfer.%20J%20Neurochem.%202006;98:641%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR290">
<span class="label">290.</span><cite>Chung W-S, Allen NJ, Eroglu C. Astrocytes control synapse formation, function, and elimination. Cold Spring Harb Perspect Biol. 2015;7: a020370.
</cite> [<a href="https://doi.org/10.1101/cshperspect.a020370" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4527946/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25663667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chung%20W-S,%20Allen%20NJ,%20Eroglu%20C.%20Astrocytes%20control%20synapse%20formation,%20function,%20and%20elimination.%20Cold%20Spring%20Harb%20Perspect%20Biol.%202015;7:%20a020370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR291">
<span class="label">291.</span><cite>Lee J-H, Kim J, Noh S, Lee H, Lee SY, Mun JY, et al. Astrocytes phagocytose adult hippocampal synapses for circuit homeostasis. Nature. 2021;590:612–7.
</cite> [<a href="https://doi.org/10.1038/s41586-020-03060-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33361813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20J-H,%20Kim%20J,%20Noh%20S,%20Lee%20H,%20Lee%20SY,%20Mun%20JY,%20et%20al.%20Astrocytes%20phagocytose%20adult%20hippocampal%20synapses%20for%20circuit%20homeostasis.%20Nature.%202021;590:612%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR292">
<span class="label">292.</span><cite>Bazargani N, Attwell D. Astrocyte calcium signaling: the third wave. Nat Neurosci. 2016;19:182–9.
</cite> [<a href="https://doi.org/10.1038/nn.4201" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26814587/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bazargani%20N,%20Attwell%20D.%20Astrocyte%20calcium%20signaling:%20the%20third%20wave.%20Nat%20Neurosci.%202016;19:182%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR293">
<span class="label">293.</span><cite>Garwood CJ, Ratcliffe LE, Simpson JE, Heath PR, Ince PG, Wharton SB. Astrocytes in Alzheimer’s disease and other age-associated dementias: a supporting player with a central role. Neuropathol Appl Neurobiol. 2017;43:281–98.
</cite> [<a href="https://doi.org/10.1111/nan.12338" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27442752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Garwood%20CJ,%20Ratcliffe%20LE,%20Simpson%20JE,%20Heath%20PR,%20Ince%20PG,%20Wharton%20SB.%20Astrocytes%20in%20Alzheimer%E2%80%99s%20disease%20and%20other%20age-associated%20dementias:%20a%20supporting%20player%20with%20a%20central%20role.%20Neuropathol%20Appl%20Neurobiol.%202017;43:281%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR294">
<span class="label">294.</span><cite>Bushong EA, Martone ME, Jones YZ, Ellisman MH. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci. 2002;22:183–92.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.22-01-00183.2002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6757596/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11756501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bushong%20EA,%20Martone%20ME,%20Jones%20YZ,%20Ellisman%20MH.%20Protoplasmic%20astrocytes%20in%20CA1%20stratum%20radiatum%20occupy%20separate%20anatomical%20domains.%20J%20Neurosci.%202002;22:183%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR295">
<span class="label">295.</span><cite>Oberheim NA, Takano T, Han X, He W, Lin JHC, Wang F, et al. Uniquely hominid features of adult human astrocytes. J Neurosci. 2009;29:3276–87.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.4707-08.2009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2819812/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19279265/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oberheim%20NA,%20Takano%20T,%20Han%20X,%20He%20W,%20Lin%20JHC,%20Wang%20F,%20et%20al.%20Uniquely%20hominid%20features%20of%20adult%20human%20astrocytes.%20J%20Neurosci.%202009;29:3276%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR296">
<span class="label">296.</span><cite>Olabarria M, Noristani HN, Verkhratsky A, Rodríguez JJ. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer’s disease. Glia. 2010;58:831–8.
</cite> [<a href="https://doi.org/10.1002/glia.20967" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20140958/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Olabarria%20M,%20Noristani%20HN,%20Verkhratsky%20A,%20Rodr%C3%ADguez%20JJ.%20Concomitant%20astroglial%20atrophy%20and%20astrogliosis%20in%20a%20triple%20transgenic%20animal%20model%20of%20Alzheimer%E2%80%99s%20disease.%20Glia.%202010;58:831%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR297">
<span class="label">297.</span><cite>St-Pierre M-K, Carrier M, González Ibáñez F, Khakpour M, Wallman M-J, Parent M, et al. Astrocytes display ultrastructural alterations and heterogeneity in the hippocampus of aged APP-PS1 mice and human post-mortem brain samples. J Neuroinflammation. 2023;20: 73.
</cite> [<a href="https://doi.org/10.1186/s12974-023-02752-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10015698/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36918925/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?St-Pierre%20M-K,%20Carrier%20M,%20Gonz%C3%A1lez%20Ib%C3%A1%C3%B1ez%20F,%20Khakpour%20M,%20Wallman%20M-J,%20Parent%20M,%20et%20al.%20Astrocytes%20display%20ultrastructural%20alterations%20and%20heterogeneity%20in%20the%20hippocampus%20of%20aged%20APP-PS1%20mice%20and%20human%20post-mortem%20brain%20samples.%20J%20Neuroinflammation.%202023;20:%2073." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR298">
<span class="label">298.</span><cite>Morgan TE, Rozovsky I, Goldsmith SK, Stone DJ, Yoshida T, Finch CE. Increased transcription of the astrocyte gene GFAP during middle-age is attenuated by food restriction: implications for the role of oxidative stress. Free Radic Biol Med. 1997;23:524–8.
</cite> [<a href="https://doi.org/10.1016/s0891-5849(97)00120-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9214592/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Morgan%20TE,%20Rozovsky%20I,%20Goldsmith%20SK,%20Stone%20DJ,%20Yoshida%20T,%20Finch%20CE.%20Increased%20transcription%20of%20the%20astrocyte%20gene%20GFAP%20during%20middle-age%20is%20attenuated%20by%20food%20restriction:%20implications%20for%20the%20role%20of%20oxidative%20stress.%20Free%20Radic%20Biol%20Med.%201997;23:524%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR299">
<span class="label">299.</span><cite>Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481–7.
</cite> [<a href="https://doi.org/10.1038/nature21029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5404890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28099414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liddelow%20SA,%20Guttenplan%20KA,%20Clarke%20LE,%20Bennett%20FC,%20Bohlen%20CJ,%20Schirmer%20L,%20et%20al.%20Neurotoxic%20reactive%20astrocytes%20are%20induced%20by%20activated%20microglia.%20Nature.%202017;541:481%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR300">
<span class="label">300.</span><cite>Bandyopadhyay S, Hartley DM, Cahill CM, Lahiri DK, Chattopadhyay N, Rogers JT. Interleukin-1alpha stimulates non-amyloidogenic pathway by alpha-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase. J Neurosci Res. 2006;84:106–18.
</cite> [<a href="https://doi.org/10.1002/jnr.20864" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16724341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bandyopadhyay%20S,%20Hartley%20DM,%20Cahill%20CM,%20Lahiri%20DK,%20Chattopadhyay%20N,%20Rogers%20JT.%20Interleukin-1alpha%20stimulates%20non-amyloidogenic%20pathway%20by%20alpha-secretase%20(ADAM-10%20and%20ADAM-17)%20cleavage%20of%20APP%20in%20human%20astrocytic%20cells%20involving%20p38%20MAP%20kinase.%20J%20Neurosci%20Res.%202006;84:106%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR301">
<span class="label">301.</span><cite>Arranz AM, De Strooper B. The role of astroglia in Alzheimer’s disease: pathophysiology and clinical implications. Lancet Neurol. 2019;18:406–14.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(18)30490-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30795987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Arranz%20AM,%20De%20Strooper%20B.%20The%20role%20of%20astroglia%20in%20Alzheimer%E2%80%99s%20disease:%20pathophysiology%20and%20clinical%20implications.%20Lancet%20Neurol.%202019;18:406%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR302">
<span class="label">302.</span><cite>Liu C-C, Hu J, Zhao N, Wang J, Wang N, Cirrito JR, et al. Astrocytic LRP1 mediates brain Aβ clearance and impacts amyloid deposition. J Neurosci. 2017;37:4023–31.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.3442-16.2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5391682/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28275161/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20C-C,%20Hu%20J,%20Zhao%20N,%20Wang%20J,%20Wang%20N,%20Cirrito%20JR,%20et%20al.%20Astrocytic%20LRP1%20mediates%20brain%20A%CE%B2%20clearance%20and%20impacts%20amyloid%20deposition.%20J%20Neurosci.%202017;37:4023%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR303">
<span class="label">303.</span><cite>Auderset L, Cullen CL, Young KM. Low density lipoprotein-receptor related protein 1 is differentially expressed by neuronal and glial populations in the developing and mature mouse central nervous system. PLoS One. 2016;11: e0155878.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0155878" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4900551/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27280679/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Auderset%20L,%20Cullen%20CL,%20Young%20KM.%20Low%20density%20lipoprotein-receptor%20related%20protein%201%20is%20differentially%20expressed%20by%20neuronal%20and%20glial%20populations%20in%20the%20developing%20and%20mature%20mouse%20central%20nervous%20system.%20PLoS%20One.%202016;11:%20e0155878." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR304">
<span class="label">304.</span><cite>Singh I, Sagare AP, Coma M, Perlmutter D, Gelein R, Bell RD, et al. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. Proc Natl Acad Sci U S A. 2013;110:14771–6.
</cite> [<a href="https://doi.org/10.1073/pnas.1302212110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3767519/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23959870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Singh%20I,%20Sagare%20AP,%20Coma%20M,%20Perlmutter%20D,%20Gelein%20R,%20Bell%20RD,%20et%20al.%20Low%20levels%20of%20copper%20disrupt%20brain%20amyloid-%CE%B2%20homeostasis%20by%20altering%20its%20production%20and%20clearance.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202013;110:14771%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR305">
<span class="label">305.</span><cite>Lian H, Yang L, Cole A, Sun L, Chiang AC-A, Fowler SW, et al. NFκb-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer’s disease. Neuron. 2015;85:101–15.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2014.11.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4289109/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25533482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lian%20H,%20Yang%20L,%20Cole%20A,%20Sun%20L,%20Chiang%20AC-A,%20Fowler%20SW,%20et%20al.%20NF%CE%BAb-activated%20astroglial%20release%20of%20complement%20C3%20compromises%20neuronal%20morphology%20and%20function%20associated%20with%20Alzheimer%E2%80%99s%20disease.%20Neuron.%202015;85:101%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR306">
<span class="label">306.</span><cite>Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, et al. Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A. 1992;89:10016–20.
</cite> [<a href="https://doi.org/10.1073/pnas.89.21.10016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC50268/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1438191/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rogers%20J,%20Cooper%20NR,%20Webster%20S,%20Schultz%20J,%20McGeer%20PL,%20Styren%20SD,%20et%20al.%20Complement%20activation%20by%20beta-amyloid%20in%20Alzheimer%20disease.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%201992;89:10016%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR307">
<span class="label">307.</span><cite>Steele ML, Robinson SR. Reactive astrocytes give neurons less support: implications for Alzheimer’s disease. Neurobiol Aging. 2012;33:423.e1-423.e13.
</cite> [<a href="https://doi.org/10.1016/j.neurobiolaging.2010.09.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21051108/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Steele%20ML,%20Robinson%20SR.%20Reactive%20astrocytes%20give%20neurons%20less%20support:%20implications%20for%20Alzheimer%E2%80%99s%20disease.%20Neurobiol%20Aging.%202012;33:423.e1-423.e13." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR308">
<span class="label">308.</span><cite>Scheiber IF, Dringen R. Astrocyte functions in the copper homeostasis of the brain. Neurochem Int. 2013;62:556–65.
</cite> [<a href="https://doi.org/10.1016/j.neuint.2012.08.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22982300/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Scheiber%20IF,%20Dringen%20R.%20Astrocyte%20functions%20in%20the%20copper%20homeostasis%20of%20the%20brain.%20Neurochem%20Int.%202013;62:556%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR309">
<span class="label">309.</span><cite>Rocchi A, Valensin D, Aldinucci C, Giani G, Barbucci R, Gaggelli E, et al. NMR metabolomic investigation of astrocytes interacted with Aβ42 or its complexes with either copper(II) or zinc(II). J Inorg Biochem. 2012;117:326–33.
</cite> [<a href="https://doi.org/10.1016/j.jinorgbio.2012.08.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23062696/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rocchi%20A,%20Valensin%20D,%20Aldinucci%20C,%20Giani%20G,%20Barbucci%20R,%20Gaggelli%20E,%20et%20al.%20NMR%20metabolomic%20investigation%20of%20astrocytes%20interacted%20with%20A%CE%B242%20or%20its%20complexes%20with%20either%20copper(II)%20or%20zinc(II).%20J%20Inorg%20Biochem.%202012;117:326%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR310">
<span class="label">310.</span><cite>Xie H, Kang YJ. Role of copper in angiogenesis and its medicinal implications. Curr Med Chem. 2009;16:1304–14.
</cite> [<a href="https://doi.org/10.2174/092986709787846622" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19355887/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xie%20H,%20Kang%20YJ.%20Role%20of%20copper%20in%20angiogenesis%20and%20its%20medicinal%20implications.%20Curr%20Med%20Chem.%202009;16:1304%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR311">
<span class="label">311.</span><cite>Huang Y, Hickey RP, Yeh JL, Liu D, Dadak A, Young LH, et al. Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J. 2004;18:1138–40.</cite> [<a href="https://doi.org/10.1096/fj.04-1510fje" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15132980/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20Y,%20Hickey%20RP,%20Yeh%20JL,%20Liu%20D,%20Dadak%20A,%20Young%20LH,%20et%20al.%20Cardiac%20myocyte-specific%20HIF-1alpha%20deletion%20alters%20vascularization,%20energy%20availability,%20calcium%20flux,%20and%20contractility%20in%20the%20normoxic%20heart.%20FASEB%20J.%202004;18:1138%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR312">
<span class="label">312.</span><cite>Haskew-Layton RE, Payappilly JB, Smirnova NA, Ma TC, Chan KK, Murphy TH, et al. Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway. Proc Natl Acad Sci U S A. 2010;107:17385–90.
</cite> [<a href="https://doi.org/10.1073/pnas.1003996107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2951414/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20855618/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Haskew-Layton%20RE,%20Payappilly%20JB,%20Smirnova%20NA,%20Ma%20TC,%20Chan%20KK,%20Murphy%20TH,%20et%20al.%20Controlled%20enzymatic%20production%20of%20astrocytic%20hydrogen%20peroxide%20protects%20neurons%20from%20oxidative%20stress%20via%20an%20Nrf2-independent%20pathway.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202010;107:17385%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR313">
<span class="label">313.</span><cite>Adlard PA, Bush AI. Metals and Alzheimer’s disease: how far have we come in the clinic? J Alzheimers Dis. 2018;62:1369–79.
</cite> [<a href="https://doi.org/10.3233/JAD-170662" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5870044/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29562528/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Adlard%20PA,%20Bush%20AI.%20Metals%20and%20Alzheimer%E2%80%99s%20disease:%20how%20far%20have%20we%20come%20in%20the%20clinic?%20J%20Alzheimers%20Dis.%202018;62:1369%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR314">
<span class="label">314.</span><cite>Kessler H, Bayer TA, Bach D, Schneider-Axmann T, Supprian T, Herrmann W, et al. Intake of copper has no effect on cognition in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial. J Neural Transm Vienna Austria. 1996;2008(115):1181–7.</cite> [<a href="https://doi.org/10.1007/s00702-008-0080-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2516533/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18587525/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kessler%20H,%20Bayer%20TA,%20Bach%20D,%20Schneider-Axmann%20T,%20Supprian%20T,%20Herrmann%20W,%20et%20al.%20Intake%20of%20copper%20has%20no%20effect%20on%20cognition%20in%20patients%20with%20mild%20Alzheimer%E2%80%99s%20disease:%20a%20pilot%20phase%202%20clinical%20trial.%20J%20Neural%20Transm%20Vienna%20Austria.%201996;2008(115):1181%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR315">
<span class="label">315.</span><cite>Squitti R, Rossini PM, Cassetta E, Moffa F, Pasqualetti P, Cortesi M, et al. D-penicillamine reduces serum oxidative stress in Alzheimer’s disease patients. Eur J Clin Invest. 2002;32:51–9.
</cite> [<a href="https://doi.org/10.1046/j.1365-2362.2002.00933.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11851727/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Squitti%20R,%20Rossini%20PM,%20Cassetta%20E,%20Moffa%20F,%20Pasqualetti%20P,%20Cortesi%20M,%20et%20al.%20D-penicillamine%20reduces%20serum%20oxidative%20stress%20in%20Alzheimer%E2%80%99s%20disease%20patients.%20Eur%20J%20Clin%20Invest.%202002;32:51%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR316">
<span class="label">316.</span><cite>Serra B, Primo J, García M, Amorós I, Aragó M. Merino C. Wilson’s disease with severe neurological manifestations: response to trientine plus zinc therapy. Gastroenterol Hepatol. 2004;27:307–10.
</cite> [<a href="https://doi.org/10.1016/s0210-5705(03)70465-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15117609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Serra%20B,%20Primo%20J,%20Garc%C3%ADa%20M,%20Amor%C3%B3s%20I,%20Arag%C3%B3%20M.%20Merino%20C.%20Wilson%E2%80%99s%20disease%20with%20severe%20neurological%20manifestations:%20response%20to%20trientine%20plus%20zinc%20therapy.%20Gastroenterol%20Hepatol.%202004;27:307%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR317">
<span class="label">317.</span><cite>McLachlan DRC, Kruck TPA, Kalow W, Andrews DF, Dalton AJ, Bell MY, et al. Intramuscular desferrioxamine in patients with Alzheimer’s disease. The Lancet. 1991;337:1304–8.</cite> [<a href="https://doi.org/10.1016/0140-6736(91)92978-b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1674295/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McLachlan%20DRC,%20Kruck%20TPA,%20Kalow%20W,%20Andrews%20DF,%20Dalton%20AJ,%20Bell%20MY,%20et%20al.%20Intramuscular%20desferrioxamine%20in%20patients%20with%20Alzheimer%E2%80%99s%20disease.%20The%20Lancet.%201991;337:1304%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR318">
<span class="label">318.</span><cite>Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, et al. Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer’s disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2008;7(9):779–86.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(08)70167-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18672400/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lannfelt%20L,%20Blennow%20K,%20Zetterberg%20H,%20Batsman%20S,%20Ames%20D,%20Harrison%20J,%20et%20al.%20Safety,%20efficacy,%20and%20biomarker%20findings%20of%20PBT2%20in%20targeting%20A%CE%B2%20as%20a%20modifying%20therapy%20for%20Alzheimer%E2%80%99s%20disease:%20a%20phase%20IIa,%20double-blind,%20randomised,%20placebo-controlled%20trial.%20Lancet%20Neurol.%202008;7(9):779%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR319">
<span class="label">319.</span><cite>Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol. 2003;60:1685–91.
</cite> [<a href="https://doi.org/10.1001/archneur.60.12.1685" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14676042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ritchie%20CW,%20Bush%20AI,%20Mackinnon%20A,%20Macfarlane%20S,%20Mastwyk%20M,%20MacGregor%20L,%20et%20al.%20Metal-protein%20attenuation%20with%20iodochlorhydroxyquin%20(clioquinol)%20targeting%20Abeta%20amyloid%20deposition%20and%20toxicity%20in%20Alzheimer%20disease:%20a%20pilot%20phase%202%20clinical%20trial.%20Arch%20Neurol.%202003;60:1685%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR320">
<span class="label">320.</span><cite>Villemagne VL, Rowe CC, Barnham KJ, Cherny R, Woodward M, Bozinosvski S, et al. A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer’s disease: the PBT2-204 IMAGINE study. Alzheimers Dement. 2017;3:622–35.</cite> [<a href="https://doi.org/10.1016/j.trci.2017.10.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5702880/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29201996/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Villemagne%20VL,%20Rowe%20CC,%20Barnham%20KJ,%20Cherny%20R,%20Woodward%20M,%20Bozinosvski%20S,%20et%20al.%20A%20randomized,%20exploratory%20molecular%20imaging%20study%20targeting%20amyloid%20%CE%B2%20with%20a%20novel%208-OH%20quinoline%20in%20Alzheimer%E2%80%99s%20disease:%20the%20PBT2-204%20IMAGINE%20study.%20Alzheimers%20Dement.%202017;3:622%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR321">
<span class="label">321.</span><cite>Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254–61.
</cite> [<a href="https://doi.org/10.1126/science.abf0529" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9273333/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35298263/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsvetkov%20P,%20Coy%20S,%20Petrova%20B,%20Dreishpoon%20M,%20Verma%20A,%20Abdusamad%20M,%20et%20al.%20Copper%20induces%20cell%20death%20by%20targeting%20lipoylated%20TCA%20cycle%20proteins.%20Science.%202022;375:1254%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR322">
<span class="label">322.</span><cite>Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer’s disease transgenic mice. Neuron. 2001;30:665–76.
</cite> [<a href="https://doi.org/10.1016/s0896-6273(01)00317-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11430801/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cherny%20RA,%20Atwood%20CS,%20Xilinas%20ME,%20Gray%20DN,%20Jones%20WD,%20McLean%20CA,%20et%20al.%20Treatment%20with%20a%20copper-zinc%20chelator%20markedly%20and%20rapidly%20inhibits%20%CE%B2-amyloid%20accumulation%20in%20Alzheimer%E2%80%99s%20disease%20transgenic%20mice.%20Neuron.%202001;30:665%E2%80%9376." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR323">
<span class="label">323.</span><cite>White AR, Du T, Laughton KM, Volitakis I, Sharples RA, Xilinas ME, et al. Degradation of the Alzheimer disease amyloid β-peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem. 2006;281:17670–80.
</cite> [<a href="https://doi.org/10.1074/jbc.M602487200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16648635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?White%20AR,%20Du%20T,%20Laughton%20KM,%20Volitakis%20I,%20Sharples%20RA,%20Xilinas%20ME,%20et%20al.%20Degradation%20of%20the%20Alzheimer%20disease%20amyloid%20%CE%B2-peptide%20by%20metal-dependent%20up-regulation%20of%20metalloprotease%20activity.%20J%20Biol%20Chem.%202006;281:17670%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR324">
<span class="label">324.</span><cite>Embi N, Rylatt DB, Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Eur J Biochem. 1980;107:519–27.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/6249596/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Embi%20N,%20Rylatt%20DB,%20Cohen%20P.%20Glycogen%20synthase%20kinase-3%20from%20rabbit%20skeletal%20muscle.%20Eur%20J%20Biochem.%201980;107:519%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR325">
<span class="label">325.</span><cite>Bhat RV, Shanley J, Correll MP, Fieles WE, Keith RA, Scott CW, et al. Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci U S A. 2000;97:11074–9.
</cite> [<a href="https://doi.org/10.1073/pnas.190297597" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC27150/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10995469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bhat%20RV,%20Shanley%20J,%20Correll%20MP,%20Fieles%20WE,%20Keith%20RA,%20Scott%20CW,%20et%20al.%20Regulation%20and%20localization%20of%20tyrosine216%20phosphorylation%20of%20glycogen%20synthase%20kinase-3beta%20in%20cellular%20and%20animal%20models%20of%20neuronal%20degeneration.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202000;97:11074%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR326">
<span class="label">326.</span><cite>Cohen P, Alessi DR, Cross DA. PDK1, one of the missing links in insulin signal transduction? FEBS Lett. 1997;410:3–10.
</cite> [<a href="https://doi.org/10.1016/s0014-5793(97)00490-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9247112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cohen%20P,%20Alessi%20DR,%20Cross%20DA.%20PDK1,%20one%20of%20the%20missing%20links%20in%20insulin%20signal%20transduction?%20FEBS%20Lett.%201997;410:3%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR327">
<span class="label">327.</span><cite>Tsujio I, Tanaka T, Kudo T, Nishikawa T, Shinozaki K, Grundke-Iqbal I, et al. Inactivation of glycogen synthase kinase-3 by protein kinase C δ: implications for regulation of τ phosphorylation. FEBS Lett. 2000;469:111–7.
</cite> [<a href="https://doi.org/10.1016/s0014-5793(00)01234-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10708767/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsujio%20I,%20Tanaka%20T,%20Kudo%20T,%20Nishikawa%20T,%20Shinozaki%20K,%20Grundke-Iqbal%20I,%20et%20al.%20Inactivation%20of%20glycogen%20synthase%20kinase-3%20by%20protein%20kinase%20C%20%CE%B4:%20implications%20for%20regulation%20of%20%CF%84%20phosphorylation.%20FEBS%20Lett.%202000;469:111%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR328">
<span class="label">328.</span><cite>Cross DAE, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS, Cohen P. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J. 1994;303:21–6.
</cite> [<a href="https://doi.org/10.1042/bj3030021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1137550/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7945242/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cross%20DAE,%20Alessi%20DR,%20Vandenheede%20JR,%20McDowell%20HE,%20Hundal%20HS,%20Cohen%20P.%20The%20inhibition%20of%20glycogen%20synthase%20kinase-3%20by%20insulin%20or%20insulin-like%20growth%20factor%201%20in%20the%20rat%20skeletal%20muscle%20cell%20line%20L6%20is%20blocked%20by%20wortmannin,%20but%20not%20by%20rapamycin:%20evidence%20that%20wortmannin%20blocks%20activation%20of%20the%20mitogen-activated%20protein%20kinase%20pathway%20in%20L6%20cells%20between%20Ras%20and%20Raf.%20Biochem%20J.%201994;303:21%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR329">
<span class="label">329.</span><cite>Lauretti E, Dincer O, Praticò D. Glycogen synthase kinase-3 signaling in Alzheimer’s disease. Biochim Biophys Acta. 2020;1867: 118664.</cite> [<a href="https://doi.org/10.1016/j.bbamcr.2020.118664" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7047718/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32006534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lauretti%20E,%20Dincer%20O,%20Pratic%C3%B2%20D.%20Glycogen%20synthase%20kinase-3%20signaling%20in%20Alzheimer%E2%80%99s%20disease.%20Biochim%20Biophys%20Acta.%202020;1867:%20118664." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR330">
<span class="label">330.</span><cite>Jain AK, Jaiswal AK. GSK-3β acts upstream of fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem. 2007;282:16502–10.
</cite> [<a href="https://doi.org/10.1074/jbc.M611336200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17403689/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jain%20AK,%20Jaiswal%20AK.%20GSK-3%CE%B2%20acts%20upstream%20of%20fyn%20kinase%20in%20regulation%20of%20nuclear%20export%20and%20degradation%20of%20NF-E2%20related%20factor%202.%20J%20Biol%20Chem.%202007;282:16502%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR331">
<span class="label">331.</span><cite>Shirazi SK, Wood JG. The protein tyrosine kinase, fyn, in Alzheimer’s disease pathology. NeuroReport. 1993;4:435–7.
</cite> [<a href="https://doi.org/10.1097/00001756-199304000-00024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8388744/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shirazi%20SK,%20Wood%20JG.%20The%20protein%20tyrosine%20kinase,%20fyn,%20in%20Alzheimer%E2%80%99s%20disease%20pathology.%20NeuroReport.%201993;4:435%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR332">
<span class="label">332.</span><cite>Lee G, Thangavel R, Sharma VM, Litersky JM, Bhaskar K, Fang SM, et al. Phosphorylation of tau by fyn: implications for Alzheimer’s disease. J Neurosci. 2004;24:2304–12.</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.4162-03.2004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6730442/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14999081/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20G,%20Thangavel%20R,%20Sharma%20VM,%20Litersky%20JM,%20Bhaskar%20K,%20Fang%20SM,%20et%20al.%20Phosphorylation%20of%20tau%20by%20fyn:%20implications%20for%20Alzheimer%E2%80%99s%20disease.%20J%20Neurosci.%202004;24:2304%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR333">
<span class="label">333.</span><cite>Suzuki T, Okumura-Noji K. NMDA receptor subunits epsilon 1 (NR2A) and epsilon 2 (NR2B) are substrates for Fyn in the postsynaptic density fraction isolated from the rat brain. Biochem Biophys Res Commun. 1995;216:582–8.
</cite> [<a href="https://doi.org/10.1006/bbrc.1995.2662" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7488151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Suzuki%20T,%20Okumura-Noji%20K.%20NMDA%20receptor%20subunits%20epsilon%201%20(NR2A)%20and%20epsilon%202%20(NR2B)%20are%20substrates%20for%20Fyn%20in%20the%20postsynaptic%20density%20fraction%20isolated%20from%20the%20rat%20brain.%20Biochem%20Biophys%20Res%20Commun.%201995;216:582%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR334">
<span class="label">334.</span><cite>Kim D-K, Song J-W, Park J-D, Choi B-S. Copper induces the accumulation of amyloid-beta in the brain. Mol Cell Toxicol. 2013;9:57–66.</cite> [<a href="https://scholar.google.com/scholar_lookup?Kim%20D-K,%20Song%20J-W,%20Park%20J-D,%20Choi%20B-S.%20Copper%20induces%20the%20accumulation%20of%20amyloid-beta%20in%20the%20brain.%20Mol%20Cell%20Toxicol.%202013;9:57%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR335">
<span class="label">335.</span><cite>Rueda-Carrasco J, Sokolova D, Lee S, Childs T, Jurčáková N, Crowley G, et al. Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer’s disease models. EMBO J. 2023;42: e113246.
</cite> [<a href="https://doi.org/10.15252/embj.2022113246" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10548173/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37575021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rueda-Carrasco%20J,%20Sokolova%20D,%20Lee%20S,%20Childs%20T,%20Jur%C4%8D%C3%A1kov%C3%A1%20N,%20Crowley%20G,%20et%20al.%20Microglia-synapse%20engulfment%20via%20PtdSer-TREM2%20ameliorates%20neuronal%20hyperactivity%20in%20Alzheimer%E2%80%99s%20disease%20models.%20EMBO%20J.%202023;42:%20e113246." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR336">
<span class="label">336.</span><cite>Targa Dias Anastacio H, Matosin N, Ooi L. Neuronal hyperexcitability in Alzheimer’s disease: what are the drivers behind this aberrant phenotype? Transl Psychiatry. 2022;12:1–14.
</cite> [<a href="https://doi.org/10.1038/s41398-022-02024-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9217953/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35732622/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Targa%20Dias%20Anastacio%20H,%20Matosin%20N,%20Ooi%20L.%20Neuronal%20hyperexcitability%20in%20Alzheimer%E2%80%99s%20disease:%20what%20are%20the%20drivers%20behind%20this%20aberrant%20phenotype?%20Transl%20Psychiatry.%202022;12:1%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR337">
<span class="label">337.</span><cite>Zhao J, Shi Q, Tian H, Li Y, Liu Y, Xu Z, et al. TDMQ20, a specific copper chelator, reduces memory impairments in Alzheimer’s disease mouse models. ACS Chem Neurosci. 2021;12:140–9.
</cite> [<a href="https://doi.org/10.1021/acschemneuro.0c00621" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33322892/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20J,%20Shi%20Q,%20Tian%20H,%20Li%20Y,%20Liu%20Y,%20Xu%20Z,%20et%20al.%20TDMQ20,%20a%20specific%20copper%20chelator,%20reduces%20memory%20impairments%20in%20Alzheimer%E2%80%99s%20disease%20mouse%20models.%20ACS%20Chem%20Neurosci.%202021;12:140%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR338">
<span class="label">338.</span><cite>Guthrie LM, Soma S, Yuan S, Silva A, Zulkifli M, Snavely TC, et al. Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice. Science. 2020;368:620–5.
</cite> [<a href="https://doi.org/10.1126/science.aaz8899" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7304446/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32381719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guthrie%20LM,%20Soma%20S,%20Yuan%20S,%20Silva%20A,%20Zulkifli%20M,%20Snavely%20TC,%20et%20al.%20Elesclomol%20alleviates%20Menkes%20pathology%20and%20mortality%20by%20escorting%20Cu%20to%20cuproenzymes%20in%20mice.%20Science.%202020;368:620%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR339">
<span class="label">339.</span><cite>Jenagaratnam L, McShane R. Clioquinol for the treatment of Alzheimer’s Disease. Cochrane Database Syst Rev. 2006:(1):CD005380.</cite> [<a href="https://doi.org/10.1002/14651858.CD005380.pub2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16437529/" class="usa-link">PubMed</a>]</li>
<li id="CR340">
<span class="label">340.</span><cite>Donnelly PS, Caragounis A, Du T, Laughton KM, Volitakis I, Cherny RA, et al. Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-β peptide. J Biol Chem. 2008;283:4568–77.
</cite> [<a href="https://doi.org/10.1074/jbc.M705957200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18086681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Donnelly%20PS,%20Caragounis%20A,%20Du%20T,%20Laughton%20KM,%20Volitakis%20I,%20Cherny%20RA,%20et%20al.%20Selective%20intracellular%20release%20of%20copper%20and%20zinc%20ions%20from%20bis(thiosemicarbazonato)%20complexes%20reduces%20levels%20of%20Alzheimer%20disease%20amyloid-%CE%B2%20peptide.%20J%20Biol%20Chem.%202008;283:4568%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR341">
<span class="label">341.</span><cite>Okafor M, Gonzalez P, Ronot P, Masoudi IE, Boos A, Ory S, et al. Development of Cu(II)-specific peptide shuttles capable of preventing Cu–amyloid beta toxicity and importing bioavailable Cu into cells. Chem Sci. 2022;13:11829–40.
</cite> [<a href="https://doi.org/10.1039/d2sc02593k" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9580518/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36320914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Okafor%20M,%20Gonzalez%20P,%20Ronot%20P,%20Masoudi%20IE,%20Boos%20A,%20Ory%20S,%20et%20al.%20Development%20of%20Cu(II)-specific%20peptide%20shuttles%20capable%20of%20preventing%20Cu%E2%80%93amyloid%20beta%20toxicity%20and%20importing%20bioavailable%20Cu%20into%20cells.%20Chem%20Sci.%202022;13:11829%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR342">
<span class="label">342.</span><cite>Li Y, Nguyen M, Vendier L, Robert A, Liu Y, Meunier B. X-Ray diffraction structure of Cu(II) and Zn(II) complexes of 8-aminoquinoline derivatives (TDMQ), related to the activity of these chelators as potential drugs against Alzheimer’s disease. J Mol Struct. 2022;1251: 132078.</cite> [<a href="https://scholar.google.com/scholar_lookup?Li%20Y,%20Nguyen%20M,%20Vendier%20L,%20Robert%20A,%20Liu%20Y,%20Meunier%20B.%20X-Ray%20diffraction%20structure%20of%20Cu(II)%20and%20Zn(II)%20complexes%20of%208-aminoquinoline%20derivatives%20(TDMQ),%20related%20to%20the%20activity%20of%20these%20chelators%20as%20potential%20drugs%20against%20Alzheimer%E2%80%99s%20disease.%20J%20Mol%20Struct.%202022;1251:%20132078." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR343">
<span class="label">343.</span><cite>Zhang W, Liu Y, Hureau C, Robert A, Meunier B. N4 -tetradentate chelators efficiently regulate copper homeostasis and prevent ROS production induced by copper-amyloid-β1-16. Chem Weinh Bergstr Ger. 2018;24:7825–9.</cite> [<a href="https://doi.org/10.1002/chem.201801387" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6120676/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29687932/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20W,%20Liu%20Y,%20Hureau%20C,%20Robert%20A,%20Meunier%20B.%20N4%20-tetradentate%20chelators%20efficiently%20regulate%20copper%20homeostasis%20and%20prevent%20ROS%20production%20induced%20by%20copper-amyloid-%CE%B21-16.%20Chem%20Weinh%20Bergstr%20Ger.%202018;24:7825%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR344">
<span class="label">344.</span><cite>Okafor M, Schmitt D, Gasman S, Raibaut L, Hureau C, Faller P, et al. Next-generation Cu(II) selective peptide shuttles prevent Cu(Aβ)-induced toxicity and microglial activation in organotypic hippocampal slices. bioRxiv; 2024. p. 2024.09.04.611242.</cite>
</li>
<li id="CR345">
<span class="label">345.</span><cite>López-Guerrero VE, Posadas Y, Sánchez-López C, Smart A, Miranda J, Singewald K, et al. A copper-binding peptide with therapeutic potential against Alzheimer’s Disease: from the blood-brain barrier to metal competition. ACS Chem Neurosci. 2025;16(2):241–61.
</cite> [<a href="https://doi.org/10.1021/acschemneuro.4c00796" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11741003/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39723808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?L%C3%B3pez-Guerrero%20VE,%20Posadas%20Y,%20S%C3%A1nchez-L%C3%B3pez%20C,%20Smart%20A,%20Miranda%20J,%20Singewald%20K,%20et%20al.%20A%20copper-binding%20peptide%20with%20therapeutic%20potential%20against%20Alzheimer%E2%80%99s%20Disease:%20from%20the%20blood-brain%20barrier%20to%20metal%20competition.%20ACS%20Chem%20Neurosci.%202025;16(2):241%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Not applicable.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Translational Neurodegeneration are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s40035-025-00504-6"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/40035_2025_Article_504.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.8 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372260/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372260/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372260%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372260/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372260/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372260/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40847318/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372260/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40847318/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372260/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372260/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="tveyF4anvBPhe9lT47kDZIxhvtWAd3p6AzEaXIAjcJvVXJHoWaWPC027q6gVL1KN">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
